{
  "pmcid": "PMC12675485",
  "source": "PMC",
  "download_date": "2025-12-09T16:37:22.083958",
  "metadata": {
    "journal_title": "Frontiers in Public Health",
    "journal_nlm_ta": "Front Public Health",
    "journal_iso_abbrev": "Front Public Health",
    "journal": "Frontiers in Public Health",
    "pmcid": "PMC12675485",
    "pmid": "41358250",
    "doi": "10.3389/fpubh.2025.1689911",
    "title": "Artificial intelligence in chronic disease self-management: current applications and future directions",
    "authors": [
      "Du Ying",
      "Yang Peng",
      "Liu Yuntao",
      "Deng Chunxia",
      "Li Xin"
    ],
    "abstract": "Objective This study aims to summarize current applications of artificial intelligence (AI) for chronic disease self-management, critically appraise their effectiveness, and identify implementation challenges and future directions for research and clinical integration. Methods A narrative literature review of peer-reviewed, English-language studies identified via PubMed, Web of Science, and Scopus was conducted, using combinations of “artificial intelligence,” “chronic disease,” “self-management,” “remote monitoring,” “predictive analytics,” “conversational agent,” and “mobile health.” Reference lists of key reviews were snowballed. We included studies that described or evaluated AI-enabled self-management tools or interventions for chronic conditions and excluded non-AI, acute-care, editorial, and non-human studies. Findings were synthesized thematically. Results The literature consistently identifies four roles of AI in chronic care: (1) personalized decision support and treatment optimization; (2) continuous monitoring and risk prediction from patient-generated data; (3) conversational agents delivering education, adherence support, reminders, behavioral coaching, and mental-health support; and (4) AI-enabled Mobile health (mHealth) platforms that connect patients with clinicians and coordinate care. Recurrent challenges reported include data privacy and security risks, algorithmic bias and limited generalizability, interoperability and workflow-integration barriers, variable usability and sustained engagement (digital divide- inequalities in access to digital technologies and the internet, often influenced by age, income, or geography), and insufficient high-quality evidence on clinical effectiveness and cost-effectiveness. Conclusion Future directions focus on developing more accurate, explainable, and trustworthy AI models, better clinical integration, leveraging advanced AI for engagement, rigorous evaluation, and addressing ethical and implementation barriers to realize AI’s full potential in empowering patients and improving chronic disease outcomes.",
    "keywords": [
      "artificial intelligence",
      "chronic disease self-management",
      "personalized interventions",
      "predictive analytics",
      "digital health platforms"
    ]
  },
  "xml": "<?xml version=\"1.0\"  ?><!DOCTYPE pmc-articleset PUBLIC \"-//NLM//DTD ARTICLE SET 2.0//EN\" \"https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd\"><pmc-articleset><article xmlns:mml=\"http://www.w3.org/1998/Math/MathML\" xmlns:ali=\"http://www.niso.org/schemas/ali/1.0/\" xml:lang=\"en\" article-type=\"review-article\" dtd-version=\"1.4\"><processing-meta base-tagset=\"archiving\" mathml-version=\"3.0\" table-model=\"xhtml\" tagset-family=\"jats\"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type=\"nlm-ta\">Front Public Health</journal-id><journal-id journal-id-type=\"iso-abbrev\">Front Public Health</journal-id><journal-id journal-id-type=\"pmc-domain-id\">2277</journal-id><journal-id journal-id-type=\"pmc-domain\">frontpubhealth</journal-id><journal-id journal-id-type=\"publisher-id\">Front. Public Health</journal-id><journal-title-group><journal-title>Frontiers in Public Health</journal-title></journal-title-group><issn pub-type=\"epub\">2296-2565</issn><publisher><publisher-name>Frontiers Media SA</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type=\"pmcid\">PMC12675485</article-id><article-id pub-id-type=\"pmcid-ver\">PMC12675485.1</article-id><article-id pub-id-type=\"pmcaid\">12675485</article-id><article-id pub-id-type=\"pmcaiid\">12675485</article-id><article-id pub-id-type=\"pmid\">41358250</article-id><article-id pub-id-type=\"doi\">10.3389/fpubh.2025.1689911</article-id><article-version-alternatives><article-version article-version-type=\"pmc-version\">1</article-version><article-version article-version-type=\"Version of Record\" vocab=\"NISO-RP-8-2008\"/></article-version-alternatives><article-categories><subj-group subj-group-type=\"heading\"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Artificial intelligence in chronic disease self-management: current applications and future directions</article-title></title-group><contrib-group><contrib contrib-type=\"author\" corresp=\"yes\"><name name-style=\"western\"><surname>Du</surname><given-names initials=\"Y\">Ying</given-names></name><xref rid=\"aff1\" ref-type=\"aff\">\n<sup>1</sup>\n</xref><xref rid=\"c001\" ref-type=\"corresp\">\n<sup>*</sup>\n</xref><uri xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"https://loop.frontiersin.org/people/3178356\"/><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"methodology\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/methodology/\">Methodology</role><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"Project administration\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/project-administration/\">Project administration</role><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"resources\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/resources/\">Resources</role><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"Writing &#x2013; original draft\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/writing-original-draft/\">Writing &#8211; original draft</role><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"Writing &#x2013; review &amp; editing\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/writing-review-editing/\">Writing &#8211; review &amp; editing</role></contrib><contrib contrib-type=\"author\"><name name-style=\"western\"><surname>Yang</surname><given-names initials=\"P\">Peng</given-names></name><xref rid=\"aff2\" ref-type=\"aff\">\n<sup>2</sup>\n</xref><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"conceptualization\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/conceptualization/\">Conceptualization</role><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"Data curation\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/data-curation/\">Data curation</role><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"Formal analysis\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/formal-analysis/\">Formal analysis</role><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"Writing &#x2013; original draft\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/writing-original-draft/\">Writing &#8211; original draft</role><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"Writing &#x2013; review &amp; editing\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/writing-review-editing/\">Writing &#8211; review &amp; editing</role></contrib><contrib contrib-type=\"author\"><name name-style=\"western\"><surname>Liu</surname><given-names initials=\"Y\">Yuntao</given-names></name><xref rid=\"aff3\" ref-type=\"aff\">\n<sup>3</sup>\n</xref><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"Data curation\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/data-curation/\">Data curation</role><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"investigation\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/investigation/\">Investigation</role><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"methodology\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/methodology/\">Methodology</role><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"Writing &#x2013; review &amp; editing\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/writing-review-editing/\">Writing &#8211; review &amp; editing</role></contrib><contrib contrib-type=\"author\"><name name-style=\"western\"><surname>Deng</surname><given-names initials=\"C\">Chunxia</given-names></name><xref rid=\"aff4\" ref-type=\"aff\">\n<sup>4</sup>\n</xref><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"Data curation\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/data-curation/\">Data curation</role><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"Formal analysis\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/formal-analysis/\">Formal analysis</role><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"software\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/software/\">Software</role><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"visualization\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/visualization/\">Visualization</role><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"Writing &#x2013; review &amp; editing\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/writing-review-editing/\">Writing &#8211; review &amp; editing</role></contrib><contrib contrib-type=\"author\"><name name-style=\"western\"><surname>Li</surname><given-names initials=\"X\">Xin</given-names></name><xref rid=\"aff5\" ref-type=\"aff\">\n<sup>5</sup>\n</xref><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"Data curation\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/data-curation/\">Data curation</role><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"investigation\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/investigation/\">Investigation</role><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"software\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/software/\">Software</role><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"supervision\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/supervision/\">Supervision</role><role vocab=\"credit\" vocab-identifier=\"https://credit.niso.org/\" vocab-term=\"Writing &#x2013; review &amp; editing\" vocab-term-identifier=\"https://credit.niso.org/contributor-roles/writing-review-editing/\">Writing &#8211; review &amp; editing</role></contrib></contrib-group><aff id=\"aff1\"><label>1</label><institution>Department of Health Management, Affiliated Renhe Hospital of China Three Gorges University</institution>, <city>Yichang, Hubei</city>, <country country=\"cn\">China</country></aff><aff id=\"aff2\"><label>2</label><institution>Department of Anesthesiology, Affiliated Renhe Hospital of China Three Gorges University</institution>, <city>Yichang, Hubei</city>, <country country=\"cn\">China</country></aff><aff id=\"aff3\"><label>3</label><institution>Department of Endocrinology, Affiliated Renhe Hospital of China Three Gorges University</institution>, <city>Yichang, Hubei</city>, <country country=\"cn\">China</country></aff><aff id=\"aff4\"><label>4</label><institution>Department of General Surgery, Affiliated Renhe Hospital of China Three Gorges University</institution>, <city>Yichang, Hubei</city>, <country country=\"cn\">China</country></aff><aff id=\"aff5\"><label>5</label><institution>Department of Nursing, Affiliated Renhe Hospital of China Three Gorges University</institution>, <city>Yichang, Hubei</city>, <country country=\"cn\">China</country></aff><author-notes><corresp id=\"c001\"><label>*</label>Correspondence: Ying Du, <email xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"mailto:m13972517469@163.com\">m13972517469@163.com</email></corresp></author-notes><pub-date publication-format=\"electronic\" date-type=\"pub\" iso-8601-date=\"2025-11-20\"><day>20</day><month>11</month><year>2025</year></pub-date><pub-date publication-format=\"electronic\" date-type=\"collection\"><year>2025</year></pub-date><volume>13</volume><issue-id pub-id-type=\"pmc-issue-id\">480651</issue-id><elocation-id>1689911</elocation-id><history><date date-type=\"received\"><day>21</day><month>8</month><year>2025</year></date><date date-type=\"accepted\"><day>31</day><month>10</month><year>2025</year></date></history><pub-history><event event-type=\"pmc-release\"><date><day>20</day><month>11</month><year>2025</year></date></event><event event-type=\"pmc-live\"><date><day>05</day><month>12</month><year>2025</year></date></event><event event-type=\"pmc-last-change\"><date iso-8601-date=\"2025-12-08 15:25:12.403\"><day>08</day><month>12</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>Copyright &#169; 2025 Du, Yang, Liu, Deng and Li.</copyright-statement><copyright-year>2025</copyright-year><copyright-holder>Du, Yang, Liu, Deng and Li</copyright-holder><license><ali:license_ref specific-use=\"textmining\" content-type=\"ccbylicense\" start_date=\"2025-11-20\">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open-access article distributed under the terms of the <ext-link xmlns:xlink=\"http://www.w3.org/1999/xlink\" ext-link-type=\"uri\" xlink:href=\"https://creativecommons.org/licenses/by/4.0/\">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><self-uri xmlns:xlink=\"http://www.w3.org/1999/xlink\" content-type=\"pmc-pdf\" xlink:href=\"fpubh-13-1689911.pdf\"/><abstract><sec id=\"sec1\"><title>Objective</title><p>This study aims to summarize current applications of artificial intelligence (AI) for chronic disease self-management, critically appraise their effectiveness, and identify implementation challenges and future directions for research and clinical integration.</p></sec><sec id=\"sec2\"><title>Methods</title><p>A narrative literature review of peer-reviewed, English-language studies identified via PubMed, Web of Science, and Scopus was conducted, using combinations of &#8220;artificial intelligence,&#8221; &#8220;chronic disease,&#8221; &#8220;self-management,&#8221; &#8220;remote monitoring,&#8221; &#8220;predictive analytics,&#8221; &#8220;conversational agent,&#8221; and &#8220;mobile health.&#8221; Reference lists of key reviews were snowballed. We included studies that described or evaluated AI-enabled self-management tools or interventions for chronic conditions and excluded non-AI, acute-care, editorial, and non-human studies. Findings were synthesized thematically.</p></sec><sec id=\"sec3\"><title>Results</title><p>The literature consistently identifies four roles of AI in chronic care: (1) personalized decision support and treatment optimization; (2) continuous monitoring and risk prediction from patient-generated data; (3) conversational agents delivering education, adherence support, reminders, behavioral coaching, and mental-health support; and (4) AI-enabled Mobile health (mHealth) platforms that connect patients with clinicians and coordinate care. Recurrent challenges reported include data privacy and security risks, algorithmic bias and limited generalizability, interoperability and workflow-integration barriers, variable usability and sustained engagement (digital divide- inequalities in access to digital technologies and the internet, often influenced by age, income, or geography), and insufficient high-quality evidence on clinical effectiveness and cost-effectiveness.</p></sec><sec id=\"sec4\"><title>Conclusion</title><p>Future directions focus on developing more accurate, explainable, and trustworthy AI models, better clinical integration, leveraging advanced AI for engagement, rigorous evaluation, and addressing ethical and implementation barriers to realize AI&#8217;s full potential in empowering patients and improving chronic disease outcomes.</p></sec></abstract><kwd-group><kwd>artificial intelligence</kwd><kwd>chronic disease self-management</kwd><kwd>personalized interventions</kwd><kwd>predictive analytics</kwd><kwd>digital health platforms</kwd></kwd-group><funding-group><funding-statement>The author(s) declare that no financial support was received for the research and/or publication of this article.</funding-statement></funding-group><counts><fig-count count=\"1\"/><table-count count=\"2\"/><equation-count count=\"0\"/><ref-count count=\"108\"/><page-count count=\"11\"/><word-count count=\"9749\"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>section-at-acceptance</meta-name><meta-value>Digital Public Health</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type=\"intro\" id=\"sec5\"><label>1</label><title>Introduction</title><p>Chronic diseases, such as diabetes, cardiovascular diseases, respiratory disorders, and mental health conditions, represent a significant global health burden, characterized by their long-term nature and the necessity for continuous management (<xref rid=\"ref1\" ref-type=\"bibr\">1</xref>, <xref rid=\"ref2\" ref-type=\"bibr\">2</xref>). Effective self-management by patients is paramount to improving health outcomes, maintaining quality of life, and reducing healthcare costs (<xref rid=\"ref2\" ref-type=\"bibr\">2</xref>, <xref rid=\"ref3\" ref-type=\"bibr\">3</xref>). Self-management involves a range of behaviors, including medication adherence, lifestyle modifications (diet, exercise), symptom monitoring, and active participation in treatment decisions (<xref rid=\"ref4\" ref-type=\"bibr\">4</xref>, <xref rid=\"ref5\" ref-type=\"bibr\">5</xref>) However, supporting patients in consistently performing these complex tasks over a lifetime presents substantial challenges for traditional healthcare systems, often limited by resources and geographical barriers, particularly in rural or underserved areas (<xref rid=\"ref6\" ref-type=\"bibr\">6</xref>, <xref rid=\"ref7\" ref-type=\"bibr\">7</xref>).</p><p>The rapid advancements in artificial intelligence (AI) and related digital health technologies, including mobile health (mHealth) and wearable devices, offer transformative potential to address these challenges and revolutionize chronic disease self-management (<xref rid=\"ref8\" ref-type=\"bibr\">8&#8211;10</xref>). AI can process vast amounts of patient-generated data from various sources, such as Electronic Health Record (EHR)s, wearable sensors, and mobile applications, to provide personalized insights, predictive warnings, and interactive support, moving healthcare towards a more predictive, preventive, and personalized model (<xref rid=\"ref11\" ref-type=\"bibr\">11</xref>). Unlike prior reviews that focus on single tools (e.g., chatbots) or single diseases (e.g., diabetes), our review takes a task-based, cross-modal perspective, mapping diverse AI technologies directly onto the core components of patient self-management. This approach offers a unified framework that clarifies both where AI has matured and where gaps remain. By examining diverse AI modalities and their implementation across various chronic conditions, this review seeks to provide a comprehensive overview of the evolving landscape and highlight areas requiring further research and development to fully realize AI&#8217;s potential in empowering patients and improving health outcomes.</p></sec><sec id=\"sec6\"><label>2</label><title>Literature search and selection</title><p>This review followed a narrative approach. We searched PubMed, Web of Science, and Scopus for English-language studies published up to May 2025 using keyword combinations including &#8220;artificial intelligence,&#8221; &#8220;chronic disease,&#8221; &#8220;self-management,&#8221; &#8220;remote monitoring,&#8221; and &#8220;digital health.&#8221; Additional references were identified by screening citations in relevant reviews. We included studies that described or evaluated AI-enabled self-management tools for chronic conditions, while excluding non-AI, acute-care, non-human, and editorial/commentary articles. As this was a narrative review, no formal quality assessment or systematic synthesis (e.g., PRISMA flow diagram) was undertaken.</p></sec><sec id=\"sec7\"><label>3</label><title>Current applications of AI in chronic disease self-management</title><p>The application of artificial intelligence in chronic disease self-management is multifaceted, leveraging various AI techniques to address different aspects of patient care and support. These applications can broadly be categorized by the type of AI technology employed or the specific function they serve within the self-management process. This section will delve into the current state of AI applications, examining their use in personalized interventions, predictive analytics, monitoring, and patient engagement tools like conversational agents&#8212;an AI-powered virtual assistant or chatbot that interacts with patients via text or speech to provide education, reminders, or coaching&#8212;drawing upon recent literature across different chronic conditions.</p><sec id=\"sec8\"><label>3.1</label><title>AI for personalized interventions and decision support</title><p>One of the most significant promises of AI in chronic disease management is its ability to enable personalized interventions and provide data-driven decision support, moving away from a &#8220;one-size-fits-all&#8221; approach (<xref rid=\"ref12\" ref-type=\"bibr\">12</xref>). Machine learning (ML) algorithms analyze high-dimensional, longitudinal data to identify patterns and predict individual responses to treatments or lifestyle changes, thereby informing day-to-day self-management decisions. Diabetes exemplifies this precision approach: models integrating continuous glucose monitors (CGM), insulin pumps records, diet logs, and activity data generate tailored recommendations for insulin dosing, meal planning, and exercise with the goal of optimizing glycemic control (<xref rid=\"ref13\" ref-type=\"bibr\">13&#8211;26</xref>). Diabetes education tools increasingly embed AI to personalize content and coaching, strengthening self-management skills (<xref rid=\"ref27\" ref-type=\"bibr\">27</xref>, <xref rid=\"ref28\" ref-type=\"bibr\">28</xref>). Prospective system-validity studies demonstrate next-day hypoglycemia prediction from mobile/CGM data with random forest accuracy 0.814 (F1&#8239;=&#8239;0.812; sensitivity&#8239;=&#8239;0.815; specificity&#8239;=&#8239;0.824), outperforming alternative models (accuracy 0.65&#8211;0.80). Explainable Artificial Intelligence&#8211;driven Clinical Decision Support Systems (AI-CDSS) can make daily self-management more predictive and proactive by fusing data from smartphones, wearables, and CGMs (<xref rid=\"ref29\" ref-type=\"bibr\">29</xref>), while &#8220;nurse-in-the-loop&#8221; predictive digital twin&#8212;a virtual, patient-specific model that simulates health status and treatment responses to support personalized care&#8212;strategies for Type 2 Diabetes (T2D) showcase how transfer-learned models can deliver individualized feedback aligned with clinical expertise (<xref rid=\"ref30\" ref-type=\"bibr\">30</xref>). In oncology survivorship, emerging tools personalize surveillance and supportive-care recommendations (e.g., symptom triage, fatigue/exercise prescriptions, toxicity monitoring), aligning advice with individual risk profiles and preferences.</p></sec><sec id=\"sec9\"><label>3.2</label><title>AI for monitoring and predictive analytics</title><p>A core contribution of AI to self-management is the ability to transform continuous, multimodal data streams&#8212;physiological signals from wearables and home devices, symptom reports, medication logs, and EHR histories into timely risk assessment and early-warning insights that patients and clinicians can act on between visits. Models trained on longitudinal data support near-real-time monitoring, short-horizon exacerbation prediction, and trend detection that trigger tailored advice or escalation pathways, thereby complementing decision support systems.</p><p>In cardiovascular disease, monitoring pipelines increasingly fuse signals such as heart rate dynamics and rhythm strips with clinical history to detect atrial fibrillation (AF) episodes, anticipate deterioration, and inform self-care prompts or remote reviews (<xref rid=\"ref31\" ref-type=\"bibr\">31&#8211;35</xref>). These systems illustrate how passive sensing coupled with predictive analytics can shorten the time from signal to action in routine self-management.</p><p>The monitoring&#8211;prediction stack spans risk stratification, diagnostic augmentation, screening, and patient support. Explainable AI stratifies exacerbation risk from features such as smoking history, BMI, and symptom profiles (<xref rid=\"ref36\" ref-type=\"bibr\">36</xref>). In specialist settings, adding explainable AI to pulmonologist PFT interpretation increased mean diagnostic accuracy versus pulmonologists alone&#8212;although a subset performed worse, underscoring the need for clinical oversight (<xref rid=\"ref36\" ref-type=\"bibr\">36</xref>, <xref rid=\"ref37\" ref-type=\"bibr\">37</xref>). Imaging models provide staging and prognostic precision: CT deep learning in Chronic Obstructive Pulmonary Disease (COPD) Gene/ECLIPSE achieved ~50% exact GOLD staging and ~75% within one stage, predicted exacerbations and mortality, and reached AUC 0.89; PPV 0.847 for COPD identification in ECLIPSE; combining CT radiomics + demographics + spirometry further improved progression prediction over any single modality. At primary-care level, case-finding tools report usable operating points: a graph convolutional network achieved accuracy 0.77 (AUC 0.81) on weakly labeled CT; an AI &#8220;robot&#8221; questionnaire reached sensitivity 76.11%, specificity 84.76%, AUC 0.858; and a multi-instance learning classifier reported AUC 0.742 (<xref rid=\"ref38\" ref-type=\"bibr\">38</xref>, <xref rid=\"ref39\" ref-type=\"bibr\">39</xref>).</p><p>Beyond cardiometabolic disease, monitoring and prediction are expanding across other conditions. In chronic kidney disease (CKD), longitudinal EMRs underpin AI models that predict progression trajectories to guide precision management (<xref rid=\"ref40\" ref-type=\"bibr\">40</xref>, <xref rid=\"ref41\" ref-type=\"bibr\">41</xref>), with systems such as TrajVis translating model outputs into interpretable clinical insights (<xref rid=\"ref42\" ref-type=\"bibr\">42</xref>). In addition, a comparative modeling study for early CKD identification trained a deep neural network (multilayer perceptron) on a 400-patient dataset (75/25 train&#8211;test split; McNemar test for model comparison) and reported 100% test accuracy, outperforming logistic regression (96%) and SVM (82%); the reported confusion matrix showed perfect classification of both CKD and non-CKD cases, underscoring potential while also highlighting the need for external validation and larger, multi-site cohorts (<xref rid=\"ref43\" ref-type=\"bibr\">43</xref>). For end-stage kidney disease, proof-of-concept models suggest AI can help steer blood-pressure and volume strategies by learning from prior response, such as through artificial neural networks that predict session-specific outcomes and enable personalized adjustments to minimize intradialytic hypotension while optimizing fluid removal (<xref rid=\"ref44\" ref-type=\"bibr\">44</xref>).</p></sec><sec id=\"sec10\"><label>3.3</label><title>Conversational AI and intelligent coaching systems</title><p>These systems target engagement&#8212;personalized education, adherence support, and behavioral coaching&#8212;grounded in behavioral science and &#8220;nudge&#8221; principles. Unlike decision-support engines or passive risk models, engagement-focused systems emphasize human&#8211;AI dialogue and habit formation, with personalization and explainability as key levers (<xref rid=\"ref45\" ref-type=\"bibr\">45&#8211;47</xref>).</p><p>Diabetes remains the most developed use case for AI-enabled engagement. mHealth apps increasingly integrate CGM/pump, diet, and activity data to deliver individualized education and real-time coaching around dosing, meals, and exercise. AI-driven education modules adapt content to literacy and learning needs (<xref rid=\"ref48\" ref-type=\"bibr\">48&#8211;50</xref>), while nudge-based features encourage sustained lifestyle change (<xref rid=\"ref51\" ref-type=\"bibr\">51</xref>, <xref rid=\"ref52\" ref-type=\"bibr\">52</xref>). Evidence maturity is mixed but encouraging: the breadth of tools reflects rapid diffusion in diabetes, and feasibility/acceptability is supported even in low-resource settings where peer-educator models are being tested to extend reach and cultural fit. At the same time, durable engagement and rigorous external validation remain necessary to translate personalization gains into consistent clinical improvements (<xref rid=\"ref53\" ref-type=\"bibr\">53&#8211;55</xref>).</p><p>Conversational/ natural language processing (NLP) personalization can also improve engagement with diabetes education (mean engagement ratio 0.31 with personalization vs. 0.26 without) (<xref rid=\"ref56\" ref-type=\"bibr\">56</xref>). In chronic limb-threatening ischemia (CLTI), AI/ML approaches aim to improve accurate diagnosis, outcome prediction, and identify disparities in treatment, highlighting the potential role for decision support in addressing inequities.</p><p>AI-powered digital pain coaches deliver individualized pacing, exercise, and cognitive-behavioral strategies via conversational interfaces. Prospective and multicenter studies report significant improvements in pain interference, physical function, and psychological distress over 12&#8239;weeks, supporting the role of tailored coaching in everyday self-management (<xref rid=\"ref57\" ref-type=\"bibr\">57</xref>). These benefits underscore the potential of engagement-centric AI to shift outcomes even when pharmacologic or procedural options are limited.</p><p>Because anxiety, depression, and low mood commonly co-occur with chronic conditions, conversational agents increasingly provide personalized emotional support, self-monitoring, and triage. Early results suggest acceptability and user-reported benefit, but concerns around ethical safeguards, accuracy, and escalation pathways are prominent (<xref rid=\"ref58\" ref-type=\"bibr\">58</xref>, <xref rid=\"ref59\" ref-type=\"bibr\">59</xref>), reinforcing the need for transparent reporting and integration with clinical oversight.</p><p>On the patient side, virtual agents co-designed with user&#8217;s support exacerbation action plans, mood management, and daily tasks with good acceptability and perceived usefulness (<xref rid=\"ref60\" ref-type=\"bibr\">60</xref>, <xref rid=\"ref61\" ref-type=\"bibr\">61</xref>); at the sensing layer, smartphone auscultation and AI-augmented stethoscopes are being evaluated for wheeze/symptom recognition to enable home tele-monitoring (<xref rid=\"ref62\" ref-type=\"bibr\">62</xref>, <xref rid=\"ref63\" ref-type=\"bibr\">63</xref>). Digital programs that embed algorithmic feedback improve quality of life and self-efficacy, although effects on healthcare utilization remain mixed (<xref rid=\"ref64\" ref-type=\"bibr\">64</xref>).</p></sec><sec id=\"sec11\"><label>3.4</label><title>AI in mHealth and digital health platforms</title><p>AI-enabled mHealth platforms coordinate information, decisions, and actions between patients and clinicians by fusing home-collected signals (wearables, sensors, symptom diaries) with EHR data, then routing triage, escalation, and follow-up through secure messaging, teleconsultation, and shared care plans. The aim is to close the &#8220;between-visit&#8221; gap with timely guidance, medication titration, and appointment or testing prompts while documenting actions back to the record. In heart failure (HF), platforms increasingly pair post-discharge risk models with symptom check-ins to trigger medication reconciliation, complication surveillance, rehabilitation/exercise pacing, and timely clinic contact. Evidence remains early-phase, but perioperative studies offer concrete operating points that motivate such transition workflows: ML can predict intraoperative hypotension up to 15&#8239;min in advance (AUC 0.95, sensitivity 88%, specificity 87%); continuous ward monitoring with gradient-boosted models has anticipated stage-2 AKI&#8239;~&#8239;24&#8239;min before KDIGO criteria; and the PRODIGY score uses continuous capnography and oximetry to prospectively stratify risk of opioid-induced respiratory depression on general wards. At the same time, a pilot randomized evaluation of hypotension-prediction decision support did not reduce hypotension when alerts were frequently ignored, underscoring the need for robust workflow integration and escalation pathways as these tools move into the post-discharge transition context (<xref rid=\"ref65\" ref-type=\"bibr\">65</xref>, <xref rid=\"ref66\" ref-type=\"bibr\">66</xref>).</p></sec><sec id=\"sec12\"><label>3.5</label><title>Evidence maturity and gaps</title><p>Beyond functional categorizations, disease-specific manifestations of chronic conditions necessitate tailored AI approaches. This section explores these implementations across major chronic diseases, delineating how AI addresses distinct pathophysiological and self-management challenges (<xref rid=\"tab1\" ref-type=\"table\">Table 1</xref>; <xref rid=\"fig1\" ref-type=\"fig\">Figure 1</xref>).</p><table-wrap position=\"float\" id=\"tab1\" orientation=\"portrait\"><label>Table 1</label><caption><p>AI applications in chronic disease self-management: key functions, technologies, and outcomes.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Chronic condition</th><th align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Core AI functions</th><th align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Key technologies/tools</th><th align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Reported outcomes/advantages</th><th align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">References</th></tr></thead><tbody><tr><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Diabetes</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Personalized insulin dosing; Glycemic prediction; Behavioral coaching</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">CGM&#8239;+&#8239;Closed-loop systems; AI mHealth apps; ML-based glucose prediction algorithms</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Improved glycemic control; Reduced hypoglycemia events; Enhanced adherence to lifestyle modifications</td><td align=\"center\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">(<xref rid=\"ref9\" ref-type=\"bibr\">9</xref>, <xref rid=\"ref19\" ref-type=\"bibr\">19&#8211;24</xref>, <xref rid=\"ref28\" ref-type=\"bibr\">28</xref>, <xref rid=\"ref32\" ref-type=\"bibr\">32</xref>)</td></tr><tr><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Cardiovascular diseases/heart failure</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Remote deterioration detection; Risk stratification; Personalized care planning</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Wearable sensors [ECG, blood pressure (BP)]; AI remote monitoring platforms; Predictive analytics models</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Early detection of clinical deterioration; Reduced hospitalizations; Proactive intervention facilitation</td><td align=\"center\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">(<xref rid=\"ref50\" ref-type=\"bibr\">50</xref>, <xref rid=\"ref67\" ref-type=\"bibr\">67</xref>)</td></tr><tr><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Chronic obstructive pulmonary disease (COPD)</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Risk prediction; Exacerbation support; Symptom monitoring</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Explainable AI (XAI) frameworks; Virtual conversational agents; Smartphone-based monitoring</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Targeted screening; Improved self-efficacy during exacerbations; Enhanced quality of life</td><td align=\"center\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">(<xref rid=\"ref34\" ref-type=\"bibr\">34&#8211;37</xref>, <xref rid=\"ref63\" ref-type=\"bibr\">63</xref>)</td></tr><tr><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Chronic pain</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Activity-pain correlation analysis; Personalized behavioral guidance</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">AI-powered digital coaching platforms; Mobile apps with ML-based feedback systems</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Reduced pain interference; Improved physical function; Decreased anxiety/depression</td><td align=\"center\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">(<xref rid=\"ref70\" ref-type=\"bibr\">70</xref>, <xref rid=\"ref71\" ref-type=\"bibr\">71</xref>)</td></tr><tr><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Periodontitis</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Oral hygiene adherence monitoring; Personalized feedback</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">AI-enabled toothbrush sensors; Targeted mHealth micromessages</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Improved oral hygiene performance; Enhanced periodontal therapy outcomes</td><td align=\"center\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">(<xref rid=\"ref33\" ref-type=\"bibr\">33</xref>)</td></tr><tr><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Other conditions<sup>&#8224;</sup></td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Risk prediction; Symptom tracking; Personalized education</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Chatbots (e.g., haemophilia); LLMs (e.g., ChatGPT); Predictive digital twins</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Improved disease knowledge (haemophilia); Theoretical mental health support; Individualized management strategies</td><td align=\"center\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">(<xref rid=\"ref12\" ref-type=\"bibr\">12</xref>, <xref rid=\"ref26\" ref-type=\"bibr\">26</xref>, <xref rid=\"ref45\" ref-type=\"bibr\">45&#8211;47</xref>, <xref rid=\"ref72\" ref-type=\"bibr\">72</xref>, <xref rid=\"ref73\" ref-type=\"bibr\">73</xref>)</td></tr></tbody></table><table-wrap-foot><p>AI, Artificial Intelligence; BP, Blood Pressure; CGM, Continuous Glucose Monitoring; COPD, Chronic Obstructive Pulmonary Disease; ECG, Electrocardiogram; LLM, Large Language Model; ML, Machine Learning; mHealth, mobile Health; XAI, Explainable AI. Outcomes: Reflects outcomes reported in cited studies (e.g., &#8220;reduced hospitalizations&#8221; in CVD/HF; &#8220;improved oral hygiene&#8221; in periodontitis). <sup>&#8224;</sup>Other Conditions: Includes haemophilia, mental health, hepatitis C, epilepsy, and inflammatory bowel disease where evidence is emerging but less established.</p></table-wrap-foot></table-wrap><fig position=\"float\" id=\"fig1\" orientation=\"portrait\"><label>Figure 1</label><caption><p>Examples of AI applications in chronic diseases. This figure illustrates various applications of AI in managing chronic conditions such as diabetes, cardiovascular diseases, and other chronic diseases (e.g., chronic pain, obesity, mental health). It highlights AI&#8217;s role in self-monitoring, telemedicine, risk prediction, and personalized treatment strategies.</p></caption><graphic xmlns:xlink=\"http://www.w3.org/1999/xlink\" position=\"float\" orientation=\"portrait\" xlink:href=\"fpubh-13-1689911-g001.jpg\"><alt-text content-type=\"machine-generated\">Infographic titled \"AI in Chronic Disease Self-Management\" showcasing applications in diabetes, cardiovascular, and other conditions. For diabetes: closed-loop insulin systems, glucose prediction, lifestyle analysis, education, mHealth apps. For cardiovascular: risk prediction, remote monitoring, personalized care, vital signs analysis, self-care platforms. Other conditions include exacerbation risk prediction, conversational support, digital interventions for chronic pain, obesity, mental health, inflammatory bowel disease, chronic kidney disease, and epilepsy. Central image of a brain symbolizes AI's role.</alt-text></graphic></fig><p>Across chronic conditions, the strongest maturation is seen in monitoring and predictive analytics, where longitudinal sensing and EHR data support near&#8211;real-time risk assessment and early-warning prompts. Feasibility and user acceptance are consistent in AF/CVD and COPD, and trajectory modelling in CKD provides actionable forecasts (<xref rid=\"ref42\" ref-type=\"bibr\">42</xref>, <xref rid=\"ref67\" ref-type=\"bibr\">67</xref>, <xref rid=\"ref68\" ref-type=\"bibr\">68</xref>). However, The impact on service outcomes is heterogeneous and appears to depend strongly on patient engagement and workflow integration (<xref rid=\"ref43\" ref-type=\"bibr\">43</xref>). For personalized decision support, promising signals come from diabetes (CGM/pump&#8211;integrated coaching, AI-CDSS, and nurse-in-the-loop &#8220;digital twin&#8221; strategies) and from HF care planning and titration. Yet broader clinical utility hinges on data quality, external validation, interpretability, and seamless integration into routines of care (<xref rid=\"ref12\" ref-type=\"bibr\">12</xref>, <xref rid=\"ref24\" ref-type=\"bibr\">24</xref>, <xref rid=\"ref69\" ref-type=\"bibr\">69</xref>). Engagement-focused systems&#8212;conversational education, adherence support, and behavioral coaching&#8212;show improvements in patients-reported outcomes (PROs) in chronic pain and diabetes education, and are feasible even in low-resource settings (<xref rid=\"ref70\" ref-type=\"bibr\">70</xref>, <xref rid=\"ref71\" ref-type=\"bibr\">71</xref>). At the same time, long-term retention is variable, effects on healthcare utilization remain mixed in respiratory disease programs, and ethical/accuracy questions persist for mental-health comorbidity agents.</p><p>Taken together, the field has progressed from feasibility toward prospective and real-world deployment in several niches, but generalizability and durability are the main bottlenecks. Priorities include: multi-site external validation and transparent reporting; pragmatic/hybrid-effectiveness evaluations with standardized PROs and economic endpoints; and design for sustained engagement and workflow interoperability so that model outputs translate into reliable, patient-centered action (<xref rid=\"ref32\" ref-type=\"bibr\">32</xref>, <xref rid=\"ref72\" ref-type=\"bibr\">72</xref>, <xref rid=\"ref73\" ref-type=\"bibr\">73</xref>).</p></sec></sec><sec id=\"sec13\"><label>4</label><title>Challenges and considerations for AI in chronic disease self-management</title><p>Despite the transformative potential of AI in chronic disease self-management, significant challenges and considerations must be addressed to ensure its safe, effective, and equitable implementation. These challenges span technical, ethical, regulatory, and socio-behavioral domains (<xref rid=\"tab2\" ref-type=\"table\">Table 2</xref>). A key concern is data privacy and security. AI systems for self-management often rely on collecting sensitive personal health data from various sources, including wearables, apps, and EHRs (<xref rid=\"ref6\" ref-type=\"bibr\">6</xref>, <xref rid=\"ref8\" ref-type=\"bibr\">8</xref>). Robust cybersecurity measures and compliance with regulations are essential to maintain patient trust (<xref rid=\"ref6\" ref-type=\"bibr\">6</xref>, <xref rid=\"ref8\" ref-type=\"bibr\">8</xref>). Ethical issues include algorithmic bias, transparency, and informed consent. Biased data may exacerbate disparities, while the &#8220;black box&#8221; nature of some AI models hinders trust among patients and clinicians. Enhancing transparency and ensuring meaningful informed consent remain priorities (<xref rid=\"ref8\" ref-type=\"bibr\">8</xref>). Implementation barriers are also notable. Limited digital health literacy, especially among older adults and socioeconomically disadvantaged groups, and inequitable access to smartphones or internet connectivity restrict uptake (<xref rid=\"ref6\" ref-type=\"bibr\">6</xref>, <xref rid=\"ref74\" ref-type=\"bibr\">74</xref>). Integrating AI into clinical workflows and EHRs poses technical and logistical hurdles, requiring interdisciplinary collaboration and training for health-care professionals. Importantly, even accurate models fail if alerts are ignored or escalation pathways are unclear, underscoring the need for workflow fit and human-in-the-loop oversight (<xref rid=\"ref43\" ref-type=\"bibr\">43</xref>). Significant evidence gaps remain, particularly regarding long-term effectiveness, standardized outcome measures, and external validation across diverse populations. While monitoring and prediction tools show feasibility and patient-reported benefits, clinical outcomes remain heterogeneous and generalizability limited due to single-center or narrow cohorts. Large-scale, prospective validation with standardized outcomes is urgently needed. While engagement-focused AI demonstrates short-term improvements in PROs, challenges such as inconsistent retention and limited external validation highlight the need for further research. Similarly, mHealth platforms and telemonitoring improve adherence yet show mixed effects on hospitalization or long-term outcomes, with interoperability challenges limiting health-system deployment. Finally, In addition, ongoing regulatory uncertainty and concerns about patient trust present major barriers to widespread adoption. Frameworks for clinical AI remain in flux, complicating adoption (<xref rid=\"ref10\" ref-type=\"bibr\">10</xref>). Sustained patient engagement requires building trust, as false alerts or over-reliance on automation can erode confidence (<xref rid=\"ref9\" ref-type=\"bibr\">9</xref>). Addressing these multifaceted challenges demands coordinated efforts among researchers, developers, clinicians, policymakers, and patients.</p><table-wrap position=\"float\" id=\"tab2\" orientation=\"portrait\"><label>Table 2</label><caption><p>Cross-cutting challenges and solution requirements for AI in chronic disease self-management.</p></caption><table frame=\"hsides\" rules=\"groups\"><thead><tr><th align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Challenge domain</th><th align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Specific issues</th><th align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Associated risks</th><th align=\"left\" valign=\"top\" rowspan=\"1\" colspan=\"1\">Key solution requirements</th><th align=\"center\" valign=\"top\" rowspan=\"1\" colspan=\"1\">References</th></tr></thead><tbody><tr><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Data privacy and security</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Collection/storage of sensitive biometric, activity, and EHR data; Cross-platform data sharing</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Patient data breaches; Non-compliance with regulations; Erosion of trust</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Robust encryption (e.g., end-to-end); Strict adherence to GDPR/HIPAA; Decentralized data storage (e.g., federated learning)</td><td align=\"center\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">(<xref rid=\"ref6\" ref-type=\"bibr\">6</xref>, <xref rid=\"ref8\" ref-type=\"bibr\">8</xref>, <xref rid=\"ref45\" ref-type=\"bibr\">45</xref>, <xref rid=\"ref69\" ref-type=\"bibr\">69</xref>)</td></tr><tr><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Algorithmic bias and transparency</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Training data unrepresentativeness; &#8220;Black box&#8221; decision-making; Limited explainability</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Perpetuation of health disparities; Clinician skepticism; Patient mistrust</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Development of Explainable AI (XAI) frameworks; Diverse multi-center datasets; Algorithmic fairness audits</td><td align=\"center\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">(<xref rid=\"ref8\" ref-type=\"bibr\">8</xref>, <xref rid=\"ref24\" ref-type=\"bibr\">24</xref>, <xref rid=\"ref42\" ref-type=\"bibr\">42</xref>, <xref rid=\"ref59\" ref-type=\"bibr\">59</xref>, <xref rid=\"ref68\" ref-type=\"bibr\">68</xref>, <xref rid=\"ref108\" ref-type=\"bibr\">108</xref>)</td></tr><tr><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Implementation barriers</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Low digital literacy (e.g., elderly/low-SES groups); Limited tech access (rural/LMICs); Workflow integration difficulties</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Digital divide exacerbation; Low adoption rates; Clinical workflow disruptions</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Culturally adapted training programs; Low-cost/offline-capable devices; Interoperability standards (e.g., HL7 FHIR)</td><td align=\"center\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">(<xref rid=\"ref6\" ref-type=\"bibr\">6</xref>, <xref rid=\"ref26\" ref-type=\"bibr\">26</xref>, <xref rid=\"ref32\" ref-type=\"bibr\">32</xref>, <xref rid=\"ref59\" ref-type=\"bibr\">59</xref>, <xref rid=\"ref74\" ref-type=\"bibr\">74</xref>)</td></tr><tr><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Evidence and regulatory gaps</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Insufficient long-term efficacy data; Lack of standardized outcome measures; Evolving regulatory frameworks</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Unproven clinical utility; Reimbursement uncertainties; Delayed market access</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Large-scale RCTs with real-world endpoints; Consensus frameworks for AI validation; Adaptive regulatory pathways (e.g., FDA SaMD)</td><td align=\"center\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">(<xref rid=\"ref10\" ref-type=\"bibr\">10</xref>, <xref rid=\"ref12\" ref-type=\"bibr\">12</xref>, <xref rid=\"ref66\" ref-type=\"bibr\">66</xref>, <xref rid=\"ref69\" ref-type=\"bibr\">69</xref>)</td></tr><tr><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Clinical integration and trust</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">False alerts (e.g., AF detection); Lack of clinician training; Patient over-reliance</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Alert fatigue; Reduced confidence in AI; Undermined patient-clinician relationships</td><td align=\"left\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">Hybrid &#8220;human-in-the-loop&#8221; oversight (e.g., nurse-led AI); Clinician education modules; Fail-safe mechanisms for critical alerts</td><td align=\"center\" valign=\"middle\" rowspan=\"1\" colspan=\"1\">(<xref rid=\"ref22\" ref-type=\"bibr\">22</xref>, <xref rid=\"ref24\" ref-type=\"bibr\">24</xref>, <xref rid=\"ref25\" ref-type=\"bibr\">25</xref>, <xref rid=\"ref66\" ref-type=\"bibr\">66</xref>)</td></tr></tbody></table><table-wrap-foot><p>AF, Atrial Fibrillation; AI, Artificial Intelligence; EHR, Electronic Health Record; FDA, U. S. Food and Drug Administration; FHIR, Fast Healthcare Interoperability Resources; GDPR, General Data Protection Regulation; HIPAA, Health Insurance Portability and Accountability Act; HL7, Health Level Seven International; LMICs, Low- and Middle-Income Countries; RCT, Randomized Controlled Trial; SaMD, Software as a Medical Device; SES, Socioeconomic Status; XAI, Explainable AI.</p></table-wrap-foot></table-wrap><p>In addition to these challenges, three barriers to broad adoption deserve emphasis. First, data integration and standardization remain formidable, as AI systems require multimodal, large-scale datasets combining imaging, EHR, and wearable signals. Heterogeneous data formats, inconsistent data quality, and siloed healthcare systems complicate the development of robust AI models, often requiring advanced data harmonization techniques and interoperable platforms to ensure compatibility across diverse data sources. For example, integrating continuous glucose monitoring data with EHRs for diabetes management demands standardized ontologies and secure data-sharing protocols to enable real-time, actionable insights (<xref rid=\"ref75\" ref-type=\"bibr\">75</xref>). Second, regulatory clarity is evolving; notably, the U. S. Food and Drug Administration (FDA)&#8217;s December 2024 guidance on &#8220;Predetermined Change Control Plans&#8221; for continuously learning AI devices marks an important milestone. This guidance facilitates adaptive AI algorithms by allowing pre-approved modifications while ensuring safety and efficacy, yet uncertainties around reimbursement and liability persist, delaying integration into clinical practice (<xref rid=\"ref76\" ref-type=\"bibr\">76</xref>). Harmonizing global regulatory frameworks remains critical to streamline deployment across jurisdictions (<xref rid=\"ref77\" ref-type=\"bibr\">77</xref>). Third, ethical considerations are paramount: explainable AI is critical to foster clinician and patient trust, and physicians should play a leading role in driving AI innovation to ensure alignment with real-world clinical needs. Explainable AI models, such as those incorporating interpretable decision trees or attention mechanisms, enhance transparency by elucidating decision-making processes, thereby reducing skepticism among clinicians and patients (<xref rid=\"ref78\" ref-type=\"bibr\">78</xref>). Moreover, physician-led innovation ensures AI tools address practical clinical challenges, such as optimizing chronic disease monitoring or personalizing treatment plans, by incorporating domain expertise into algorithm design and validation (<xref rid=\"ref79\" ref-type=\"bibr\">79</xref>). Collaborative initiatives, such as clinician-researcher partnerships, are essential to align AI development with patient-centered care priorities (<xref rid=\"ref80\" ref-type=\"bibr\">80</xref>).</p></sec><sec id=\"sec14\"><label>5</label><title>Current AI use cases in cardiovascular medicine beyond self-management</title><p>AI applications extend beyond patient self-management to broader domains in cardiovascular medicine, including procedural, diagnostic, and efficiency areas. These use cases demonstrate AI&#8217;s versatility in addressing AF and related conditions, offering insights into potential integrations with self-management tools. This section outlines key examples, emphasizing their methodologies, findings, and implications, drawn from large-scale studies and clinical trials.</p><p>In AF screening and monitoring, consumer wearables have leveraged AI for large-scale, real-world detection. The Apple Heart Study, a prospective single-arm trial involving over 419,000 participants, utilized photoplethysmography (PPG) sensors on the Apple Watch combined with a ML algorithm to detect irregular pulses suggestive of AF. The algorithm achieved a positive predictive value of 84% for confirmed AF on subsequent ECG patches, with 34% of notified participants having AF episodes lasting &#8805;30&#8239;min, demonstrating high feasibility for opportunistic screening and user engagement, though limitations included underrepresentation of older adults (<xref rid=\"ref81\" ref-type=\"bibr\">81</xref>). Similarly, the Fitbit Heart Study enrolled 455,699 participants and employed a PPG-based deep learning algorithm, reporting 98.7% sensitivity for AF episodes &gt;30&#8239;min and a positive predictive value of 98% among those with irregular rhythms, underscoring cost-effective population-level monitoring with minimal false positives (<xref rid=\"ref82\" ref-type=\"bibr\">82</xref>). The Samsung HEARTBEAT study, using Galaxy Watch devices, validated PPG algorithms against 12-lead ECGs, achieving 92.9% accuracy in AF detection over 14&#8239;days, highlighting usability for continuous monitoring in ambulatory settings (<xref rid=\"ref83\" ref-type=\"bibr\">83</xref>). These studies illustrate AI&#8217;s potential to enhance early AF detection and burden quantification, bridging gaps in intermittent monitoring for chronic cardiovascular self-management.</p><p>Procedural challenges in AF ablation, such as prolonged ablation times (often exceeding 3&#8211;4&#8239;h), labor-intensive manual mapping, inconsistent lesion formation leading to incomplete transmurality, and difficulties in identifying extra-pulmonary vein (extra-PV) targets like rotors or focal drivers, have created opportunities for AI-driven solutions to streamline workflows, enhance precision, and improve outcomes (<xref rid=\"ref84\" ref-type=\"bibr\">84</xref>, <xref rid=\"ref85\" ref-type=\"bibr\">85</xref>). These limitations in traditional approaches, which rely on operator experience and can result in recurrence rates of 20&#8211;40% in persistent AF, underscore the need for automated, data-driven tools that reduce variability and procedural duration while supporting personalized strategies (<xref rid=\"ref85\" ref-type=\"bibr\">85</xref>, <xref rid=\"ref86\" ref-type=\"bibr\">86</xref>). For AI-assisted mapping and imaging, tools like Volta VX1 employ ML to analyze multipolar electrograms during AF ablation, identifying dispersion areas in real-time with high inter-operator agreement (kappa 0.85), improving procedural efficiency and reducing recurrence rates in persistent AF by targeting non-pulmonary vein drivers (<xref rid=\"ref87\" ref-type=\"bibr\">87</xref>). CARTO AI, integrated into the CARTO electroanatomic mapping system, uses neural networks for automated annotation of complex fractionated atrial electrograms, facilitating faster substrate mapping and personalized ablation strategies, with studies showing reduced mapping time by 30% while maintaining accuracy comparable to expert manual review (<xref rid=\"ref88\" ref-type=\"bibr\">88</xref>). Additionally, AI-guided MRI segmentation tools, such as deep learning-based convolutional neural networks for atrial scar and fibrosis delineation in late gadolinium-enhanced cardiac MRI, enable automated identification of extra-PV ablation targets with segmentation accuracy comparable to manual methods, reducing pre-procedural planning time and aiding in tailored lesion sets to minimize gaps and improve long-term success (<xref rid=\"ref89\" ref-type=\"bibr\">89</xref>, <xref rid=\"ref90\" ref-type=\"bibr\">90</xref>). US2. AI echocardiography applies convolutional neural networks to automate full echocardiographic analysis, measuring parameters like ejection fraction and chamber dimensions with 95% agreement to expert readings, enabling rapid point-of-care diagnostics for HF and valvular disease in AF patients (<xref rid=\"ref91\" ref-type=\"bibr\">91</xref>). These applications enhance precision in procedural interventions, potentially informing future AI-driven self-management by providing baseline data for personalized monitoring.</p><p>Efficiency tools further expand AI&#8217;s utility. AI risk scoring models, such as those predicting incident AF from clinical data and polygenic scores, integrate ML with EHRs to achieve AUCs of 0.85&#8211;0.90, outperforming traditional scores like CHARGE-AF by identifying high-risk individuals for preventive strategies (<xref rid=\"ref92\" ref-type=\"bibr\">92</xref>). For ECG labeling, deep learning algorithms automate AF classification with &gt;99% accuracy, reducing manual review time in large datasets and supporting scalable diagnostics (<xref rid=\"ref93\" ref-type=\"bibr\">93</xref>). Prediction of AF from sinus rhythm ECGs uses convolutional neural networks to detect subtle features, predicting future AF with AUC 0.87 in cohorts like UK Biobank, aiding early intervention in at-risk populations (<xref rid=\"ref94\" ref-type=\"bibr\">94</xref>). The TAILORED AF trial, a randomized controlled study, employed AI to guide real-time lesion delivery during ablation by mapping spatiotemporal dispersion, resulting in 74% freedom from AF at 12&#8239;months in the AI arm versus 58% in controls, demonstrating superior outcomes through adaptive, individualized procedures (<xref rid=\"ref95\" ref-type=\"bibr\">95</xref>).</p><p>Collectively, these use cases exemplify AI&#8217;s clinical breadth, distinct from but complementary to patient-centered self-management, emphasizing the need for integration to optimize chronic disease outcomes.</p></sec><sec sec-type=\"discussion\" id=\"sec15\"><label>6</label><title>Discussion</title><p>An important distinction that emerges from the reviewed literature is between early-phase feasibility or pilot studies and validated clinical applications. Many AI-enabled tools, such as conversational agents for patient engagement or predictive analytics for exacerbation risk, have primarily been evaluated in small, single-center feasibility trials or short-term pilots. These studies provide valuable proof-of-concept evidence and user-acceptability insights but do not establish clinical effectiveness. In contrast, validated clinical applications&#8212;those tested in large-scale, prospective, or real-world settings&#8212;remain relatively limited. For example, while some AI-supported decision support systems in diabetes and remote monitoring platforms in HF have undergone prospective evaluations and regulatory clearance, most other domains lack comparable validation (<xref rid=\"ref96\" ref-type=\"bibr\">96</xref>, <xref rid=\"ref97\" ref-type=\"bibr\">97</xref>). This distinction underscores that the field, while promising, remains in a transitional stage between early feasibility studies and fully validated clinical applications. Feasibility evidence is encouraging, but widespread clinical adoption requires rigorous multi-site randomized trials, standardized outcome measures, and long-term effectiveness and cost-effectiveness data. Taken together, these observations underscore that while feasibility studies demonstrate promising signals. Validated applications, however, remain relatively scarce, underscoring the importance of conducting large-scale, multi-site clinical trials. In addition to these evidence-related challenges, regulatory oversight&#8212;particularly from the FDA&#8212;is playing an increasingly important role in shaping the clinical implementation of AI. The FDA regulates many AI systems under its Software as a Medical Device (SaMD) framework, requiring robust evaluation of safety, effectiveness, and quality assurance before approval (<xref rid=\"ref98\" ref-type=\"bibr\">98</xref>). Recent guidance, including the introduction of &#8220;Predetermined Change Control Plans,&#8221; marks a pivotal step by allowing certain AI algorithms to adapt and update post-approval while maintaining oversight (<xref rid=\"ref99\" ref-type=\"bibr\">99</xref>). Pilot initiatives such as the Digital Health Software Precertification Program also demonstrate the FDA&#8217;s intent to accelerate the evaluation process for digital health innovations (<xref rid=\"ref100\" ref-type=\"bibr\">100</xref>). Nevertheless, evolving requirements and uncertainties regarding reimbursement, liability, and interoperability continue to create barriers for widespread adoption. Thus, FDA regulation acts as both a safeguard&#8212;ensuring patient safety and building trust&#8212;and a challenge, as stakeholders must continuously adapt to meet changing regulatory expectations.</p><p>The limitations of conventional monitoring strategies further illustrate this gap in clinical practice. For instance, intermittent approaches such as 24-h or 7-d ambulatory Electrocardiogram (ECG) recordings detect only a fraction of AF episodes, with reported sensitivities of approximately 16 and 42%, respectively, compared with implantable cardiac monitors that achieve up to 99% sensitivity in detecting AF episodes lasting &#8805;2&#8239;min, as demonstrated in a review of ambulatory ECG monitoring strategies where prolonged continuous monitoring significantly outperformed shorter intermittent recordings in identifying paroxysmal AF in patients with cryptogenic stroke or suspected arrhythmia (<xref rid=\"ref101\" ref-type=\"bibr\">101</xref>). This limited sensitivity hampers timely diagnosis and accurate burden quantification, especially for patients with paroxysmal AF. AI-enabled wearable devices have the potential to overcome these limitations by providing continuous, unobtrusive monitoring in real-world settings. When coupled with advanced algorithms, these devices can enhance early AF detection, enable more precise assessment of arrhythmia burden, and support proactive intervention strategies. For example, large-scale screening studies like the Apple Heart Study utilized PPG-based algorithms with ML to detect irregular pulse suggestive of AF, achieving a positive predictive value of 84% for confirmed AF episodes and demonstrating high user engagement with over 400,000 participants, thereby highlighting the feasibility of AI-driven wearables for population-level AF detection and burden estimation in chronic cardiovascular self-management (<xref rid=\"ref81\" ref-type=\"bibr\">81</xref>). Similarly, the Fitbit Heart Study employed PPG sensors integrated with deep learning models to identify AF, reporting a 98.7% sensitivity for AF episodes lasting &gt;30&#8239;min and underscoring cost-effective, scalable alternatives to traditional monitoring (<xref rid=\"ref82\" ref-type=\"bibr\">82</xref>). This context underscores how AI not only augments existing monitoring modalities but also addresses critical diagnostic blind spots inherent in conventional strategies.</p><p>Prior studies typically narrow to a single tool class (e.g., chatbots) or to a specific population/technology stack and largely inventory systems without linking them to the day-to-day work of self-management; chatbot reviews deem the evidence promising yet heterogeneous and note inconsistent technical reporting, limiting cross-disease comparability (<xref rid=\"ref102\" ref-type=\"bibr\">102</xref>), while aging-focused surveys summarize ML/NLP advances but are not organized around patient tasks or mHealth/wearable workflows (<xref rid=\"ref103\" ref-type=\"bibr\">103</xref>), and bibliometric overviews describe a fragmented field and call for implementation-relevant studies (<xref rid=\"ref104\" ref-type=\"bibr\">104</xref>). In this review, we synthesize predictive analytics, continuous sensing/remote monitoring, conversational agents, and AI-enabled mHealth platforms and map them to core self-management tasks&#8212;personalized decision support; continuous monitoring and risk prediction; education/adherence/behavioral coaching; and patient&#8211;clinician care coordination&#8212;thereby clarifying where roles are maturing (e.g., monitoring/risk prediction) versus under-developed (e.g., sustained engagement and emotional support) and providing a cross-modal, task-anchored lens absent from chatbot-only work (<xref rid=\"ref102\" ref-type=\"bibr\">102</xref>). We also reconcile mixed clinical signals by placing encouraging single-arm findings (e.g., an AI-powered digital pain coach over 12&#8239;weeks) alongside a null multicenter randomized controlled trial (RCT) (<xref rid=\"ref70\" ref-type=\"bibr\">70</xref>, <xref rid=\"ref105\" ref-type=\"bibr\">105</xref>). Importantly, we connect patient-articulated priorities&#8212;personalization, emotional/social support, proactive monitoring, service integration, and ethics/governance (<xref rid=\"ref106\" ref-type=\"bibr\">106</xref>)&#8212;to implementation pathways using NASSS and privacy-preserving infrastructures such as federated learning and blockchain. Unlike aging-focused reviews or platform papers that emphasize architectures without cross-disease appraisal (<xref rid=\"ref103\" ref-type=\"bibr\">103</xref>, <xref rid=\"ref107\" ref-type=\"bibr\">107</xref>), our synthesis spans conditions and technologies yet remain organized by the work patients and clinicians actually perform. Collectively, this yields a pragmatic agenda&#8212;pragmatic/hybrid designs with standardized PROs and economic endpoints (<xref rid=\"ref70\" ref-type=\"bibr\">70</xref>, <xref rid=\"ref105\" ref-type=\"bibr\">105</xref>), transparent technical reporting to enable comparability (<xref rid=\"ref102\" ref-type=\"bibr\">102</xref>), and privacy-preserving data pipelines aligned with health-system integration (NASSS)&#8212;and, to our knowledge, the first cross-modal, task-based account of AI for chronic-disease self-management.</p></sec><sec id=\"sec16\"><label>7</label><title>Future directions and opportunities</title><p>Looking ahead, the future of AI in chronic disease self-management holds immense potential, provided that current challenges are effectively addressed. Several key directions are emerging.</p><p>First, more trustworthy AI models are needed, with improvements in accuracy, reliability, and explainable AI (XAI) to enhance transparency and build trust among users and clinicians (<xref rid=\"ref12\" ref-type=\"bibr\">12</xref>, <xref rid=\"ref13\" ref-type=\"bibr\">13</xref>). Ethical design principles must be embedded from the outset, actively working to mitigate bias and ensure equitable access (<xref rid=\"ref8\" ref-type=\"bibr\">8</xref>). Second, integration into existing healthcare ecosystems is critical. Interoperable platforms should link patient-generated data from wearables and mHealth tools with EHRs and clinical workflows. Hybrid approaches such as &#8220;nurse-in-the-loop&#8221; models- a hydrid model where nurses oversee or validate the recommendations generated by AI systems, ensuring clinical appropriateness and patient safety-can combine AI efficiency with human oversight, ensuring care remains personalized and compassionate (<xref rid=\"ref20\" ref-type=\"bibr\">20</xref>). Third, advancements in generative AI and NLP offer new opportunities to enhance patient engagement and education. Future conversational agents could become more empathetic, context-aware, and capable of delivering personalized self-management content, supporting adherence and sustained behavior change. Finally, rigorous evaluation and responsible implementation are essential. Large-scale RCTs and pragmatic trials are needed to establish effectiveness, cost-effectiveness, and long-term impact. Research should also address diverse patient populations, digital literacy gaps, and cultural adaptation. Clear regulatory pathways (e.g., recent FDA guidance on adaptive AI), along with interdisciplinary collaboration, will be crucial to ensure safe, scalable adoption.</p></sec><sec sec-type=\"conclusions\" id=\"sec17\"><label>8</label><title>Conclusion</title><p>Artificial intelligence is rapidly emerging as a powerful tool with the potential to fundamentally transform chronic disease self-management. By enabling personalized interventions, enhancing monitoring and predictive capabilities, and supporting patient engagement through conversational agents and digital platforms, AI provides innovative ways to help individuals manage complex, lifelong conditions.</p><p>Unlike prior reviews that typically focus on a single technology (e.g., chatbots) or a single disease (e.g., diabetes), this narrative review provides a task-oriented, cross-modal synthesis that integrates diverse AI modalities across multiple chronic conditions. This unique lens explicitly maps AI applications to the core self-management tasks of patients&#8212;personalized decision support, continuous monitoring and prediction, behavioral coaching, and patient&#8211;clinician care coordination&#8212;thereby offering a unifying framework absent from earlier work. In addition, our review incorporates the regulatory dimension, highlighting how evolving FDA guidance and other oversight frameworks critically shape the translation of AI into clinical practice, an aspect often underrepresented in the literature.</p><p>Current applications, particularly in diabetes and cardiovascular disease, show encouraging results such as improved treatment personalization, early detection of complications, and enhanced adherence. However, most evidence to date arises from feasibility or pilot studies, with validated clinical deployments in large-scale or real-world contexts still limited.</p><p>Bridging this gap requires rigorous multi-site trials, standardized outcome measures, and long-term effectiveness and cost-effectiveness evaluations. Only by generating robust clinical evidence and addressing challenges such as data privacy, algorithmic bias, and equitable access can AI move from promising prototypes to trustworthy, widely adopted solutions. Ultimately, by situating AI applications within both patient self-management tasks and real-world adoption pathways, this review contributes a novel and pragmatic roadmap for advancing AI toward reliable, patient-centered improvements in chronic disease outcomes.</p></sec></body><back><fn-group><fn id=\"fn0001\" fn-type=\"edited-by\"><p>Edited by: <ext-link xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"https://loop.frontiersin.org/people/1964348/overview\" ext-link-type=\"uri\">Han Feng</ext-link>, Tulane University, United States</p></fn><fn id=\"fn0002\" fn-type=\"reviewed-by\"><p>Reviewed by: <ext-link xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"https://loop.frontiersin.org/people/2956238/overview\" ext-link-type=\"uri\">Mohammad Atasi</ext-link>, Tulane University, United States</p><p><ext-link xmlns:xlink=\"http://www.w3.org/1999/xlink\" xlink:href=\"https://loop.frontiersin.org/people/3188199/overview\" ext-link-type=\"uri\">Alex El Darzi</ext-link>, Tulane Medical Center, United States</p></fn></fn-group><sec sec-type=\"author-contributions\" id=\"sec18\"><title>Author contributions</title><p>YD: Methodology, Project administration, Resources, Writing &#8211; original draft, Writing &#8211; review &amp; editing. PY: Conceptualization, Data curation, Formal analysis, Writing &#8211; original draft, Writing &#8211; review &amp; editing. YL: Data curation, Investigation, Methodology, Writing &#8211; review &amp; editing. CD: Data curation, Formal analysis, Software, Visualization, Writing &#8211; review &amp; editing. XL: Data curation, Investigation, Software, Supervision, Writing &#8211; review &amp; editing.</p></sec><sec sec-type=\"COI-statement\" id=\"sec20\"><title>Conflict of interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec><sec sec-type=\"ai-statement\" id=\"sec21\"><title>Generative AI statement</title><p>The authors declare that no Gen AI was used in the creation of this manuscript.</p><p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p></sec><sec sec-type=\"disclaimer\" id=\"sec22\"><title>Publisher&#8217;s note</title><p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p></sec><ref-list><title>References</title><ref id=\"ref1\"><label>1.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Pathan</surname><given-names>A</given-names></name></person-group>. <article-title>Urgent health challenges for the next decade 2030: World Health Organization</article-title>. <source>NeuroPharmac J</source>. (<year>2020</year>):<fpage>113</fpage>&#8211;<lpage>7</lpage>. doi: <pub-id pub-id-type=\"doi\">10.37881/1.512</pub-id></mixed-citation></ref><ref id=\"ref2\"><label>2.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Iovino</surname><given-names>P</given-names></name><name name-style=\"western\"><surname>Uchmanowicz</surname><given-names>I</given-names></name><name name-style=\"western\"><surname>Vellone</surname><given-names>E</given-names></name></person-group>. <article-title>Self-care: an effective strategy to manage chronic diseases</article-title>. <source>Adv Clin Exp Med</source>. (<year>2024</year>) <volume>33</volume>:<fpage>767</fpage>&#8211;<lpage>71</lpage>. doi: <pub-id pub-id-type=\"doi\">10.17219/acem/191102</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">39194160</pub-id></mixed-citation></ref><ref id=\"ref3\"><label>3.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Hamine</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Gerth-Guyette</surname><given-names>E</given-names></name><name name-style=\"western\"><surname>Faulx</surname><given-names>D</given-names></name><name name-style=\"western\"><surname>Green</surname><given-names>BB</given-names></name><name name-style=\"western\"><surname>Ginsburg</surname><given-names>AS</given-names></name></person-group>. <article-title>Impact of mHealth chronic disease management on treatment adherence an d patient outcomes: a systematic review</article-title>. <source>J Med Internet Res</source>. (<year>2015</year>) <volume>17</volume>:<fpage>e52</fpage>. doi: <pub-id pub-id-type=\"doi\">10.2196/jmir.3951</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">25803266</pub-id><pub-id pub-id-type=\"pmcid\">PMC4376208</pub-id></mixed-citation></ref><ref id=\"ref4\"><label>4.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Ara'ujo-Soares</surname><given-names>V</given-names></name><name name-style=\"western\"><surname>Hankonen</surname><given-names>N</given-names></name><name name-style=\"western\"><surname>Presseau</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Rodrigues</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Sniehotta</surname><given-names>FF</given-names></name></person-group>. <article-title>Developing behavior change interventions for self-management in chroni c illness: an integrative overview</article-title>. <source>Eur Psychol</source>. (<year>2019</year>) <volume>24</volume>:<fpage>7</fpage>&#8211;<lpage>25</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1027/1016-9040/a000330</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">31496632</pub-id><pub-id pub-id-type=\"pmcid\">PMC6727632</pub-id></mixed-citation></ref><ref id=\"ref5\"><label>5.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Pereira Guerreiro</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Strawbridge</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Cavaco</surname><given-names>AM</given-names></name><name name-style=\"western\"><surname>Br'ito F'elix</surname><given-names>I</given-names></name><name name-style=\"western\"><surname>Marques</surname><given-names>MM</given-names></name><name name-style=\"western\"><surname>Cadogan</surname><given-names>C</given-names></name></person-group>. <article-title>Development of a European competency framework for health and other pr ofessionals to support behaviour change in persons self-managing chron ic disease</article-title>. <source>BMC Med Educ</source>. (<year>2021</year>) <volume>21</volume>:<fpage>287</fpage>. doi: <pub-id pub-id-type=\"doi\">10.1186/s12909-021-02720-w</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">34016108</pub-id><pub-id pub-id-type=\"pmcid\">PMC8136137</pub-id></mixed-citation></ref><ref id=\"ref6\"><label>6.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Igwama</surname><given-names>GT</given-names></name><name name-style=\"western\"><surname>Nwankwo</surname><given-names>EI</given-names></name><name name-style=\"western\"><surname>Emeihe</surname><given-names>EV</given-names></name><name name-style=\"western\"><surname>Ajegbile</surname><given-names>MD</given-names></name></person-group>. <article-title>AI-enhanced remote monitoring for chronic disease management in rural areas</article-title>. <source>Int J Appl Res Soc Sci</source>. (<year>2024</year>) <volume>6</volume>:<fpage>1824</fpage>&#8211;<lpage>47</lpage>. doi: <pub-id pub-id-type=\"doi\">10.51594/ijarss.v6i8.1428</pub-id></mixed-citation></ref><ref id=\"ref7\"><label>7.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Canaud</surname><given-names>B</given-names></name><name name-style=\"western\"><surname>Davenport</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Leray-Moragues</surname><given-names>H</given-names></name><name name-style=\"western\"><surname>Morena-Carrere</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Cristol</surname><given-names>JP</given-names></name><name name-style=\"western\"><surname>Kooman</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Digital health support: current status and future development for enha ncing dialysis patient care and empowering patients</article-title>. <source>Toxins</source>. (<year>2024</year>) <volume>16</volume>:<fpage>211</fpage>. doi: <pub-id pub-id-type=\"doi\">10.3390/toxins16050211</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">38787063</pub-id><pub-id pub-id-type=\"pmcid\">PMC11125858</pub-id></mixed-citation></ref><ref id=\"ref8\"><label>8.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Muthineni</surname><given-names>SR</given-names></name></person-group>. <article-title>AI in mobile health apps: transforming chronic disease management</article-title>. <source>Int J Sci Res Computer Sci Eng Inf Technol</source>. (<year>2025</year>) <volume>11</volume>:<fpage>108</fpage>&#8211;<lpage>16</lpage>. doi: <pub-id pub-id-type=\"doi\">10.32628/CSEIT25111212</pub-id></mixed-citation></ref><ref id=\"ref9\"><label>9.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Klonoff</surname><given-names>AN</given-names></name><name name-style=\"western\"><surname>Lee</surname><given-names>W-A</given-names></name><name name-style=\"western\"><surname>Xu</surname><given-names>NY</given-names></name><name name-style=\"western\"><surname>Nguyen</surname><given-names>KT</given-names></name><name name-style=\"western\"><surname>DuBord</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Kerr</surname><given-names>D</given-names></name></person-group>. <article-title>Six digital health technologies that will transform diabetes</article-title>. <source>J Diabetes Sci Technol</source>. (<year>2021</year>) <volume>17</volume>:<fpage>239</fpage>&#8211;<lpage>49</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1177/19322968211043498</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">34558330</pub-id><pub-id pub-id-type=\"pmcid\">PMC9846384</pub-id></mixed-citation></ref><ref id=\"ref10\"><label>10.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Farai</surname><given-names>OA</given-names></name><name name-style=\"western\"><surname>Ogundairo</surname><given-names>O</given-names></name><name name-style=\"western\"><surname>Maduka</surname><given-names>CP</given-names></name><name name-style=\"western\"><surname>Okongwu</surname><given-names>CC</given-names></name><name name-style=\"western\"><surname>Babarinde</surname><given-names>AO</given-names></name><name name-style=\"western\"><surname>Sodamade</surname><given-names>OT</given-names></name></person-group>. <article-title>Digital health technologies in chronic disease management: a global pe rspective</article-title>. <source>Int J Res Sci Innov</source>. (<year>2024</year>) <volume>X</volume>:<fpage>533</fpage>&#8211;<lpage>51</lpage>. doi: <pub-id pub-id-type=\"doi\">10.51244/IJRSI.2023.1012041</pub-id></mixed-citation></ref><ref id=\"ref11\"><label>11.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Subramanian</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Wojtusciszyn</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Favre</surname><given-names>L</given-names></name><name name-style=\"western\"><surname>Boughorbel</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Shan</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Letaief</surname><given-names>KB</given-names></name><etal/></person-group>. <article-title>Precision medicine in the era of artificial intelligence: implications in chronic disease management</article-title>. <source>J Transl Med</source>. (<year>2020</year>) <volume>18</volume>:<fpage>472</fpage>. doi: <pub-id pub-id-type=\"doi\">10.1186/s12967-020-02658-5</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">33298113</pub-id><pub-id pub-id-type=\"pmcid\">PMC7725219</pub-id></mixed-citation></ref><ref id=\"ref12\"><label>12.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Farrag</surname><given-names>AN</given-names></name><name name-style=\"western\"><surname>Kamel</surname><given-names>AM</given-names></name><name name-style=\"western\"><surname>El-Baraky</surname><given-names>IA</given-names></name></person-group>. <article-title>Opportunities and challenges for the application of artificial intelli gence paradigms into the management of endemic viral infections: the e xample of chronic hepatitis C virus</article-title>. <source>Rev Med Virol</source>. (<year>2024</year>) <volume>34</volume>. doi: <pub-id pub-id-type=\"doi\">10.1002/rmv.2514</pub-id></mixed-citation></ref><ref id=\"ref13\"><label>13.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Liu</surname><given-names>K</given-names></name><name name-style=\"western\"><surname>Li</surname><given-names>L</given-names></name><name name-style=\"western\"><surname>Ma</surname><given-names>Y</given-names></name><name name-style=\"western\"><surname>Jiang</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Liu</surname><given-names>Z</given-names></name><name name-style=\"western\"><surname>Ye</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Machine learning models for blood glucose level prediction in patients with diabetes mellitus: systematic review and network meta-analysis</article-title>. <source>JMIR Med Inform</source>. (<year>2023</year>) <volume>11</volume>:<fpage>e47833</fpage>. doi: <pub-id pub-id-type=\"doi\">10.2196/47833</pub-id><pub-id pub-id-type=\"pmid\">37983072</pub-id><pub-id pub-id-type=\"pmcid\">PMC10696506</pub-id></mixed-citation></ref><ref id=\"ref14\"><label>14.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Kurdi</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Alamer</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Wali</surname><given-names>H</given-names></name><name name-style=\"western\"><surname>Badr</surname><given-names>AF</given-names></name><name name-style=\"western\"><surname>Pendergrass</surname><given-names>ML</given-names></name><name name-style=\"western\"><surname>Ahmed</surname><given-names>N</given-names></name><etal/></person-group>. <article-title>Proof-of-concept study of using supervised machine learning algorithms to predict self-care and glycemic control in type 1 diabetes patients on insulin pump therapy</article-title>. <source>Endocr Pract</source>. (<year>2023</year>) <volume>29</volume>:<fpage>448</fpage>&#8211;<lpage>55</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1016/j.eprac.2023.03.002</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">36898528</pub-id></mixed-citation></ref><ref id=\"ref15\"><label>15.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Hankosky</surname><given-names>ER</given-names></name><name name-style=\"western\"><surname>Katz</surname><given-names>ML</given-names></name><name name-style=\"western\"><surname>Fan</surname><given-names>L</given-names></name><name name-style=\"western\"><surname>Liu</surname><given-names>D</given-names></name><name name-style=\"western\"><surname>Chinthammit</surname><given-names>C</given-names></name><name name-style=\"western\"><surname>Brnabic</surname><given-names>AJ</given-names></name><etal/></person-group>. <article-title>Predictors of insulin pump initiation among people with type 2 diabetes from a US claims database using machine learning</article-title>. <source>Curr Med Res Opin</source>. (<year>2023</year>) <volume>39</volume>:<fpage>843</fpage>&#8211;<lpage>53</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1080/03007995.2023.2205795</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">37139823</pub-id></mixed-citation></ref><ref id=\"ref16\"><label>16.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Ali</surname><given-names>H</given-names></name><name name-style=\"western\"><surname>Niazi</surname><given-names>IK</given-names></name><name name-style=\"western\"><surname>White</surname><given-names>D</given-names></name><name name-style=\"western\"><surname>Akhter</surname><given-names>MN</given-names></name><name name-style=\"western\"><surname>Madanian</surname><given-names>S</given-names></name></person-group>. <article-title>Comparison of machine learning models for predicting interstitial glucose using smart watch and food log</article-title>. <source>Electronics</source>. (<year>2024</year>) <volume>13</volume>:<fpage>3192</fpage>. doi: <pub-id pub-id-type=\"doi\">10.3390/electronics13163192</pub-id></mixed-citation></ref><ref id=\"ref17\"><label>17.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Jafar</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Kobayati</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Tsoukas</surname><given-names>MA</given-names></name><name name-style=\"western\"><surname>Haidar</surname><given-names>A</given-names></name></person-group>. <article-title>Personalized insulin dosing using reinforcement learning for high-fat meals and aerobic exercises in type 1 diabetes: a proof-of-concept trial</article-title>. <source>Nat Commun</source>. (<year>2024</year>) <volume>15</volume>:<fpage>6585</fpage>. doi: <pub-id pub-id-type=\"doi\">10.1038/s41467-024-50764-5</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">39097566</pub-id><pub-id pub-id-type=\"pmcid\">PMC11297938</pub-id></mixed-citation></ref><ref id=\"ref18\"><label>18.</label><mixed-citation publication-type=\"other\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Khedekar</surname><given-names>L.</given-names></name><name name-style=\"western\"><surname>Jain</surname><given-names>S.</given-names></name><name name-style=\"western\"><surname>Jadhav</surname><given-names>S.</given-names></name><name name-style=\"western\"><surname>Jagdale</surname><given-names>S.</given-names></name><name name-style=\"western\"><surname>Jain</surname><given-names>J.</given-names></name><name name-style=\"western\"><surname>Jain</surname><given-names>J.</given-names></name></person-group> (<year>2025</year>) <source>Optimizing disease prediction using machine learning techniques and personalized nutrition and diet plan</source></mixed-citation></ref><ref id=\"ref19\"><label>19.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Contreras</surname><given-names>I</given-names></name><name name-style=\"western\"><surname>Vehi</surname><given-names>J</given-names></name></person-group>. <article-title>Artificial intelligence for diabetes management and decision support: literature review</article-title>. <source>J Med Internet Res</source>. (<year>2018</year>) <volume>20</volume>:<fpage>e10775</fpage>. doi: <pub-id pub-id-type=\"doi\">10.2196/10775</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">29848472</pub-id><pub-id pub-id-type=\"pmcid\">PMC6000484</pub-id></mixed-citation></ref><ref id=\"ref20\"><label>20.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Nomura</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Noguchi</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Kometani</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Furukawa</surname><given-names>K</given-names></name><name name-style=\"western\"><surname>Yoneda</surname><given-names>T</given-names></name></person-group>. <article-title>Artificial intelligence in current diabetes management and prediction</article-title>. <source>Curr Diab Rep</source>. (<year>2021</year>) <volume>21</volume>:<fpage>61</fpage>. doi: <pub-id pub-id-type=\"doi\">10.1007/s11892-021-01423-2</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">34902070</pub-id><pub-id pub-id-type=\"pmcid\">PMC8668843</pub-id></mixed-citation></ref><ref id=\"ref21\"><label>21.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Joachim</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Forkan</surname><given-names>ARM</given-names></name><name name-style=\"western\"><surname>Jayaraman</surname><given-names>PP</given-names></name><name name-style=\"western\"><surname>Morshed</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Wickramasinghe</surname><given-names>N</given-names></name></person-group>. <article-title>A nudge-inspired AI-driven health platform for self-management of diab etes</article-title>. <source>Sensors</source>. (<year>2022</year>) <volume>22</volume>:<fpage>4620</fpage>. doi: <pub-id pub-id-type=\"doi\">10.3390/s22124620</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">35746402</pub-id><pub-id pub-id-type=\"pmcid\">PMC9227220</pub-id></mixed-citation></ref><ref id=\"ref22\"><label>22.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Faruqui</surname><given-names>SHA</given-names></name><name name-style=\"western\"><surname>Alaeddini</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Du</surname><given-names>Y</given-names></name><name name-style=\"western\"><surname>Li</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Sharma</surname><given-names>K</given-names></name><name name-style=\"western\"><surname>Wang</surname><given-names>J</given-names></name></person-group>. <article-title>Nurse-in-the-loop artificial intelligence for precision management of type 2 diabetes in a clinical trial utilizing transfer-learned predict ive digital twin</article-title>. <source>arXiv</source>. (<year>2024</year>)</mixed-citation></ref><ref id=\"ref23\"><label>23.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Jin</surname><given-names>X</given-names></name><name name-style=\"western\"><surname>Cai</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Xu</surname><given-names>T</given-names></name><name name-style=\"western\"><surname>Zhang</surname><given-names>X</given-names></name></person-group>. <article-title>Artificial intelligence biosensors for continuous glucose monitoring</article-title>. <source>Interdiscip Mater</source>. (<year>2023</year>) <volume>2</volume>:<fpage>290</fpage>&#8211;<lpage>307</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1002/idm2.12069</pub-id></mixed-citation></ref><ref id=\"ref24\"><label>24.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Nimri</surname><given-names>R</given-names></name><name name-style=\"western\"><surname>Phillip</surname><given-names>M</given-names></name></person-group>. <article-title>Enhancing care in type 1 diabetes with artificial intelligence driven clinical decision support systems</article-title>. <source>Horm Res Paediatr</source>. (<year>2025</year>) <volume>98</volume>:<fpage>1</fpage>&#8211;<lpage>22</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1159/000546713</pub-id><pub-id pub-id-type=\"pmid\">40472820</pub-id></mixed-citation></ref><ref id=\"ref25\"><label>25.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Mistry</surname><given-names>P</given-names></name></person-group>. <article-title>Artificial intelligence in primary care</article-title>. <source>Br J Gen Pract</source>. (<year>2019</year>) <volume>69</volume>:<fpage>422</fpage>&#8211;<lpage>3</lpage>. doi: <pub-id pub-id-type=\"doi\">10.3399/bjgp19X705137</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">31467001</pub-id><pub-id pub-id-type=\"pmcid\">PMC6715470</pub-id></mixed-citation></ref><ref id=\"ref26\"><label>26.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Hinchliffe</surname><given-names>N</given-names></name><name name-style=\"western\"><surname>Capehorn</surname><given-names>MS</given-names></name><name name-style=\"western\"><surname>Bewick</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Feenie</surname><given-names>J</given-names></name></person-group>. <article-title>The potential role of digital health in obesity care</article-title>. <source>Adv Ther</source>. (<year>2022</year>) <volume>39</volume>:<fpage>4397</fpage>&#8211;<lpage>412</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1007/s12325-022-02265-4</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">35925469</pub-id><pub-id pub-id-type=\"pmcid\">PMC9362065</pub-id></mixed-citation></ref><ref id=\"ref27\"><label>27.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Jiang</surname><given-names>X</given-names></name><name name-style=\"western\"><surname>Lv</surname><given-names>G</given-names></name><name name-style=\"western\"><surname>Li</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Yuan</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Lu</surname><given-names>ZK</given-names></name></person-group>. <article-title>Predicting diabetes self-management education engagement: machine learning algorithms and models</article-title>. <source>BMJ Open Diabetes Res Care</source>. (<year>2025</year>) <volume>13</volume>:<fpage>e004632</fpage>. doi: <pub-id pub-id-type=\"doi\">10.1136/bmjdrc-2024-004632</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">39965870</pub-id><pub-id pub-id-type=\"pmcid\">PMC11836835</pub-id></mixed-citation></ref><ref id=\"ref28\"><label>28.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Li</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Huang</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Zheng</surname><given-names>L</given-names></name><name name-style=\"western\"><surname>Li</surname><given-names>X</given-names></name></person-group>. <article-title>Application of artificial intelligence in diabetes education and manag ement: present status and promising prospect</article-title>. <source>Front Public Health</source>. (<year>2020</year>) <volume>8</volume>:<fpage>173</fpage>. doi: <pub-id pub-id-type=\"doi\">10.3389/fpubh.2020.00173</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">32548087</pub-id><pub-id pub-id-type=\"pmcid\">PMC7273319</pub-id></mixed-citation></ref><ref id=\"ref29\"><label>29.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Schneider</surname><given-names>D</given-names></name><name name-style=\"western\"><surname>Liedtke</surname><given-names>W</given-names></name><name name-style=\"western\"><surname>Klausen</surname><given-names>AD</given-names></name><name name-style=\"western\"><surname>Lipprandt</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Funer</surname><given-names>F</given-names></name><name name-style=\"western\"><surname>Bratan</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Indecision on the use of artificial intelligence in healthcare&#8212;a qualitative study of patient perspectives on trust, responsibility and self-determination using AI-CDSS</article-title>. <source>Digit Health</source>. (<year>2025</year>) <volume>11</volume>:<fpage>20552076251339522</fpage>. doi: <pub-id pub-id-type=\"doi\">10.1177/20552076251339522</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">40469779</pub-id><pub-id pub-id-type=\"pmcid\">PMC12134509</pub-id></mixed-citation></ref><ref id=\"ref30\"><label>30.</label><mixed-citation publication-type=\"other\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Faruqui</surname><given-names>S. H. A.</given-names></name><name name-style=\"western\"><surname>Alaeddini</surname><given-names>A.</given-names></name><name name-style=\"western\"><surname>Du</surname><given-names>Y.</given-names></name><name name-style=\"western\"><surname>Li</surname><given-names>S.</given-names></name><name name-style=\"western\"><surname>Sharma</surname><given-names>K.</given-names></name><name name-style=\"western\"><surname>Wang</surname><given-names>J.</given-names></name></person-group> (<year>2024</year>). <article-title>Nurse-in-the-loop artificial intelligence for precision management of type 2 diabetes in a clinical trial utilizing transfer-learned predictive digital twin</article-title>. <comment>arXiv preprint arXiv:2401.02661.</comment></mixed-citation></ref><ref id=\"ref31\"><label>31.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Molt&#243;-Balado</surname><given-names>P</given-names></name><name name-style=\"western\"><surname>Revert&#233;-Villarroya</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Alonso-Barber&#225;n</surname><given-names>V</given-names></name><name name-style=\"western\"><surname>Moncl&#250;s-Arasa</surname><given-names>C</given-names></name><name name-style=\"western\"><surname>Balado-Albiol</surname><given-names>MT</given-names></name><name name-style=\"western\"><surname>Clua-Queralt</surname><given-names>J</given-names></name><etal/></person-group>. <article-title>Machine learning approaches to predict major adverse cardiovascular events in atrial fibrillation</article-title>. <source>Technologies</source>. (<year>2024</year>) <volume>12</volume>:<fpage>13</fpage>. doi: <pub-id pub-id-type=\"doi\">10.3390/technologies12020013</pub-id></mixed-citation></ref><ref id=\"ref32\"><label>32.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Steinman</surname><given-names>L</given-names></name><name name-style=\"western\"><surname>Heang</surname><given-names>H</given-names></name><name name-style=\"western\"><surname>Pelt</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Ide</surname><given-names>N</given-names></name><name name-style=\"western\"><surname>Cui</surname><given-names>H</given-names></name><name name-style=\"western\"><surname>Rao</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Facilitators and barriers to chronic disease self-management and mobil e health interventions for people living with diabetes and hypertensio n in Cambodia: qualitative study</article-title>. <source>J Med Internet Res Mhealth Uhealth</source>. (<year>2020</year>) <volume>8</volume>:<fpage>e13536</fpage>. doi: <pub-id pub-id-type=\"doi\">10.2196/13536</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">32329737</pub-id><pub-id pub-id-type=\"pmcid\">PMC7210501</pub-id></mixed-citation></ref><ref id=\"ref33\"><label>33.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Li</surname><given-names>Y</given-names></name><name name-style=\"western\"><surname>Wu</surname><given-names>X</given-names></name><name name-style=\"western\"><surname>Liu</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Deng</surname><given-names>K</given-names></name><name name-style=\"western\"><surname>Tullini</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Zhang</surname><given-names>X</given-names></name><etal/></person-group>. <article-title>Enhanced control of periodontitis by an artificial intelligence-enable d multimodal-sensing toothbrush and targeted &lt;scp&gt;mHealth&lt;/scp&gt; microm essages: a randomized trial</article-title>. <source>J Clin Periodontol</source>. (<year>2024</year>) <volume>51</volume>:<fpage>1632</fpage>&#8211;<lpage>43</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1111/jcpe.13987</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">38631679</pub-id><pub-id pub-id-type=\"pmcid\">PMC11651722</pub-id></mixed-citation></ref><ref id=\"ref34\"><label>34.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Zhuang</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Hassan</surname><given-names>II</given-names></name><name name-style=\"western\"><surname>Ahmad</surname><given-names>WWMA</given-names></name><name name-style=\"western\"><surname>Abdul Kadir</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Liu</surname><given-names>X</given-names></name><name name-style=\"western\"><surname>Li</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Effectiveness of digital health interventions for chronic obstructive pulmonary disease: systematic review and meta-analysis</article-title>. <source>J Med Internet Res</source>. (<year>2025</year>) <volume>27</volume>:<fpage>e76323</fpage>. doi: <pub-id pub-id-type=\"doi\">10.2196/76323</pub-id><pub-id pub-id-type=\"pmid\">40418567</pub-id><pub-id pub-id-type=\"pmcid\">PMC12149779</pub-id></mixed-citation></ref><ref id=\"ref35\"><label>35.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Park</surname><given-names>Y</given-names></name><name name-style=\"western\"><surname>Lee</surname><given-names>C</given-names></name><name name-style=\"western\"><surname>Jung</surname><given-names>JY</given-names></name></person-group>. <article-title>Digital healthcare for airway diseases from personal environmental exposure</article-title>. <source>Yonsei Med J</source>. (<year>2022</year>) <volume>63</volume>:<fpage>S1</fpage>&#8211;<lpage>S13</lpage>. doi: <pub-id pub-id-type=\"doi\">10.3349/ymj.2022.63.S1</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">35040601</pub-id><pub-id pub-id-type=\"pmcid\">PMC8790581</pub-id></mixed-citation></ref><ref id=\"ref36\"><label>36.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Wang</surname><given-names>X</given-names></name><name name-style=\"western\"><surname>Qiao</surname><given-names>Y</given-names></name><name name-style=\"western\"><surname>Cui</surname><given-names>Y</given-names></name><name name-style=\"western\"><surname>Ren</surname><given-names>H</given-names></name><name name-style=\"western\"><surname>Zhao</surname><given-names>Y</given-names></name><name name-style=\"western\"><surname>Linghu</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>An explainable artificial intelligence framework for risk prediction of COPD in smokers</article-title>. <source>BMC Public Health</source>. (<year>2023</year>) <volume>23</volume>:<fpage>2164</fpage>. doi: <pub-id pub-id-type=\"doi\">10.1186/s12889-023-17011-w</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">37932692</pub-id><pub-id pub-id-type=\"pmcid\">PMC10626705</pub-id></mixed-citation></ref><ref id=\"ref37\"><label>37.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Easton</surname><given-names>K</given-names></name><name name-style=\"western\"><surname>Potter</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Bec</surname><given-names>R</given-names></name><name name-style=\"western\"><surname>Bennion</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Christensen</surname><given-names>H</given-names></name><name name-style=\"western\"><surname>Grindell</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>A virtual agent to support individuals living with physical and mental comorbidities: co-design and acceptability testing</article-title>. <source>J Med Internet Res</source>. (<year>2019</year>) <volume>21</volume>:<fpage>e12996</fpage>. doi: <pub-id pub-id-type=\"doi\">10.2196/12996</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">31148545</pub-id><pub-id pub-id-type=\"pmcid\">PMC6658240</pub-id></mixed-citation></ref><ref id=\"ref38\"><label>38.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Yang</surname><given-names>X</given-names></name></person-group>. <article-title>Application and prospects of artificial intelligence technology in early screening of chronic obstructive pulmonary disease at primary healthcare institutions in China</article-title>. <source>Int J Chron Obstruct Pulmon Dis</source>. (<year>2024</year>) <volume>19</volume>:<fpage>1061</fpage>&#8211;<lpage>7</lpage>. doi: <pub-id pub-id-type=\"doi\">10.2147/COPD.S458935</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">38765765</pub-id><pub-id pub-id-type=\"pmcid\">PMC11102166</pub-id></mixed-citation></ref><ref id=\"ref39\"><label>39.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Robertson</surname><given-names>NM</given-names></name><name name-style=\"western\"><surname>Centner</surname><given-names>CS</given-names></name><name name-style=\"western\"><surname>Siddharthan</surname><given-names>T</given-names></name></person-group>. <article-title>Integrating artificial intelligence in the diagnosis of COPD globally: a way forward</article-title>. <source>Chronic Obstr Pulm Dis</source>. (<year>2023</year>) <volume>11</volume>:<fpage>114</fpage>.<pub-id pub-id-type=\"doi\" assigning-authority=\"pmc\">10.15326/jcopdf.2023.0449</pub-id><pub-id pub-id-type=\"pmcid\">PMC10913925</pub-id><pub-id pub-id-type=\"pmid\">37828644</pub-id></mixed-citation></ref><ref id=\"ref40\"><label>40.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Aminnejad</surname><given-names>N</given-names></name><name name-style=\"western\"><surname>Greiver</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Huang</surname><given-names>H</given-names></name></person-group>. <article-title>Predicting the onset of chronic kidney disease (CKD) for diabetic patients with aggregated longitudinal EMR data</article-title>. <source>PLoS Digital Health</source>. (<year>2025</year>) <volume>4</volume>:<fpage>e0000700</fpage>. doi: <pub-id pub-id-type=\"doi\">10.1371/journal.pdig.0000700</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">39841679</pub-id><pub-id pub-id-type=\"pmcid\">PMC11753645</pub-id></mixed-citation></ref><ref id=\"ref41\"><label>41.</label><mixed-citation publication-type=\"book\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Cleary</surname><given-names>F. A. Y. E.</given-names></name></person-group> (<year>2024</year>) <source>Challenges of studying and predicting chronic kidney disease progression and its complications using routinely collected electronic healthcare records (doctoral dissertation, London School of Hygiene &amp; tropical medicine)</source>. <publisher-loc>London</publisher-loc>.</mixed-citation></ref><ref id=\"ref42\"><label>42.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Li</surname><given-names>Z</given-names></name><name name-style=\"western\"><surname>Liu</surname><given-names>X</given-names></name><name name-style=\"western\"><surname>Tang</surname><given-names>Z</given-names></name><name name-style=\"western\"><surname>Jin</surname><given-names>N</given-names></name><name name-style=\"western\"><surname>Zhang</surname><given-names>P</given-names></name><name name-style=\"western\"><surname>Eadon</surname><given-names>MT</given-names></name><etal/></person-group>. <article-title>Trajvis: a visual clinical decision support system to translate artificial intelligence trajectory models in the precision management of chronic kidney disease</article-title>. <source>J Am Med Inform Assoc</source>. (<year>2024</year>) <volume>31</volume>:<fpage>2474</fpage>&#8211;<lpage>85</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1093/jamia/ocae158</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">38916922</pub-id><pub-id pub-id-type=\"pmcid\">PMC11491615</pub-id></mixed-citation></ref><ref id=\"ref43\"><label>43.</label><mixed-citation publication-type=\"journal\"><label/><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Sawhney</surname><given-names>R</given-names></name><name name-style=\"western\"><surname>Malik</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Sharma</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Narayan</surname><given-names>V</given-names></name></person-group>. <article-title>A comparative assessment of artificial intelligence models used for early prediction and evaluation of chronic kidney disease</article-title>. <source>Decis Anal J</source>. (<year>2023</year>) <volume>6</volume>:<fpage>100169</fpage>. doi: <pub-id pub-id-type=\"doi\">10.1016/j.dajour.2023.100169</pub-id></mixed-citation></ref><ref id=\"ref44\"><label>44.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Barbieri</surname><given-names>C</given-names></name><name name-style=\"western\"><surname>Cattinelli</surname><given-names>I</given-names></name><name name-style=\"western\"><surname>Neri</surname><given-names>L</given-names></name><name name-style=\"western\"><surname>Mari</surname><given-names>F</given-names></name><name name-style=\"western\"><surname>Ramos</surname><given-names>R</given-names></name><name name-style=\"western\"><surname>Brancaccio</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Development of an artificial intelligence model to guide the management of blood pressure, fluid volume, and dialysis dose in end-stage kidney disease patients: proof of concept and first clinical assessment</article-title>. <source>Kidney Dis</source>. (<year>2019</year>) <volume>5</volume>:<fpage>28</fpage>&#8211;<lpage>33</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1159/000493479</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">30815462</pub-id><pub-id pub-id-type=\"pmcid\">PMC6388445</pub-id></mixed-citation></ref><ref id=\"ref45\"><label>45.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Alhur</surname><given-names>A</given-names></name></person-group>. <article-title>Redefining healthcare with artificial intelligence (AI): the contributions of ChatGPT, Gemini, and co-pilot</article-title>. <source>Cureus</source>. (<year>2024</year>) <volume>16</volume>:<fpage>e57795</fpage>. doi: <pub-id pub-id-type=\"doi\">10.7759/cureus.57795</pub-id><pub-id pub-id-type=\"pmid\">38721180</pub-id><pub-id pub-id-type=\"pmcid\">PMC11077095</pub-id></mixed-citation></ref><ref id=\"ref46\"><label>46.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Alanezi</surname><given-names>F</given-names></name></person-group>. <article-title>Assessing the effectiveness of ChatGPT in delivering mental health support: a qualitative study</article-title>. <source>J Multidiscip Healthc</source>. (<year>2024</year>) <volume>17</volume>:<fpage>461</fpage>&#8211;<lpage>71</lpage>. doi: <pub-id pub-id-type=\"doi\">10.2147/JMDH.S447368</pub-id><pub-id pub-id-type=\"pmid\">38314011</pub-id><pub-id pub-id-type=\"pmcid\">PMC10838501</pub-id></mixed-citation></ref><ref id=\"ref47\"><label>47.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Babington-Ashaye</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Moerloose</surname><given-names>P</given-names></name><name name-style=\"western\"><surname>Diop</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Geissbuhler</surname><given-names>A</given-names></name></person-group>. <article-title>Design, development and usability of an educational AI chatbot for people with Haemophilia in Senegal</article-title>. <source>Haemophilia</source>. (<year>2023</year>) <volume>29</volume>:<fpage>1063</fpage>&#8211;<lpage>73</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1111/hae.14815</pub-id><pub-id pub-id-type=\"pmid\">37347648</pub-id></mixed-citation></ref><ref id=\"ref48\"><label>48.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Yoon</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Lau</surname><given-names>R</given-names></name><name name-style=\"western\"><surname>Kwan</surname><given-names>YH</given-names></name><name name-style=\"western\"><surname>Liu</surname><given-names>H</given-names></name><name name-style=\"western\"><surname>Sahrin</surname><given-names>R</given-names></name><name name-style=\"western\"><surname>Phang</surname><given-names>JK</given-names></name><etal/></person-group>. <article-title>Acceptability of an AI-enabled family module in a mobile app for enhanced diabetes management: patient and family perspectives</article-title>. <source>Digit Health</source>. (<year>2025</year>) <volume>11</volume>:<fpage>20552076251322654</fpage>. doi: <pub-id pub-id-type=\"doi\">10.1177/20552076251322654</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">40144049</pub-id><pub-id pub-id-type=\"pmcid\">PMC11938869</pub-id></mixed-citation></ref><ref id=\"ref49\"><label>49.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Sone</surname><given-names>PE</given-names></name><name name-style=\"western\"><surname>Ebune</surname><given-names>EJ</given-names></name><name name-style=\"western\"><surname>Odama</surname><given-names>A</given-names></name></person-group>. <article-title>AI-driven behavioral health education to reduce diabetes distress: early clinical evidence informing AI chatbot design</article-title>. <source>Glob Acad J Med Sci</source>. (<year>2024</year>) <volume>6</volume>. doi: <pub-id pub-id-type=\"doi\">10.36348/gajms.2024.v06i06.010</pub-id></mixed-citation></ref><ref id=\"ref50\"><label>50.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Barrett</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Boyne</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Brandts</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Brunner-La Rocca</surname><given-names>H-P</given-names></name><name name-style=\"western\"><surname>De Maesschalck</surname><given-names>L</given-names></name><name name-style=\"western\"><surname>De Wit</surname><given-names>K</given-names></name><etal/></person-group>. <article-title>Artificial intelligence supported patient self-care in chronic heart f ailure: a paradigm shift from reactive to predictive, preventive and p ersonalised care</article-title>. <source>EPMA J</source>. (<year>2019</year>) <volume>10</volume>:<fpage>445</fpage>&#8211;<lpage>64</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1007/s13167-019-00188-9</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">31832118</pub-id><pub-id pub-id-type=\"pmcid\">PMC6882991</pub-id></mixed-citation></ref><ref id=\"ref51\"><label>51.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Zhang</surname><given-names>Q</given-names></name><name name-style=\"western\"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style=\"western\"><surname>Long</surname><given-names>T</given-names></name><name name-style=\"western\"><surname>Wu</surname><given-names>Y</given-names></name><name name-style=\"western\"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style=\"western\"><surname>Li</surname><given-names>M</given-names></name></person-group>. <article-title>Effects of nudge strategy-based dietary education intervention in patients with type 2 diabetes mellitus: a cluster randomized controlled trial</article-title>. <source>Diabetes Metab</source>. (<year>2024</year>) <volume>50</volume>:<fpage>101563</fpage>. doi: <pub-id pub-id-type=\"doi\">10.1016/j.diabet.2024.101563</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">38981568</pub-id></mixed-citation></ref><ref id=\"ref52\"><label>52.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Yu</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Fu</surname><given-names>Y</given-names></name><name name-style=\"western\"><surname>Du</surname><given-names>H</given-names></name><name name-style=\"western\"><surname>Wu</surname><given-names>Q</given-names></name><name name-style=\"western\"><surname>Zhang</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Zhao</surname><given-names>B</given-names></name><etal/></person-group>. <article-title>The effectiveness of nudge-based interventions on self-monitoring behaviours among patients with cardiometabolic diseases: a systematic review and meta-analysis</article-title>. <source>Health Psychol Rev</source>. (<year>2025</year>):<fpage>1</fpage>&#8211;<lpage>28</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1080/17437199.2025.2532017</pub-id><pub-id pub-id-type=\"pmid\">40701164</pub-id></mixed-citation></ref><ref id=\"ref53\"><label>53.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Khalifa</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Albadawy</surname><given-names>M</given-names></name></person-group>. <article-title>Artificial intelligence for diabetes: enhancing prevention, diagnosis, and effective management</article-title>. <source>Comput Methods Programs Biomed Update</source>. (<year>2024</year>) <volume>5</volume>:<fpage>100141</fpage>. doi: <pub-id pub-id-type=\"doi\">10.1016/j.cmpbup.2024.100141</pub-id></mixed-citation></ref><ref id=\"ref54\"><label>54.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Sarma</surname><given-names>AD</given-names></name><name name-style=\"western\"><surname>Devi</surname><given-names>M</given-names></name></person-group>. <article-title>Artificial intelligence in diabetes management: transformative potential, challenges, and opportunities in healthcare</article-title>. <source>Hormones</source>. (<year>2025</year>) <volume>24</volume>:<fpage>307</fpage>&#8211;<lpage>22</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1007/s42000-025-00644-4</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">40116992</pub-id></mixed-citation></ref><ref id=\"ref55\"><label>55.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Goldstein</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Weitzman</surname><given-names>D</given-names></name><name name-style=\"western\"><surname>Lemerond</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Jones</surname><given-names>A</given-names></name></person-group>. <article-title>Determinants for scalable adoption of autonomous AI in the detection of diabetic eye disease in diverse practice types: key best practices learned through collection of real-world data</article-title>. <source>Front Digital Health</source>. (<year>2023</year>) <volume>5</volume>:<fpage>1004130</fpage>. doi: <pub-id pub-id-type=\"doi\">10.3389/fdgth.2023.1004130</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">37274764</pub-id><pub-id pub-id-type=\"pmcid\">PMC10232822</pub-id></mixed-citation></ref><ref id=\"ref56\"><label>56.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Hwang</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Zheng</surname><given-names>Y</given-names></name><name name-style=\"western\"><surname>Cho</surname><given-names>Y</given-names></name><name name-style=\"western\"><surname>Jiang</surname><given-names>Y</given-names></name></person-group>. <article-title>AI applications for chronic condition self-management: scoping review</article-title>. <source>J Med Internet Res</source>. (<year>2025</year>) <volume>27</volume>:<fpage>e59632</fpage>. doi: <pub-id pub-id-type=\"doi\">10.2196/59632</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">40198108</pub-id><pub-id pub-id-type=\"pmcid\">PMC12015343</pub-id></mixed-citation></ref><ref id=\"ref57\"><label>57.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Zhang</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Zhu</surname><given-names>L</given-names></name><name name-style=\"western\"><surname>Lin</surname><given-names>SY</given-names></name><name name-style=\"western\"><surname>Herr</surname><given-names>K</given-names></name><name name-style=\"western\"><surname>Chi</surname><given-names>CL</given-names></name><name name-style=\"western\"><surname>Demir</surname><given-names>I</given-names></name><etal/></person-group>. <article-title>Using artificial intelligence to improve pain assessment and pain management: a scoping review</article-title>. <source>J Am Med Inform Assoc</source>. (<year>2023</year>) <volume>30</volume>:<fpage>570</fpage>&#8211;<lpage>87</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1093/jamia/ocac231</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">36458955</pub-id><pub-id pub-id-type=\"pmcid\">PMC9933069</pub-id></mixed-citation></ref><ref id=\"ref58\"><label>58.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Kim</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Lee</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Kim</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Heo</surname><given-names>JI</given-names></name><name name-style=\"western\"><surname>Lee</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Shin</surname><given-names>YB</given-names></name><etal/></person-group>. <article-title>Therapeutic potential of social chatbots in alleviating loneliness and social anxiety: quasi-experimental mixed methods study</article-title>. <source>J Med Internet Res</source>. (<year>2025</year>) <volume>27</volume>:<fpage>e65589</fpage>. doi: <pub-id pub-id-type=\"doi\">10.2196/65589</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">39808786</pub-id><pub-id pub-id-type=\"pmcid\">PMC11775481</pub-id></mixed-citation></ref><ref id=\"ref59\"><label>59.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Seidu</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Owusu-Agyeman</surname><given-names>AK</given-names></name><name name-style=\"western\"><surname>Ibrahim</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Kyiu</surname><given-names>C</given-names></name><name name-style=\"western\"><surname>Ababio-Boamah</surname><given-names>C</given-names></name></person-group>. <article-title>The role of AI in improving the management of chronic diseases in developing countries</article-title>. <source>Ghana J Nurs Midwifery</source>. (<year>2024</year>) <volume>1</volume>:<fpage>1</fpage>&#8211;<lpage>15</lpage>. doi: <pub-id pub-id-type=\"doi\">10.69600/gjnmid.2024.v01.i04.1-15</pub-id></mixed-citation></ref><ref id=\"ref60\"><label>60.</label><mixed-citation publication-type=\"confproc\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Dawood</surname><given-names>S.</given-names></name><name name-style=\"western\"><surname>Alsarhan</surname><given-names>R.</given-names></name><name name-style=\"western\"><surname>Albesher</surname><given-names>A.</given-names></name><name name-style=\"western\"><surname>Alsedais</surname><given-names>F.</given-names></name><name name-style=\"western\"><surname>Aldakheel</surname><given-names>A.</given-names></name><name name-style=\"western\"><surname>Alangari</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2024</year>) <article-title>The co-design process in the creation of conversational agents for people with dementia</article-title><conf-name>International Conference on Human-Computer Interaction</conf-name><fpage>347</fpage>&#8211;<lpage>357</lpage><publisher-loc>Cham</publisher-loc><publisher-name>Springer Nature Switzerland</publisher-name></mixed-citation></ref><ref id=\"ref61\"><label>61.</label><mixed-citation publication-type=\"confproc\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Khan</surname><given-names>F.</given-names></name><name name-style=\"western\"><surname>Wu</surname><given-names>Y.</given-names></name><name name-style=\"western\"><surname>Dray</surname><given-names>J.</given-names></name><name name-style=\"western\"><surname>Hemsley</surname><given-names>B.</given-names></name><name name-style=\"western\"><surname>Kocaballi</surname><given-names>A. B.</given-names></name></person-group> (<year>2025</year>). <article-title>Conversational agents to support people with communication disability: a co-design study with speech pathologists</article-title>. In <conf-name>Proceedings of the Extended Abstracts of the CHI Conference on Human Factors in Computing Systems</conf-name> (pp. <fpage>1</fpage>&#8211;<lpage>9</lpage>).</mixed-citation></ref><ref id=\"ref62\"><label>62.</label><mixed-citation publication-type=\"other\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Hanif</surname><given-names>M. I.</given-names></name><name name-style=\"western\"><surname>Sarrafan</surname><given-names>S.</given-names></name><name name-style=\"western\"><surname>Mohamed</surname><given-names>M.</given-names></name><name name-style=\"western\"><surname>Elashmawy</surname><given-names>S.</given-names></name></person-group> (<year>2025</year>). <source>The evolution of auscultation: harnessing artificial intelligence (AI) for the future of bedside diagnostics</source>.</mixed-citation></ref><ref id=\"ref63\"><label>63.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Venditto</surname><given-names>L</given-names></name><name name-style=\"western\"><surname>Morano</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Piazza</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Zaffanello</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Tenero</surname><given-names>L</given-names></name><name name-style=\"western\"><surname>Piacentini</surname><given-names>G</given-names></name><etal/></person-group>. <article-title>Artificial intelligence and wheezing in children: where are we now?</article-title><source>Front Med</source>. (<year>2024</year>) <volume>11</volume>:<fpage>11</fpage>. doi: <pub-id pub-id-type=\"doi\">10.3389/fmed.2024.1460050</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">39257890</pub-id><pub-id pub-id-type=\"pmcid\">PMC11385867</pub-id></mixed-citation></ref><ref id=\"ref64\"><label>64.</label><mixed-citation publication-type=\"book\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Perez Vallejos</surname><given-names>E</given-names></name><name name-style=\"western\"><surname>Dowthwaite</surname><given-names>L</given-names></name><name name-style=\"western\"><surname>Creswich</surname><given-names>H</given-names></name><name name-style=\"western\"><surname>Portillo</surname><given-names>V</given-names></name><name name-style=\"western\"><surname>Koene</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Jirotka</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>The impact of algorithmic decision-making processes on young people&#8217;s well-being</article-title>. <source>Health Informatics J</source>. <publisher-loc>England</publisher-loc>: <publisher-name>Sage Publications Ltd</publisher-name>. (<year>2021</year>) <volume>27</volume>:<fpage>1460458220972750</fpage>. doi: <pub-id pub-id-type=\"doi\">10.1177/1460458220972750</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">33446031</pub-id></mixed-citation></ref><ref id=\"ref65\"><label>65.</label><mixed-citation publication-type=\"journal\"><comment>A5</comment><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Maheshwari</surname><given-names>K</given-names></name><name name-style=\"western\"><surname>Cywinski</surname><given-names>JB</given-names></name><name name-style=\"western\"><surname>Papay</surname><given-names>F</given-names></name><name name-style=\"western\"><surname>Khanna</surname><given-names>AK</given-names></name><name name-style=\"western\"><surname>Mathur</surname><given-names>P</given-names></name></person-group>. <article-title>Artificial intelligence for perioperative medicine: perioperative intelligence</article-title>. <source>Anesth Analg</source>. (<year>2023</year>) <volume>136</volume>:<fpage>637</fpage>&#8211;<lpage>45</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1213/ANE.0000000000005952</pub-id><pub-id pub-id-type=\"pmid\">35203086</pub-id></mixed-citation></ref><ref id=\"ref66\"><label>66.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Tran</surname><given-names>K-V</given-names></name><name name-style=\"western\"><surname>Filippaios</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Noorishirazi</surname><given-names>K</given-names></name><name name-style=\"western\"><surname>Ding</surname><given-names>E</given-names></name></person-group>. <article-title>False atrial fibrillation alerts from smartwatches are associated with decreased perceived physical well-being and confidence in chronic sym ptoms management</article-title>. <source>Cardiol Cardiovasc Med</source>. (<year>2023</year>) <volume>7</volume>. doi: <pub-id pub-id-type=\"doi\">10.26502/fccm.92920314</pub-id><pub-id pub-id-type=\"pmcid\">PMC10358285</pub-id><pub-id pub-id-type=\"pmid\">37476150</pub-id></mixed-citation></ref><ref id=\"ref67\"><label>67.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Hay&#305;ro&#287;lu</surname><given-names>M&#304;</given-names></name><name name-style=\"western\"><surname>Altay</surname><given-names>S</given-names></name></person-group>. <article-title>The role of artificial intelligence in coronary artery disease and atr ial fibrillation</article-title>. <source>Balkan Med J</source>. (<year>2023</year>) <volume>40</volume>:<fpage>151</fpage>&#8211;<lpage>2</lpage>. doi: <pub-id pub-id-type=\"doi\">10.4274/balkanmedj.galenos.2023.06042023</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">37025078</pub-id><pub-id pub-id-type=\"pmcid\">PMC10175890</pub-id></mixed-citation></ref><ref id=\"ref68\"><label>68.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Bagheri</surname><given-names>AB</given-names></name><name name-style=\"western\"><surname>Rouzi</surname><given-names>MD</given-names></name><name name-style=\"western\"><surname>Koohbanani</surname><given-names>NA</given-names></name><name name-style=\"western\"><surname>Mahoor</surname><given-names>MH</given-names></name><name name-style=\"western\"><surname>Finco</surname><given-names>MG</given-names></name><name name-style=\"western\"><surname>Lee</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Potential applications of artificial intelligence and machine learning on diagnosis, treatment, and outcome prediction to address health car e disparities of chronic limb-threatening ischemia</article-title>. <source>Semin Vasc Surg</source>. (<year>2023</year>) <volume>36</volume>:<fpage>454</fpage>&#8211;<lpage>9</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1053/j.semvascsurg.2023.06.003</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">37863620</pub-id></mixed-citation></ref><ref id=\"ref69\"><label>69.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Deniz-Garcia</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Fabelo</surname><given-names>H</given-names></name><name name-style=\"western\"><surname>Rodriguez-Almeida</surname><given-names>AJ</given-names></name><name name-style=\"western\"><surname>Zamora-Zamorano</surname><given-names>G</given-names></name><name name-style=\"western\"><surname>Castro-Fernandez</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Alberiche Ruano</surname><given-names>MP</given-names></name><etal/></person-group>. <article-title>Quality, usability, and effectiveness of mHealth apps and the role of artificial intelligence: current scenario and challenges</article-title>. <source>J Med Internet Res</source>. (<year>2023</year>) <volume>25</volume>:<fpage>e44030</fpage>. doi: <pub-id pub-id-type=\"doi\">10.2196/44030</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">37140973</pub-id><pub-id pub-id-type=\"pmcid\">PMC10196903</pub-id></mixed-citation></ref><ref id=\"ref70\"><label>70.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Barreveld</surname><given-names>AM</given-names></name><name name-style=\"western\"><surname>Ros&#233;n Klement</surname><given-names>ML</given-names></name><name name-style=\"western\"><surname>Cheung</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Axelsson</surname><given-names>U</given-names></name><name name-style=\"western\"><surname>Basem</surname><given-names>JI</given-names></name><name name-style=\"western\"><surname>Reddy</surname><given-names>AS</given-names></name><etal/></person-group>. <article-title>An artificial intelligence-powered, patient-centric digital tool for s elf-management of chronic pain: a prospective, multicenter clinical tr ial</article-title>. <source>Pain Med</source>. (<year>2023</year>) <volume>24</volume>:<fpage>1100</fpage>&#8211;<lpage>10</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1093/pm/pnad049</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">37104747</pub-id></mixed-citation></ref><ref id=\"ref71\"><label>71.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Lo</surname><given-names>WLA</given-names></name><name name-style=\"western\"><surname>Lei</surname><given-names>D</given-names></name><name name-style=\"western\"><surname>Li</surname><given-names>L</given-names></name><name name-style=\"western\"><surname>Huang</surname><given-names>DF</given-names></name><name name-style=\"western\"><surname>Tong</surname><given-names>K-F</given-names></name></person-group>. <article-title>The perceived benefits of an artificial intelligence&#8211;embedded mobile a pp implementing evidence-based guidelines for the self-management of c hronic neck and back pain: observational study</article-title>. <source>JMIR Mhealth Uhealth</source>. (<year>2018</year>) <volume>6</volume>:<fpage>e198</fpage>. doi: <pub-id pub-id-type=\"doi\">10.2196/mhealth.8127</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">30478019</pub-id><pub-id pub-id-type=\"pmcid\">PMC6288595</pub-id></mixed-citation></ref><ref id=\"ref72\"><label>72.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Da Rio</surname><given-names>L</given-names></name><name name-style=\"western\"><surname>Spadaccini</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Parigi</surname><given-names>TL</given-names></name><name name-style=\"western\"><surname>Gabbiadini</surname><given-names>R</given-names></name><name name-style=\"western\"><surname>Dal Buono</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Busacca</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Artificial intelligence and inflammatory bowel disease: where are we g oing?</article-title><source>World J Gastroenterol</source>. (<year>2023</year>) <volume>29</volume>:<fpage>508</fpage>&#8211;<lpage>20</lpage>. doi: <pub-id pub-id-type=\"doi\">10.3748/wjg.v29.i3.508</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">36688019</pub-id><pub-id pub-id-type=\"pmcid\">PMC9850939</pub-id></mixed-citation></ref><ref id=\"ref73\"><label>73.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Luedke</surname><given-names>MW</given-names></name><name name-style=\"western\"><surname>Blalock</surname><given-names>DV</given-names></name><name name-style=\"western\"><surname>Goldstein</surname><given-names>KM</given-names></name><name name-style=\"western\"><surname>Kosinski</surname><given-names>AS</given-names></name><name name-style=\"western\"><surname>Sinha</surname><given-names>SR</given-names></name><name name-style=\"western\"><surname>Drake</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Self-management of epilepsy: a systematic review</article-title>. <source>Ann Intern Med</source>. (<year>2019</year>) <volume>171</volume>:<fpage>117</fpage>&#8211;<lpage>26</lpage>. doi: <pub-id pub-id-type=\"doi\">10.7326/M19-0458</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">31261386</pub-id></mixed-citation></ref><ref id=\"ref74\"><label>74.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Seliverstov</surname><given-names>PV</given-names></name></person-group>. <article-title>Psychology of patient adaptation to the use of artificial intelligence in screening for chronic noncommunicable diseases</article-title>. <source>Meditsinskiy Sovet</source>. (<year>2025</year>):<fpage>266</fpage>&#8211;<lpage>72</lpage>. doi: <pub-id pub-id-type=\"doi\">10.21518/ms2024-551</pub-id></mixed-citation></ref><ref id=\"ref75\"><label>75.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Topol</surname><given-names>EJ</given-names></name></person-group>. <article-title>High-performance medicine: the convergence of human and artificial intelligence</article-title>. <source>Nat Med</source>. (<year>2019</year>) <volume>25</volume>:<fpage>44</fpage>&#8211;<lpage>56</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1038/s41591-018-0300-7</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">30617339</pub-id></mixed-citation></ref><ref id=\"ref76\"><label>76.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Rajkomar</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Dean</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Kohane</surname><given-names>I</given-names></name></person-group>. <article-title>Machine learning in medicine</article-title>. <source>N Engl J Med</source>. (<year>2019</year>) <volume>380</volume>:<fpage>1347</fpage>&#8211;<lpage>58</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1056/NEJMra1814259</pub-id><pub-id pub-id-type=\"pmid\">30943338</pub-id></mixed-citation></ref><ref id=\"ref77\"><label>77.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Parikh</surname><given-names>RB</given-names></name><name name-style=\"western\"><surname>Obermeyer</surname><given-names>Z</given-names></name><name name-style=\"western\"><surname>Navathe</surname><given-names>AS</given-names></name></person-group>. <article-title>Regulation of predictive analytics in medicine</article-title>. <source>Science</source>. (<year>2019</year>) <volume>363</volume>:<fpage>810</fpage>&#8211;<lpage>2</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1126/science.aaw0029</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">30792287</pub-id><pub-id pub-id-type=\"pmcid\">PMC6557272</pub-id></mixed-citation></ref><ref id=\"ref78\"><label>78.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Vellido</surname><given-names>A</given-names></name></person-group>. <article-title>The importance of interpretability and visualization in machine learning for applications in medicine and healthcare</article-title>. <source>Neural Comput Applic</source>. (<year>2020</year>) <volume>32</volume>:<fpage>18069</fpage>&#8211;<lpage>83</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1007/s00521-019-04051-w</pub-id></mixed-citation></ref><ref id=\"ref79\"><label>79.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Matheny</surname><given-names>ME</given-names></name><name name-style=\"western\"><surname>Whicher</surname><given-names>D</given-names></name><name name-style=\"western\"><surname>Thadaney Israni</surname><given-names>S</given-names></name></person-group>. <article-title>Artificial intelligence in health care: a report from the National Academy of medicine</article-title>. <source>JAMA</source>. (<year>2020</year>) <volume>323</volume>:<fpage>509</fpage>&#8211;<lpage>10</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1001/jama.2019.21579</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">31845963</pub-id></mixed-citation></ref><ref id=\"ref80\"><label>80.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>He</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Baxter</surname><given-names>SL</given-names></name><name name-style=\"western\"><surname>Xu</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Xu</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Zhou</surname><given-names>X</given-names></name><name name-style=\"western\"><surname>Zhang</surname><given-names>K</given-names></name></person-group>. <article-title>The practical implementation of artificial intelligence technologies in medicine</article-title>. <source>Nat Med</source>. (<year>2019</year>) <volume>25</volume>:<fpage>30</fpage>&#8211;<lpage>6</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1038/s41591-018-0307-0</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">30617336</pub-id><pub-id pub-id-type=\"pmcid\">PMC6995276</pub-id></mixed-citation></ref><ref id=\"ref81\"><label>81.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Perez</surname><given-names>MV</given-names></name><name name-style=\"western\"><surname>Mahaffey</surname><given-names>KW</given-names></name><name name-style=\"western\"><surname>Hedlin</surname><given-names>H</given-names></name><name name-style=\"western\"><surname>Rumsfeld</surname><given-names>JS</given-names></name><name name-style=\"western\"><surname>Garcia</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Ferris</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>Large-scale assessment of a smartwatch to identify atrial fibrillation</article-title>. <source>N Engl J Med</source>. (<year>2019</year>) <volume>381</volume>:<fpage>1909</fpage>&#8211;<lpage>17</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1056/NEJMoa1901183</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">31722151</pub-id><pub-id pub-id-type=\"pmcid\">PMC8112605</pub-id></mixed-citation></ref><ref id=\"ref82\"><label>82.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Lubitz</surname><given-names>SA</given-names></name><name name-style=\"western\"><surname>Faranesh</surname><given-names>AZ</given-names></name><name name-style=\"western\"><surname>Selvaggi</surname><given-names>C</given-names></name><name name-style=\"western\"><surname>Atlas</surname><given-names>SJ</given-names></name><name name-style=\"western\"><surname>McManus</surname><given-names>DD</given-names></name><name name-style=\"western\"><surname>Singer</surname><given-names>DE</given-names></name><etal/></person-group>. <article-title>Detection of atrial fibrillation in a large population using wearable devices: the Fitbit heart study</article-title>. <source>Circulation</source>. (<year>2022</year>) <volume>146</volume>:<fpage>1415</fpage>&#8211;<lpage>24</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1161/CIRCULATIONAHA.122.060291</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">36148649</pub-id><pub-id pub-id-type=\"pmcid\">PMC9640290</pub-id></mixed-citation></ref><ref id=\"ref83\"><label>83.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Han</surname><given-names>D</given-names></name><name name-style=\"western\"><surname>Yu</surname><given-names>Y</given-names></name><name name-style=\"western\"><surname>Lee</surname><given-names>IB</given-names></name><name name-style=\"western\"><surname>Wang</surname><given-names>Z</given-names></name><name name-style=\"western\"><surname>Han</surname><given-names>D</given-names></name><name name-style=\"western\"><surname>Mohagheghian</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Accuracy, usability, and adherence of smartwatches for atrial fibrillation detection in older adults after stroke: randomized controlled trial</article-title>. <source>JMIR Cardio</source>. (<year>2023</year>) <volume>7</volume>:<fpage>e45137</fpage>. doi: <pub-id pub-id-type=\"doi\">10.2196/45137</pub-id><pub-id pub-id-type=\"pmid\">38015598</pub-id><pub-id pub-id-type=\"pmcid\">PMC10716742</pub-id></mixed-citation></ref><ref id=\"ref84\"><label>84.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Calkins</surname><given-names>H</given-names></name><name name-style=\"western\"><surname>Hindricks</surname><given-names>G</given-names></name><name name-style=\"western\"><surname>Cappato</surname><given-names>R</given-names></name><name name-style=\"western\"><surname>Kim</surname><given-names>YH</given-names></name><name name-style=\"western\"><surname>Saad</surname><given-names>EB</given-names></name><name name-style=\"western\"><surname>Aguinaga</surname><given-names>L</given-names></name><etal/></person-group>. <article-title>2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation</article-title>. <source>Heart Rhythm</source>. (<year>2017</year>) <volume>14</volume>:<fpage>e275</fpage>&#8211;<lpage>444</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1016/j.hrthm.2017.05.012</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">28506916</pub-id><pub-id pub-id-type=\"pmcid\">PMC6019327</pub-id></mixed-citation></ref><ref id=\"ref85\"><label>85.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Reddy</surname><given-names>VY</given-names></name><name name-style=\"western\"><surname>Grimaldi</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>De Potter</surname><given-names>T</given-names></name><name name-style=\"western\"><surname>Vijgen</surname><given-names>JM</given-names></name><name name-style=\"western\"><surname>Bulava</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Duytschaever</surname><given-names>MF</given-names></name><etal/></person-group>. <article-title>Pulmonary vein isolation with very high power, short duration, temperature-controlled lesions: the Q-FFICIENCY study</article-title>. <source>JACC Clin Electrophysiol</source>. (<year>2019</year>) <volume>5</volume>:<fpage>778</fpage>&#8211;<lpage>86</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1016/j.jacep.2019.04.002</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">31320006</pub-id></mixed-citation></ref><ref id=\"ref86\"><label>86.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Ha&#239;ssaguerre</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Hocini</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Denis</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Shah</surname><given-names>AJ</given-names></name><name name-style=\"western\"><surname>Komatsu</surname><given-names>Y</given-names></name><name name-style=\"western\"><surname>Yamashita</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Driver domains in persistent atrial fibrillation</article-title>. <source>Circulation</source>. (<year>2014</year>) <volume>130</volume>:<fpage>530</fpage>&#8211;<lpage>8</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1161/CIRCULATIONAHA.113.005421</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">25028391</pub-id></mixed-citation></ref><ref id=\"ref87\"><label>87.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Seitz</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Durdez</surname><given-names>TM</given-names></name><name name-style=\"western\"><surname>Albenque</surname><given-names>JP</given-names></name><name name-style=\"western\"><surname>Pisapia</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Gitenay</surname><given-names>E</given-names></name><name name-style=\"western\"><surname>Durand</surname><given-names>C</given-names></name><etal/></person-group>. <article-title>Artificial intelligence software standardizes electrogram-based ablation outcome for persistent atrial fibrillation</article-title>. <source>J Cardiovasc Electrophysiol</source>. (<year>2022</year>) <volume>33</volume>:<fpage>2250</fpage>&#8211;<lpage>60</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1111/jce.15593</pub-id><pub-id pub-id-type=\"pmid\">35989543</pub-id><pub-id pub-id-type=\"pmcid\">PMC9826214</pub-id></mixed-citation></ref><ref id=\"ref88\"><label>88.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Martin</surname><given-names>CA</given-names></name><name name-style=\"western\"><surname>Curtin</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Gajendragadkar</surname><given-names>P</given-names></name></person-group>. <article-title>Advanced electroanatomic mapping: current and emerging technologies</article-title>. <source>Arrhythm Electrophysiol Rev</source>. (<year>2024</year>) <volume>13</volume>:<fpage>e01</fpage>. doi: <pub-id pub-id-type=\"doi\">10.15420/aer.2023.01</pub-id>38544812\n</mixed-citation></ref><ref id=\"ref89\"><label>89.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Xiong</surname><given-names>Z</given-names></name><name name-style=\"western\"><surname>Fedorov</surname><given-names>VV</given-names></name><name name-style=\"western\"><surname>Fu</surname><given-names>X</given-names></name><name name-style=\"western\"><surname>Cheng</surname><given-names>E</given-names></name><name name-style=\"western\"><surname>Macleod</surname><given-names>R</given-names></name><name name-style=\"western\"><surname>Zhao</surname><given-names>J</given-names></name></person-group>. <article-title>Fully automatic left atrium segmentation from late gadolinium enhanced magnetic resonance imaging using a dual fully convolutional neural network</article-title>. <source>IEEE Trans Med Imaging</source>. (<year>2019</year>) <volume>38</volume>:<fpage>515</fpage>&#8211;<lpage>24</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1109/TMI.2018.2866845</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">30716023</pub-id><pub-id pub-id-type=\"pmcid\">PMC6364320</pub-id></mixed-citation></ref><ref id=\"ref90\"><label>90.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Yang</surname><given-names>G</given-names></name><name name-style=\"western\"><surname>Chen</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Gao</surname><given-names>Z</given-names></name></person-group>. <article-title>Deep learning for cardiovascular magnetic resonance: a review</article-title>. <source>IEEE Trans Med Imaging</source>. (<year>2020</year>) <volume>39</volume>:<fpage>4060</fpage>&#8211;<lpage>78</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1109/TMI.2020.3004562</pub-id>32746147\n</mixed-citation></ref><ref id=\"ref91\"><label>91.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Huang</surname><given-names>Z</given-names></name><name name-style=\"western\"><surname>Wessler</surname><given-names>BS</given-names></name><name name-style=\"western\"><surname>Hughes</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Bhayani</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Arnold</surname><given-names>JH</given-names></name><name name-style=\"western\"><surname>Ouwerkerk</surname><given-names>W</given-names></name><etal/></person-group>. <article-title>Fully automated artificial intelligence assessment of aortic stenosis by echocardiography</article-title>. <source>JACC Cardiovasc Imaging</source>. (<year>2023</year>) <volume>16</volume>:<fpage>908</fpage>&#8211;<lpage>19</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1016/j.jcmg.2023.01.006</pub-id><pub-id pub-id-type=\"pmid\">36958708</pub-id></mixed-citation></ref><ref id=\"ref92\"><label>92.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Khurshid</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Kartoun</surname><given-names>U</given-names></name><name name-style=\"western\"><surname>Ashburner</surname><given-names>JM</given-names></name></person-group>. <article-title>Prediction of incident atrial fibrillation: a comprehensive evaluation of methodologies including artificial intelligence</article-title>. <source>JAMA Netw Open</source>. (<year>2025</year>) <volume>8</volume>:<fpage>e2431853</fpage>. doi: <pub-id pub-id-type=\"doi\">10.1001/jamanetworkopen.2024.31853</pub-id></mixed-citation></ref><ref id=\"ref93\"><label>93.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Christopoulos</surname><given-names>G</given-names></name><name name-style=\"western\"><surname>Headid</surname><given-names>RJ</given-names><suffix>3rd</suffix></name><name name-style=\"western\"><surname>Kuno</surname><given-names>T</given-names></name></person-group>. <article-title>Artificial intelligence-enhanced electrocardiography for early assessment of acute coronary syndromes in the emergency department</article-title>. <source>J Am Coll Cardiol</source>. (<year>2024</year>) <volume>83</volume>:<fpage>1360</fpage>&#8211;<lpage>70</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1016/j.jacc.2024.02.025</pub-id></mixed-citation></ref><ref id=\"ref94\"><label>94.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Attia</surname><given-names>ZI</given-names></name><name name-style=\"western\"><surname>Noseworthy</surname><given-names>PA</given-names></name><name name-style=\"western\"><surname>Lopez-Jimenez</surname><given-names>F</given-names></name></person-group>. <article-title>An artificial intelligence-enabled electrocardiogram algorithm for the prediction of atrial fibrillation from a sinus rhythm: a retrospective cohort study</article-title>. <source>Lancet Digit Health</source>. (<year>2019</year>) <volume>1</volume>:<fpage>e273</fpage>&#8211;<lpage>81</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1016/S2589-7500(19)30076-6</pub-id></mixed-citation></ref><ref id=\"ref95\"><label>95.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Taghji</surname><given-names>P</given-names></name><name name-style=\"western\"><surname>El Haddad</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Phlips</surname><given-names>T</given-names></name></person-group>. <article-title>Artificial intelligence for individualized treatment of persistent atrial fibrillation: the TAILORED-AF randomized clinical trial</article-title>. <source>Nat Med</source>. (<year>2025</year>) <volume>31</volume>:<fpage>1078</fpage>&#8211;<lpage>86</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1038/s41591-025-02877-0</pub-id><pub-id pub-id-type=\"pmcid\">PMC12003177</pub-id><pub-id pub-id-type=\"pmid\">39953289</pub-id></mixed-citation></ref><ref id=\"ref96\"><label>96.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Hu</surname><given-names>JR</given-names></name><name name-style=\"western\"><surname>Power</surname><given-names>JR</given-names></name><name name-style=\"western\"><surname>Zannad</surname><given-names>F</given-names></name><name name-style=\"western\"><surname>Lam</surname><given-names>CS</given-names></name></person-group>. <article-title>Artificial intelligence and digital tools for design and execution of cardiovascular clinical trials</article-title>. <source>Eur Heart J</source>. (<year>2025</year>) <volume>46</volume>:<fpage>814</fpage>&#8211;<lpage>26</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1093/eurheartj/ehae794</pub-id><pub-id pub-id-type=\"pmid\">39626166</pub-id></mixed-citation></ref><ref id=\"ref97\"><label>97.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Khan</surname><given-names>AH</given-names></name><name name-style=\"western\"><surname>Zainab</surname><given-names>H</given-names></name><name name-style=\"western\"><surname>Khan</surname><given-names>R</given-names></name><name name-style=\"western\"><surname>Hussain</surname><given-names>HK</given-names></name></person-group>. <article-title>Implications of AI on cardiovascular patients &#8216;routine monitoring and telemedicine</article-title>. <source>BULLET</source>. (<year>2024</year>) <volume>3</volume>:<fpage>621</fpage>&#8211;<lpage>37</lpage>.</mixed-citation></ref><ref id=\"ref98\"><label>98.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Reddy</surname><given-names>S</given-names></name></person-group>. <article-title>Global harmonization of artificial intelligence-enabled software as a medical device regulation: addressing challenges and unifying standards</article-title>. <source>Mayo Clin Proc</source>. (<year>2025</year>) <volume>3</volume>. doi: <pub-id pub-id-type=\"doi\">10.1016/j.mcpdig.2024.100191</pub-id><pub-id pub-id-type=\"pmcid\">PMC11975980</pub-id><pub-id pub-id-type=\"pmid\">40207007</pub-id></mixed-citation></ref><ref id=\"ref99\"><label>99.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Rahi</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Lather</surname><given-names>V</given-names></name><name name-style=\"western\"><surname>Rana</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Pandit</surname><given-names>J</given-names></name></person-group>. <article-title>Comprehensive framework for the global regulation and approval of AI-integrated medical devices</article-title>. <source>Appl Drug Res Clin Trials Regul Affairs</source>. (<year>2025</year>) <volume>11</volume>:<fpage>E26673371347630</fpage>. doi: <pub-id pub-id-type=\"doi\">10.2174/0126673371347630250418134235</pub-id>, PMID: 41111475\n</mixed-citation></ref><ref id=\"ref100\"><label>100.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Lee</surname><given-names>TT</given-names></name><name name-style=\"western\"><surname>Kesselheim</surname><given-names>AS</given-names></name></person-group>. <article-title>Us food and drug administration precertification pilot program for digital health software: weighing the benefits and risks</article-title>. <source>Ann Intern Med</source>. (<year>2018</year>) <volume>168</volume>:<fpage>730</fpage>&#8211;<lpage>2</lpage>. doi: <pub-id pub-id-type=\"doi\">10.7326/M17-2715</pub-id><pub-id pub-id-type=\"pmid\">29632953</pub-id></mixed-citation></ref><ref id=\"ref101\"><label>101.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Mittal</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Movsowitz</surname><given-names>C</given-names></name><name name-style=\"western\"><surname>Steinberg</surname><given-names>JS</given-names></name></person-group>. <article-title>Ambulatory external electrocardiographic monitoring: focus on atrial fibrillation</article-title>. <source>J Am Coll Cardiol</source>. (<year>2011</year>) <volume>58</volume>:<fpage>1741</fpage>&#8211;<lpage>9</lpage>. doi: <pub-id pub-id-type=\"doi\">10.1016/j.jacc.2011.07.026</pub-id><pub-id pub-id-type=\"pmid\">21996384</pub-id></mixed-citation></ref><ref id=\"ref102\"><label>102.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Kurniawan</surname><given-names>MH</given-names></name><name name-style=\"western\"><surname>Handiyani</surname><given-names>H</given-names></name><name name-style=\"western\"><surname>Nuraini</surname><given-names>T</given-names></name><name name-style=\"western\"><surname>Hariyati</surname><given-names>RTS</given-names></name><name name-style=\"western\"><surname>Sutrisno</surname><given-names>S</given-names></name></person-group>. <article-title>A systematic review of artificial intelligence-powered (AI-powered) chatbot intervention for managing chronic illness</article-title>. <source>Ann Med</source>. (<year>2024</year>) <volume>56</volume>:<fpage>2302980</fpage>. doi: <pub-id pub-id-type=\"doi\">10.1080/07853890.2024.2302980</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">38466897</pub-id><pub-id pub-id-type=\"pmcid\">PMC10930147</pub-id></mixed-citation></ref><ref id=\"ref103\"><label>103.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Feng</surname><given-names>G</given-names></name><name name-style=\"western\"><surname>Weng</surname><given-names>F</given-names></name><name name-style=\"western\"><surname>Lu</surname><given-names>W</given-names></name><name name-style=\"western\"><surname>Xu</surname><given-names>L</given-names></name><name name-style=\"western\"><surname>Zhu</surname><given-names>W</given-names></name><name name-style=\"western\"><surname>Tan</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>Artificial intelligence in chronic disease Management for Aging Populations: a systematic review of machine learning and NLP applications</article-title>. <source>Int J Gen Med</source>. (<year>2025</year>) <volume>18</volume>:<fpage>3105</fpage>&#8211;<lpage>15</lpage>. doi: <pub-id pub-id-type=\"doi\">10.2147/IJGM.S516247</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">40529344</pub-id><pub-id pub-id-type=\"pmcid\">PMC12170813</pub-id></mixed-citation></ref><ref id=\"ref104\"><label>104.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Pan</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Li</surname><given-names>R</given-names></name><name name-style=\"western\"><surname>Wei</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Peng</surname><given-names>H</given-names></name><name name-style=\"western\"><surname>Hu</surname><given-names>Z</given-names></name><name name-style=\"western\"><surname>Xiong</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Application of artificial intelligence in the health management of chronic disease: bibliometric analysis</article-title>. <source>Front Med</source>. (<year>2025</year>) <volume>11</volume>:<fpage>1506641</fpage>. doi: <pub-id pub-id-type=\"doi\">10.3389/fmed.2024.1506641</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">39839623</pub-id><pub-id pub-id-type=\"pmcid\">PMC11747633</pub-id></mixed-citation></ref><ref id=\"ref105\"><label>105.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Marcuzzi</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Nordstoga</surname><given-names>AL</given-names></name><name name-style=\"western\"><surname>Bach</surname><given-names>K</given-names></name><name name-style=\"western\"><surname>Aasdahl</surname><given-names>L</given-names></name><name name-style=\"western\"><surname>Nilsen</surname><given-names>TIL</given-names></name><name name-style=\"western\"><surname>Bardal</surname><given-names>EM</given-names></name><etal/></person-group>. <article-title>Effect of an artificial intelligence&#8211;based self-management app on musculoskeletal health in patients with neck and/or low back pain referred to specialist care: a randomized clinical trial</article-title>. <source>JAMA Netw Open</source>. (<year>2023</year>) <volume>6</volume>:<fpage>e2320400-e2320400</fpage>. doi: <pub-id pub-id-type=\"doi\">10.1001/jamanetworkopen.2023.20400</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">37368401</pub-id><pub-id pub-id-type=\"pmcid\">PMC10300712</pub-id></mixed-citation></ref><ref id=\"ref106\"><label>106.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Wang</surname><given-names>B</given-names></name><name name-style=\"western\"><surname>Asan</surname><given-names>O</given-names></name><name name-style=\"western\"><surname>Zhang</surname><given-names>Y</given-names></name></person-group>. <article-title>Shaping the future of chronic disease management: insights into patient needs for AI-based homecare systems</article-title>. <source>Int J Med Inform</source>. (<year>2024</year>) <volume>181</volume>:<fpage>105301</fpage>. doi: <pub-id pub-id-type=\"doi\">10.1016/j.ijmedinf.2023.105301</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">38029700</pub-id></mixed-citation></ref><ref id=\"ref107\"><label>107.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Yu</surname><given-names>G</given-names></name><name name-style=\"western\"><surname>Tabatabaei</surname><given-names>M</given-names></name><name name-style=\"western\"><surname>Mezei</surname><given-names>J</given-names></name><name name-style=\"western\"><surname>Zhong</surname><given-names>Q</given-names></name><name name-style=\"western\"><surname>Chen</surname><given-names>S</given-names></name><name name-style=\"western\"><surname>Li</surname><given-names>Z</given-names></name><etal/></person-group>. <article-title>Improving chronic disease management for children with knowledge graphs and artificial intelligence</article-title>. <source>Expert Syst Appl</source>. (<year>2022</year>) <volume>201</volume>:<fpage>117026</fpage>. doi: <pub-id pub-id-type=\"doi\">10.1016/j.eswa.2022.117026</pub-id></mixed-citation></ref><ref id=\"ref108\"><label>108.</label><mixed-citation publication-type=\"journal\"><person-group person-group-type=\"author\"><name name-style=\"western\"><surname>Stubberud</surname><given-names>A</given-names></name><name name-style=\"western\"><surname>Langseth</surname><given-names>H</given-names></name><name name-style=\"western\"><surname>Nachev</surname><given-names>P</given-names></name><name name-style=\"western\"><surname>Matharu</surname><given-names>MS</given-names></name><name name-style=\"western\"><surname>Tronvik</surname><given-names>E</given-names></name></person-group>. <article-title>Artificial intelligence and headache</article-title>. <source>Cephalalgia</source>. (<year>2024</year>) <volume>44</volume>. doi: <pub-id pub-id-type=\"doi\">10.1177/03331024241268290</pub-id>, PMID: <pub-id pub-id-type=\"pmid\">39099427</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>",
  "text": "pmc Front Public Health Front Public Health 2277 frontpubhealth Front. Public Health Frontiers in Public Health 2296-2565 Frontiers Media SA PMC12675485 PMC12675485.1 12675485 12675485 41358250 10.3389/fpubh.2025.1689911 1 Review Artificial intelligence in chronic disease self-management: current applications and future directions Du Ying 1 * Methodology Project administration Resources Writing &#8211; original draft Writing &#8211; review &amp; editing Yang Peng 2 Conceptualization Data curation Formal analysis Writing &#8211; original draft Writing &#8211; review &amp; editing Liu Yuntao 3 Data curation Investigation Methodology Writing &#8211; review &amp; editing Deng Chunxia 4 Data curation Formal analysis Software Visualization Writing &#8211; review &amp; editing Li Xin 5 Data curation Investigation Software Supervision Writing &#8211; review &amp; editing 1 Department of Health Management, Affiliated Renhe Hospital of China Three Gorges University , Yichang, Hubei , China 2 Department of Anesthesiology, Affiliated Renhe Hospital of China Three Gorges University , Yichang, Hubei , China 3 Department of Endocrinology, Affiliated Renhe Hospital of China Three Gorges University , Yichang, Hubei , China 4 Department of General Surgery, Affiliated Renhe Hospital of China Three Gorges University , Yichang, Hubei , China 5 Department of Nursing, Affiliated Renhe Hospital of China Three Gorges University , Yichang, Hubei , China * Correspondence: Ying Du, m13972517469@163.com 20 11 2025 2025 13 480651 1689911 21 8 2025 31 10 2025 20 11 2025 05 12 2025 08 12 2025 Copyright &#169; 2025 Du, Yang, Liu, Deng and Li. 2025 Du, Yang, Liu, Deng and Li https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. Objective This study aims to summarize current applications of artificial intelligence (AI) for chronic disease self-management, critically appraise their effectiveness, and identify implementation challenges and future directions for research and clinical integration. Methods A narrative literature review of peer-reviewed, English-language studies identified via PubMed, Web of Science, and Scopus was conducted, using combinations of &#8220;artificial intelligence,&#8221; &#8220;chronic disease,&#8221; &#8220;self-management,&#8221; &#8220;remote monitoring,&#8221; &#8220;predictive analytics,&#8221; &#8220;conversational agent,&#8221; and &#8220;mobile health.&#8221; Reference lists of key reviews were snowballed. We included studies that described or evaluated AI-enabled self-management tools or interventions for chronic conditions and excluded non-AI, acute-care, editorial, and non-human studies. Findings were synthesized thematically. Results The literature consistently identifies four roles of AI in chronic care: (1) personalized decision support and treatment optimization; (2) continuous monitoring and risk prediction from patient-generated data; (3) conversational agents delivering education, adherence support, reminders, behavioral coaching, and mental-health support; and (4) AI-enabled Mobile health (mHealth) platforms that connect patients with clinicians and coordinate care. Recurrent challenges reported include data privacy and security risks, algorithmic bias and limited generalizability, interoperability and workflow-integration barriers, variable usability and sustained engagement (digital divide- inequalities in access to digital technologies and the internet, often influenced by age, income, or geography), and insufficient high-quality evidence on clinical effectiveness and cost-effectiveness. Conclusion Future directions focus on developing more accurate, explainable, and trustworthy AI models, better clinical integration, leveraging advanced AI for engagement, rigorous evaluation, and addressing ethical and implementation barriers to realize AI&#8217;s full potential in empowering patients and improving chronic disease outcomes. artificial intelligence chronic disease self-management personalized interventions predictive analytics digital health platforms The author(s) declare that no financial support was received for the research and/or publication of this article. pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement no pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes section-at-acceptance Digital Public Health 1 Introduction Chronic diseases, such as diabetes, cardiovascular diseases, respiratory disorders, and mental health conditions, represent a significant global health burden, characterized by their long-term nature and the necessity for continuous management ( 1 , 2 ). Effective self-management by patients is paramount to improving health outcomes, maintaining quality of life, and reducing healthcare costs ( 2 , 3 ). Self-management involves a range of behaviors, including medication adherence, lifestyle modifications (diet, exercise), symptom monitoring, and active participation in treatment decisions ( 4 , 5 ) However, supporting patients in consistently performing these complex tasks over a lifetime presents substantial challenges for traditional healthcare systems, often limited by resources and geographical barriers, particularly in rural or underserved areas ( 6 , 7 ). The rapid advancements in artificial intelligence (AI) and related digital health technologies, including mobile health (mHealth) and wearable devices, offer transformative potential to address these challenges and revolutionize chronic disease self-management ( 8&#8211;10 ). AI can process vast amounts of patient-generated data from various sources, such as Electronic Health Record (EHR)s, wearable sensors, and mobile applications, to provide personalized insights, predictive warnings, and interactive support, moving healthcare towards a more predictive, preventive, and personalized model ( 11 ). Unlike prior reviews that focus on single tools (e.g., chatbots) or single diseases (e.g., diabetes), our review takes a task-based, cross-modal perspective, mapping diverse AI technologies directly onto the core components of patient self-management. This approach offers a unified framework that clarifies both where AI has matured and where gaps remain. By examining diverse AI modalities and their implementation across various chronic conditions, this review seeks to provide a comprehensive overview of the evolving landscape and highlight areas requiring further research and development to fully realize AI&#8217;s potential in empowering patients and improving health outcomes. 2 Literature search and selection This review followed a narrative approach. We searched PubMed, Web of Science, and Scopus for English-language studies published up to May 2025 using keyword combinations including &#8220;artificial intelligence,&#8221; &#8220;chronic disease,&#8221; &#8220;self-management,&#8221; &#8220;remote monitoring,&#8221; and &#8220;digital health.&#8221; Additional references were identified by screening citations in relevant reviews. We included studies that described or evaluated AI-enabled self-management tools for chronic conditions, while excluding non-AI, acute-care, non-human, and editorial/commentary articles. As this was a narrative review, no formal quality assessment or systematic synthesis (e.g., PRISMA flow diagram) was undertaken. 3 Current applications of AI in chronic disease self-management The application of artificial intelligence in chronic disease self-management is multifaceted, leveraging various AI techniques to address different aspects of patient care and support. These applications can broadly be categorized by the type of AI technology employed or the specific function they serve within the self-management process. This section will delve into the current state of AI applications, examining their use in personalized interventions, predictive analytics, monitoring, and patient engagement tools like conversational agents&#8212;an AI-powered virtual assistant or chatbot that interacts with patients via text or speech to provide education, reminders, or coaching&#8212;drawing upon recent literature across different chronic conditions. 3.1 AI for personalized interventions and decision support One of the most significant promises of AI in chronic disease management is its ability to enable personalized interventions and provide data-driven decision support, moving away from a &#8220;one-size-fits-all&#8221; approach ( 12 ). Machine learning (ML) algorithms analyze high-dimensional, longitudinal data to identify patterns and predict individual responses to treatments or lifestyle changes, thereby informing day-to-day self-management decisions. Diabetes exemplifies this precision approach: models integrating continuous glucose monitors (CGM), insulin pumps records, diet logs, and activity data generate tailored recommendations for insulin dosing, meal planning, and exercise with the goal of optimizing glycemic control ( 13&#8211;26 ). Diabetes education tools increasingly embed AI to personalize content and coaching, strengthening self-management skills ( 27 , 28 ). Prospective system-validity studies demonstrate next-day hypoglycemia prediction from mobile/CGM data with random forest accuracy 0.814 (F1&#8239;=&#8239;0.812; sensitivity&#8239;=&#8239;0.815; specificity&#8239;=&#8239;0.824), outperforming alternative models (accuracy 0.65&#8211;0.80). Explainable Artificial Intelligence&#8211;driven Clinical Decision Support Systems (AI-CDSS) can make daily self-management more predictive and proactive by fusing data from smartphones, wearables, and CGMs ( 29 ), while &#8220;nurse-in-the-loop&#8221; predictive digital twin&#8212;a virtual, patient-specific model that simulates health status and treatment responses to support personalized care&#8212;strategies for Type 2 Diabetes (T2D) showcase how transfer-learned models can deliver individualized feedback aligned with clinical expertise ( 30 ). In oncology survivorship, emerging tools personalize surveillance and supportive-care recommendations (e.g., symptom triage, fatigue/exercise prescriptions, toxicity monitoring), aligning advice with individual risk profiles and preferences. 3.2 AI for monitoring and predictive analytics A core contribution of AI to self-management is the ability to transform continuous, multimodal data streams&#8212;physiological signals from wearables and home devices, symptom reports, medication logs, and EHR histories into timely risk assessment and early-warning insights that patients and clinicians can act on between visits. Models trained on longitudinal data support near-real-time monitoring, short-horizon exacerbation prediction, and trend detection that trigger tailored advice or escalation pathways, thereby complementing decision support systems. In cardiovascular disease, monitoring pipelines increasingly fuse signals such as heart rate dynamics and rhythm strips with clinical history to detect atrial fibrillation (AF) episodes, anticipate deterioration, and inform self-care prompts or remote reviews ( 31&#8211;35 ). These systems illustrate how passive sensing coupled with predictive analytics can shorten the time from signal to action in routine self-management. The monitoring&#8211;prediction stack spans risk stratification, diagnostic augmentation, screening, and patient support. Explainable AI stratifies exacerbation risk from features such as smoking history, BMI, and symptom profiles ( 36 ). In specialist settings, adding explainable AI to pulmonologist PFT interpretation increased mean diagnostic accuracy versus pulmonologists alone&#8212;although a subset performed worse, underscoring the need for clinical oversight ( 36 , 37 ). Imaging models provide staging and prognostic precision: CT deep learning in Chronic Obstructive Pulmonary Disease (COPD) Gene/ECLIPSE achieved ~50% exact GOLD staging and ~75% within one stage, predicted exacerbations and mortality, and reached AUC 0.89; PPV 0.847 for COPD identification in ECLIPSE; combining CT radiomics + demographics + spirometry further improved progression prediction over any single modality. At primary-care level, case-finding tools report usable operating points: a graph convolutional network achieved accuracy 0.77 (AUC 0.81) on weakly labeled CT; an AI &#8220;robot&#8221; questionnaire reached sensitivity 76.11%, specificity 84.76%, AUC 0.858; and a multi-instance learning classifier reported AUC 0.742 ( 38 , 39 ). Beyond cardiometabolic disease, monitoring and prediction are expanding across other conditions. In chronic kidney disease (CKD), longitudinal EMRs underpin AI models that predict progression trajectories to guide precision management ( 40 , 41 ), with systems such as TrajVis translating model outputs into interpretable clinical insights ( 42 ). In addition, a comparative modeling study for early CKD identification trained a deep neural network (multilayer perceptron) on a 400-patient dataset (75/25 train&#8211;test split; McNemar test for model comparison) and reported 100% test accuracy, outperforming logistic regression (96%) and SVM (82%); the reported confusion matrix showed perfect classification of both CKD and non-CKD cases, underscoring potential while also highlighting the need for external validation and larger, multi-site cohorts ( 43 ). For end-stage kidney disease, proof-of-concept models suggest AI can help steer blood-pressure and volume strategies by learning from prior response, such as through artificial neural networks that predict session-specific outcomes and enable personalized adjustments to minimize intradialytic hypotension while optimizing fluid removal ( 44 ). 3.3 Conversational AI and intelligent coaching systems These systems target engagement&#8212;personalized education, adherence support, and behavioral coaching&#8212;grounded in behavioral science and &#8220;nudge&#8221; principles. Unlike decision-support engines or passive risk models, engagement-focused systems emphasize human&#8211;AI dialogue and habit formation, with personalization and explainability as key levers ( 45&#8211;47 ). Diabetes remains the most developed use case for AI-enabled engagement. mHealth apps increasingly integrate CGM/pump, diet, and activity data to deliver individualized education and real-time coaching around dosing, meals, and exercise. AI-driven education modules adapt content to literacy and learning needs ( 48&#8211;50 ), while nudge-based features encourage sustained lifestyle change ( 51 , 52 ). Evidence maturity is mixed but encouraging: the breadth of tools reflects rapid diffusion in diabetes, and feasibility/acceptability is supported even in low-resource settings where peer-educator models are being tested to extend reach and cultural fit. At the same time, durable engagement and rigorous external validation remain necessary to translate personalization gains into consistent clinical improvements ( 53&#8211;55 ). Conversational/ natural language processing (NLP) personalization can also improve engagement with diabetes education (mean engagement ratio 0.31 with personalization vs. 0.26 without) ( 56 ). In chronic limb-threatening ischemia (CLTI), AI/ML approaches aim to improve accurate diagnosis, outcome prediction, and identify disparities in treatment, highlighting the potential role for decision support in addressing inequities. AI-powered digital pain coaches deliver individualized pacing, exercise, and cognitive-behavioral strategies via conversational interfaces. Prospective and multicenter studies report significant improvements in pain interference, physical function, and psychological distress over 12&#8239;weeks, supporting the role of tailored coaching in everyday self-management ( 57 ). These benefits underscore the potential of engagement-centric AI to shift outcomes even when pharmacologic or procedural options are limited. Because anxiety, depression, and low mood commonly co-occur with chronic conditions, conversational agents increasingly provide personalized emotional support, self-monitoring, and triage. Early results suggest acceptability and user-reported benefit, but concerns around ethical safeguards, accuracy, and escalation pathways are prominent ( 58 , 59 ), reinforcing the need for transparent reporting and integration with clinical oversight. On the patient side, virtual agents co-designed with user&#8217;s support exacerbation action plans, mood management, and daily tasks with good acceptability and perceived usefulness ( 60 , 61 ); at the sensing layer, smartphone auscultation and AI-augmented stethoscopes are being evaluated for wheeze/symptom recognition to enable home tele-monitoring ( 62 , 63 ). Digital programs that embed algorithmic feedback improve quality of life and self-efficacy, although effects on healthcare utilization remain mixed ( 64 ). 3.4 AI in mHealth and digital health platforms AI-enabled mHealth platforms coordinate information, decisions, and actions between patients and clinicians by fusing home-collected signals (wearables, sensors, symptom diaries) with EHR data, then routing triage, escalation, and follow-up through secure messaging, teleconsultation, and shared care plans. The aim is to close the &#8220;between-visit&#8221; gap with timely guidance, medication titration, and appointment or testing prompts while documenting actions back to the record. In heart failure (HF), platforms increasingly pair post-discharge risk models with symptom check-ins to trigger medication reconciliation, complication surveillance, rehabilitation/exercise pacing, and timely clinic contact. Evidence remains early-phase, but perioperative studies offer concrete operating points that motivate such transition workflows: ML can predict intraoperative hypotension up to 15&#8239;min in advance (AUC 0.95, sensitivity 88%, specificity 87%); continuous ward monitoring with gradient-boosted models has anticipated stage-2 AKI&#8239;~&#8239;24&#8239;min before KDIGO criteria; and the PRODIGY score uses continuous capnography and oximetry to prospectively stratify risk of opioid-induced respiratory depression on general wards. At the same time, a pilot randomized evaluation of hypotension-prediction decision support did not reduce hypotension when alerts were frequently ignored, underscoring the need for robust workflow integration and escalation pathways as these tools move into the post-discharge transition context ( 65 , 66 ). 3.5 Evidence maturity and gaps Beyond functional categorizations, disease-specific manifestations of chronic conditions necessitate tailored AI approaches. This section explores these implementations across major chronic diseases, delineating how AI addresses distinct pathophysiological and self-management challenges ( Table 1 ; Figure 1 ). Table 1 AI applications in chronic disease self-management: key functions, technologies, and outcomes. Chronic condition Core AI functions Key technologies/tools Reported outcomes/advantages References Diabetes Personalized insulin dosing; Glycemic prediction; Behavioral coaching CGM&#8239;+&#8239;Closed-loop systems; AI mHealth apps; ML-based glucose prediction algorithms Improved glycemic control; Reduced hypoglycemia events; Enhanced adherence to lifestyle modifications ( 9 , 19&#8211;24 , 28 , 32 ) Cardiovascular diseases/heart failure Remote deterioration detection; Risk stratification; Personalized care planning Wearable sensors [ECG, blood pressure (BP)]; AI remote monitoring platforms; Predictive analytics models Early detection of clinical deterioration; Reduced hospitalizations; Proactive intervention facilitation ( 50 , 67 ) Chronic obstructive pulmonary disease (COPD) Risk prediction; Exacerbation support; Symptom monitoring Explainable AI (XAI) frameworks; Virtual conversational agents; Smartphone-based monitoring Targeted screening; Improved self-efficacy during exacerbations; Enhanced quality of life ( 34&#8211;37 , 63 ) Chronic pain Activity-pain correlation analysis; Personalized behavioral guidance AI-powered digital coaching platforms; Mobile apps with ML-based feedback systems Reduced pain interference; Improved physical function; Decreased anxiety/depression ( 70 , 71 ) Periodontitis Oral hygiene adherence monitoring; Personalized feedback AI-enabled toothbrush sensors; Targeted mHealth micromessages Improved oral hygiene performance; Enhanced periodontal therapy outcomes ( 33 ) Other conditions &#8224; Risk prediction; Symptom tracking; Personalized education Chatbots (e.g., haemophilia); LLMs (e.g., ChatGPT); Predictive digital twins Improved disease knowledge (haemophilia); Theoretical mental health support; Individualized management strategies ( 12 , 26 , 45&#8211;47 , 72 , 73 ) AI, Artificial Intelligence; BP, Blood Pressure; CGM, Continuous Glucose Monitoring; COPD, Chronic Obstructive Pulmonary Disease; ECG, Electrocardiogram; LLM, Large Language Model; ML, Machine Learning; mHealth, mobile Health; XAI, Explainable AI. Outcomes: Reflects outcomes reported in cited studies (e.g., &#8220;reduced hospitalizations&#8221; in CVD/HF; &#8220;improved oral hygiene&#8221; in periodontitis). &#8224; Other Conditions: Includes haemophilia, mental health, hepatitis C, epilepsy, and inflammatory bowel disease where evidence is emerging but less established. Figure 1 Examples of AI applications in chronic diseases. This figure illustrates various applications of AI in managing chronic conditions such as diabetes, cardiovascular diseases, and other chronic diseases (e.g., chronic pain, obesity, mental health). It highlights AI&#8217;s role in self-monitoring, telemedicine, risk prediction, and personalized treatment strategies. Infographic titled \"AI in Chronic Disease Self-Management\" showcasing applications in diabetes, cardiovascular, and other conditions. For diabetes: closed-loop insulin systems, glucose prediction, lifestyle analysis, education, mHealth apps. For cardiovascular: risk prediction, remote monitoring, personalized care, vital signs analysis, self-care platforms. Other conditions include exacerbation risk prediction, conversational support, digital interventions for chronic pain, obesity, mental health, inflammatory bowel disease, chronic kidney disease, and epilepsy. Central image of a brain symbolizes AI's role. Across chronic conditions, the strongest maturation is seen in monitoring and predictive analytics, where longitudinal sensing and EHR data support near&#8211;real-time risk assessment and early-warning prompts. Feasibility and user acceptance are consistent in AF/CVD and COPD, and trajectory modelling in CKD provides actionable forecasts ( 42 , 67 , 68 ). However, The impact on service outcomes is heterogeneous and appears to depend strongly on patient engagement and workflow integration ( 43 ). For personalized decision support, promising signals come from diabetes (CGM/pump&#8211;integrated coaching, AI-CDSS, and nurse-in-the-loop &#8220;digital twin&#8221; strategies) and from HF care planning and titration. Yet broader clinical utility hinges on data quality, external validation, interpretability, and seamless integration into routines of care ( 12 , 24 , 69 ). Engagement-focused systems&#8212;conversational education, adherence support, and behavioral coaching&#8212;show improvements in patients-reported outcomes (PROs) in chronic pain and diabetes education, and are feasible even in low-resource settings ( 70 , 71 ). At the same time, long-term retention is variable, effects on healthcare utilization remain mixed in respiratory disease programs, and ethical/accuracy questions persist for mental-health comorbidity agents. Taken together, the field has progressed from feasibility toward prospective and real-world deployment in several niches, but generalizability and durability are the main bottlenecks. Priorities include: multi-site external validation and transparent reporting; pragmatic/hybrid-effectiveness evaluations with standardized PROs and economic endpoints; and design for sustained engagement and workflow interoperability so that model outputs translate into reliable, patient-centered action ( 32 , 72 , 73 ). 4 Challenges and considerations for AI in chronic disease self-management Despite the transformative potential of AI in chronic disease self-management, significant challenges and considerations must be addressed to ensure its safe, effective, and equitable implementation. These challenges span technical, ethical, regulatory, and socio-behavioral domains ( Table 2 ). A key concern is data privacy and security. AI systems for self-management often rely on collecting sensitive personal health data from various sources, including wearables, apps, and EHRs ( 6 , 8 ). Robust cybersecurity measures and compliance with regulations are essential to maintain patient trust ( 6 , 8 ). Ethical issues include algorithmic bias, transparency, and informed consent. Biased data may exacerbate disparities, while the &#8220;black box&#8221; nature of some AI models hinders trust among patients and clinicians. Enhancing transparency and ensuring meaningful informed consent remain priorities ( 8 ). Implementation barriers are also notable. Limited digital health literacy, especially among older adults and socioeconomically disadvantaged groups, and inequitable access to smartphones or internet connectivity restrict uptake ( 6 , 74 ). Integrating AI into clinical workflows and EHRs poses technical and logistical hurdles, requiring interdisciplinary collaboration and training for health-care professionals. Importantly, even accurate models fail if alerts are ignored or escalation pathways are unclear, underscoring the need for workflow fit and human-in-the-loop oversight ( 43 ). Significant evidence gaps remain, particularly regarding long-term effectiveness, standardized outcome measures, and external validation across diverse populations. While monitoring and prediction tools show feasibility and patient-reported benefits, clinical outcomes remain heterogeneous and generalizability limited due to single-center or narrow cohorts. Large-scale, prospective validation with standardized outcomes is urgently needed. While engagement-focused AI demonstrates short-term improvements in PROs, challenges such as inconsistent retention and limited external validation highlight the need for further research. Similarly, mHealth platforms and telemonitoring improve adherence yet show mixed effects on hospitalization or long-term outcomes, with interoperability challenges limiting health-system deployment. Finally, In addition, ongoing regulatory uncertainty and concerns about patient trust present major barriers to widespread adoption. Frameworks for clinical AI remain in flux, complicating adoption ( 10 ). Sustained patient engagement requires building trust, as false alerts or over-reliance on automation can erode confidence ( 9 ). Addressing these multifaceted challenges demands coordinated efforts among researchers, developers, clinicians, policymakers, and patients. Table 2 Cross-cutting challenges and solution requirements for AI in chronic disease self-management. Challenge domain Specific issues Associated risks Key solution requirements References Data privacy and security Collection/storage of sensitive biometric, activity, and EHR data; Cross-platform data sharing Patient data breaches; Non-compliance with regulations; Erosion of trust Robust encryption (e.g., end-to-end); Strict adherence to GDPR/HIPAA; Decentralized data storage (e.g., federated learning) ( 6 , 8 , 45 , 69 ) Algorithmic bias and transparency Training data unrepresentativeness; &#8220;Black box&#8221; decision-making; Limited explainability Perpetuation of health disparities; Clinician skepticism; Patient mistrust Development of Explainable AI (XAI) frameworks; Diverse multi-center datasets; Algorithmic fairness audits ( 8 , 24 , 42 , 59 , 68 , 108 ) Implementation barriers Low digital literacy (e.g., elderly/low-SES groups); Limited tech access (rural/LMICs); Workflow integration difficulties Digital divide exacerbation; Low adoption rates; Clinical workflow disruptions Culturally adapted training programs; Low-cost/offline-capable devices; Interoperability standards (e.g., HL7 FHIR) ( 6 , 26 , 32 , 59 , 74 ) Evidence and regulatory gaps Insufficient long-term efficacy data; Lack of standardized outcome measures; Evolving regulatory frameworks Unproven clinical utility; Reimbursement uncertainties; Delayed market access Large-scale RCTs with real-world endpoints; Consensus frameworks for AI validation; Adaptive regulatory pathways (e.g., FDA SaMD) ( 10 , 12 , 66 , 69 ) Clinical integration and trust False alerts (e.g., AF detection); Lack of clinician training; Patient over-reliance Alert fatigue; Reduced confidence in AI; Undermined patient-clinician relationships Hybrid &#8220;human-in-the-loop&#8221; oversight (e.g., nurse-led AI); Clinician education modules; Fail-safe mechanisms for critical alerts ( 22 , 24 , 25 , 66 ) AF, Atrial Fibrillation; AI, Artificial Intelligence; EHR, Electronic Health Record; FDA, U. S. Food and Drug Administration; FHIR, Fast Healthcare Interoperability Resources; GDPR, General Data Protection Regulation; HIPAA, Health Insurance Portability and Accountability Act; HL7, Health Level Seven International; LMICs, Low- and Middle-Income Countries; RCT, Randomized Controlled Trial; SaMD, Software as a Medical Device; SES, Socioeconomic Status; XAI, Explainable AI. In addition to these challenges, three barriers to broad adoption deserve emphasis. First, data integration and standardization remain formidable, as AI systems require multimodal, large-scale datasets combining imaging, EHR, and wearable signals. Heterogeneous data formats, inconsistent data quality, and siloed healthcare systems complicate the development of robust AI models, often requiring advanced data harmonization techniques and interoperable platforms to ensure compatibility across diverse data sources. For example, integrating continuous glucose monitoring data with EHRs for diabetes management demands standardized ontologies and secure data-sharing protocols to enable real-time, actionable insights ( 75 ). Second, regulatory clarity is evolving; notably, the U. S. Food and Drug Administration (FDA)&#8217;s December 2024 guidance on &#8220;Predetermined Change Control Plans&#8221; for continuously learning AI devices marks an important milestone. This guidance facilitates adaptive AI algorithms by allowing pre-approved modifications while ensuring safety and efficacy, yet uncertainties around reimbursement and liability persist, delaying integration into clinical practice ( 76 ). Harmonizing global regulatory frameworks remains critical to streamline deployment across jurisdictions ( 77 ). Third, ethical considerations are paramount: explainable AI is critical to foster clinician and patient trust, and physicians should play a leading role in driving AI innovation to ensure alignment with real-world clinical needs. Explainable AI models, such as those incorporating interpretable decision trees or attention mechanisms, enhance transparency by elucidating decision-making processes, thereby reducing skepticism among clinicians and patients ( 78 ). Moreover, physician-led innovation ensures AI tools address practical clinical challenges, such as optimizing chronic disease monitoring or personalizing treatment plans, by incorporating domain expertise into algorithm design and validation ( 79 ). Collaborative initiatives, such as clinician-researcher partnerships, are essential to align AI development with patient-centered care priorities ( 80 ). 5 Current AI use cases in cardiovascular medicine beyond self-management AI applications extend beyond patient self-management to broader domains in cardiovascular medicine, including procedural, diagnostic, and efficiency areas. These use cases demonstrate AI&#8217;s versatility in addressing AF and related conditions, offering insights into potential integrations with self-management tools. This section outlines key examples, emphasizing their methodologies, findings, and implications, drawn from large-scale studies and clinical trials. In AF screening and monitoring, consumer wearables have leveraged AI for large-scale, real-world detection. The Apple Heart Study, a prospective single-arm trial involving over 419,000 participants, utilized photoplethysmography (PPG) sensors on the Apple Watch combined with a ML algorithm to detect irregular pulses suggestive of AF. The algorithm achieved a positive predictive value of 84% for confirmed AF on subsequent ECG patches, with 34% of notified participants having AF episodes lasting &#8805;30&#8239;min, demonstrating high feasibility for opportunistic screening and user engagement, though limitations included underrepresentation of older adults ( 81 ). Similarly, the Fitbit Heart Study enrolled 455,699 participants and employed a PPG-based deep learning algorithm, reporting 98.7% sensitivity for AF episodes &gt;30&#8239;min and a positive predictive value of 98% among those with irregular rhythms, underscoring cost-effective population-level monitoring with minimal false positives ( 82 ). The Samsung HEARTBEAT study, using Galaxy Watch devices, validated PPG algorithms against 12-lead ECGs, achieving 92.9% accuracy in AF detection over 14&#8239;days, highlighting usability for continuous monitoring in ambulatory settings ( 83 ). These studies illustrate AI&#8217;s potential to enhance early AF detection and burden quantification, bridging gaps in intermittent monitoring for chronic cardiovascular self-management. Procedural challenges in AF ablation, such as prolonged ablation times (often exceeding 3&#8211;4&#8239;h), labor-intensive manual mapping, inconsistent lesion formation leading to incomplete transmurality, and difficulties in identifying extra-pulmonary vein (extra-PV) targets like rotors or focal drivers, have created opportunities for AI-driven solutions to streamline workflows, enhance precision, and improve outcomes ( 84 , 85 ). These limitations in traditional approaches, which rely on operator experience and can result in recurrence rates of 20&#8211;40% in persistent AF, underscore the need for automated, data-driven tools that reduce variability and procedural duration while supporting personalized strategies ( 85 , 86 ). For AI-assisted mapping and imaging, tools like Volta VX1 employ ML to analyze multipolar electrograms during AF ablation, identifying dispersion areas in real-time with high inter-operator agreement (kappa 0.85), improving procedural efficiency and reducing recurrence rates in persistent AF by targeting non-pulmonary vein drivers ( 87 ). CARTO AI, integrated into the CARTO electroanatomic mapping system, uses neural networks for automated annotation of complex fractionated atrial electrograms, facilitating faster substrate mapping and personalized ablation strategies, with studies showing reduced mapping time by 30% while maintaining accuracy comparable to expert manual review ( 88 ). Additionally, AI-guided MRI segmentation tools, such as deep learning-based convolutional neural networks for atrial scar and fibrosis delineation in late gadolinium-enhanced cardiac MRI, enable automated identification of extra-PV ablation targets with segmentation accuracy comparable to manual methods, reducing pre-procedural planning time and aiding in tailored lesion sets to minimize gaps and improve long-term success ( 89 , 90 ). US2. AI echocardiography applies convolutional neural networks to automate full echocardiographic analysis, measuring parameters like ejection fraction and chamber dimensions with 95% agreement to expert readings, enabling rapid point-of-care diagnostics for HF and valvular disease in AF patients ( 91 ). These applications enhance precision in procedural interventions, potentially informing future AI-driven self-management by providing baseline data for personalized monitoring. Efficiency tools further expand AI&#8217;s utility. AI risk scoring models, such as those predicting incident AF from clinical data and polygenic scores, integrate ML with EHRs to achieve AUCs of 0.85&#8211;0.90, outperforming traditional scores like CHARGE-AF by identifying high-risk individuals for preventive strategies ( 92 ). For ECG labeling, deep learning algorithms automate AF classification with &gt;99% accuracy, reducing manual review time in large datasets and supporting scalable diagnostics ( 93 ). Prediction of AF from sinus rhythm ECGs uses convolutional neural networks to detect subtle features, predicting future AF with AUC 0.87 in cohorts like UK Biobank, aiding early intervention in at-risk populations ( 94 ). The TAILORED AF trial, a randomized controlled study, employed AI to guide real-time lesion delivery during ablation by mapping spatiotemporal dispersion, resulting in 74% freedom from AF at 12&#8239;months in the AI arm versus 58% in controls, demonstrating superior outcomes through adaptive, individualized procedures ( 95 ). Collectively, these use cases exemplify AI&#8217;s clinical breadth, distinct from but complementary to patient-centered self-management, emphasizing the need for integration to optimize chronic disease outcomes. 6 Discussion An important distinction that emerges from the reviewed literature is between early-phase feasibility or pilot studies and validated clinical applications. Many AI-enabled tools, such as conversational agents for patient engagement or predictive analytics for exacerbation risk, have primarily been evaluated in small, single-center feasibility trials or short-term pilots. These studies provide valuable proof-of-concept evidence and user-acceptability insights but do not establish clinical effectiveness. In contrast, validated clinical applications&#8212;those tested in large-scale, prospective, or real-world settings&#8212;remain relatively limited. For example, while some AI-supported decision support systems in diabetes and remote monitoring platforms in HF have undergone prospective evaluations and regulatory clearance, most other domains lack comparable validation ( 96 , 97 ). This distinction underscores that the field, while promising, remains in a transitional stage between early feasibility studies and fully validated clinical applications. Feasibility evidence is encouraging, but widespread clinical adoption requires rigorous multi-site randomized trials, standardized outcome measures, and long-term effectiveness and cost-effectiveness data. Taken together, these observations underscore that while feasibility studies demonstrate promising signals. Validated applications, however, remain relatively scarce, underscoring the importance of conducting large-scale, multi-site clinical trials. In addition to these evidence-related challenges, regulatory oversight&#8212;particularly from the FDA&#8212;is playing an increasingly important role in shaping the clinical implementation of AI. The FDA regulates many AI systems under its Software as a Medical Device (SaMD) framework, requiring robust evaluation of safety, effectiveness, and quality assurance before approval ( 98 ). Recent guidance, including the introduction of &#8220;Predetermined Change Control Plans,&#8221; marks a pivotal step by allowing certain AI algorithms to adapt and update post-approval while maintaining oversight ( 99 ). Pilot initiatives such as the Digital Health Software Precertification Program also demonstrate the FDA&#8217;s intent to accelerate the evaluation process for digital health innovations ( 100 ). Nevertheless, evolving requirements and uncertainties regarding reimbursement, liability, and interoperability continue to create barriers for widespread adoption. Thus, FDA regulation acts as both a safeguard&#8212;ensuring patient safety and building trust&#8212;and a challenge, as stakeholders must continuously adapt to meet changing regulatory expectations. The limitations of conventional monitoring strategies further illustrate this gap in clinical practice. For instance, intermittent approaches such as 24-h or 7-d ambulatory Electrocardiogram (ECG) recordings detect only a fraction of AF episodes, with reported sensitivities of approximately 16 and 42%, respectively, compared with implantable cardiac monitors that achieve up to 99% sensitivity in detecting AF episodes lasting &#8805;2&#8239;min, as demonstrated in a review of ambulatory ECG monitoring strategies where prolonged continuous monitoring significantly outperformed shorter intermittent recordings in identifying paroxysmal AF in patients with cryptogenic stroke or suspected arrhythmia ( 101 ). This limited sensitivity hampers timely diagnosis and accurate burden quantification, especially for patients with paroxysmal AF. AI-enabled wearable devices have the potential to overcome these limitations by providing continuous, unobtrusive monitoring in real-world settings. When coupled with advanced algorithms, these devices can enhance early AF detection, enable more precise assessment of arrhythmia burden, and support proactive intervention strategies. For example, large-scale screening studies like the Apple Heart Study utilized PPG-based algorithms with ML to detect irregular pulse suggestive of AF, achieving a positive predictive value of 84% for confirmed AF episodes and demonstrating high user engagement with over 400,000 participants, thereby highlighting the feasibility of AI-driven wearables for population-level AF detection and burden estimation in chronic cardiovascular self-management ( 81 ). Similarly, the Fitbit Heart Study employed PPG sensors integrated with deep learning models to identify AF, reporting a 98.7% sensitivity for AF episodes lasting &gt;30&#8239;min and underscoring cost-effective, scalable alternatives to traditional monitoring ( 82 ). This context underscores how AI not only augments existing monitoring modalities but also addresses critical diagnostic blind spots inherent in conventional strategies. Prior studies typically narrow to a single tool class (e.g., chatbots) or to a specific population/technology stack and largely inventory systems without linking them to the day-to-day work of self-management; chatbot reviews deem the evidence promising yet heterogeneous and note inconsistent technical reporting, limiting cross-disease comparability ( 102 ), while aging-focused surveys summarize ML/NLP advances but are not organized around patient tasks or mHealth/wearable workflows ( 103 ), and bibliometric overviews describe a fragmented field and call for implementation-relevant studies ( 104 ). In this review, we synthesize predictive analytics, continuous sensing/remote monitoring, conversational agents, and AI-enabled mHealth platforms and map them to core self-management tasks&#8212;personalized decision support; continuous monitoring and risk prediction; education/adherence/behavioral coaching; and patient&#8211;clinician care coordination&#8212;thereby clarifying where roles are maturing (e.g., monitoring/risk prediction) versus under-developed (e.g., sustained engagement and emotional support) and providing a cross-modal, task-anchored lens absent from chatbot-only work ( 102 ). We also reconcile mixed clinical signals by placing encouraging single-arm findings (e.g., an AI-powered digital pain coach over 12&#8239;weeks) alongside a null multicenter randomized controlled trial (RCT) ( 70 , 105 ). Importantly, we connect patient-articulated priorities&#8212;personalization, emotional/social support, proactive monitoring, service integration, and ethics/governance ( 106 )&#8212;to implementation pathways using NASSS and privacy-preserving infrastructures such as federated learning and blockchain. Unlike aging-focused reviews or platform papers that emphasize architectures without cross-disease appraisal ( 103 , 107 ), our synthesis spans conditions and technologies yet remain organized by the work patients and clinicians actually perform. Collectively, this yields a pragmatic agenda&#8212;pragmatic/hybrid designs with standardized PROs and economic endpoints ( 70 , 105 ), transparent technical reporting to enable comparability ( 102 ), and privacy-preserving data pipelines aligned with health-system integration (NASSS)&#8212;and, to our knowledge, the first cross-modal, task-based account of AI for chronic-disease self-management. 7 Future directions and opportunities Looking ahead, the future of AI in chronic disease self-management holds immense potential, provided that current challenges are effectively addressed. Several key directions are emerging. First, more trustworthy AI models are needed, with improvements in accuracy, reliability, and explainable AI (XAI) to enhance transparency and build trust among users and clinicians ( 12 , 13 ). Ethical design principles must be embedded from the outset, actively working to mitigate bias and ensure equitable access ( 8 ). Second, integration into existing healthcare ecosystems is critical. Interoperable platforms should link patient-generated data from wearables and mHealth tools with EHRs and clinical workflows. Hybrid approaches such as &#8220;nurse-in-the-loop&#8221; models- a hydrid model where nurses oversee or validate the recommendations generated by AI systems, ensuring clinical appropriateness and patient safety-can combine AI efficiency with human oversight, ensuring care remains personalized and compassionate ( 20 ). Third, advancements in generative AI and NLP offer new opportunities to enhance patient engagement and education. Future conversational agents could become more empathetic, context-aware, and capable of delivering personalized self-management content, supporting adherence and sustained behavior change. Finally, rigorous evaluation and responsible implementation are essential. Large-scale RCTs and pragmatic trials are needed to establish effectiveness, cost-effectiveness, and long-term impact. Research should also address diverse patient populations, digital literacy gaps, and cultural adaptation. Clear regulatory pathways (e.g., recent FDA guidance on adaptive AI), along with interdisciplinary collaboration, will be crucial to ensure safe, scalable adoption. 8 Conclusion Artificial intelligence is rapidly emerging as a powerful tool with the potential to fundamentally transform chronic disease self-management. By enabling personalized interventions, enhancing monitoring and predictive capabilities, and supporting patient engagement through conversational agents and digital platforms, AI provides innovative ways to help individuals manage complex, lifelong conditions. Unlike prior reviews that typically focus on a single technology (e.g., chatbots) or a single disease (e.g., diabetes), this narrative review provides a task-oriented, cross-modal synthesis that integrates diverse AI modalities across multiple chronic conditions. This unique lens explicitly maps AI applications to the core self-management tasks of patients&#8212;personalized decision support, continuous monitoring and prediction, behavioral coaching, and patient&#8211;clinician care coordination&#8212;thereby offering a unifying framework absent from earlier work. In addition, our review incorporates the regulatory dimension, highlighting how evolving FDA guidance and other oversight frameworks critically shape the translation of AI into clinical practice, an aspect often underrepresented in the literature. Current applications, particularly in diabetes and cardiovascular disease, show encouraging results such as improved treatment personalization, early detection of complications, and enhanced adherence. However, most evidence to date arises from feasibility or pilot studies, with validated clinical deployments in large-scale or real-world contexts still limited. Bridging this gap requires rigorous multi-site trials, standardized outcome measures, and long-term effectiveness and cost-effectiveness evaluations. Only by generating robust clinical evidence and addressing challenges such as data privacy, algorithmic bias, and equitable access can AI move from promising prototypes to trustworthy, widely adopted solutions. Ultimately, by situating AI applications within both patient self-management tasks and real-world adoption pathways, this review contributes a novel and pragmatic roadmap for advancing AI toward reliable, patient-centered improvements in chronic disease outcomes. Edited by: Han Feng , Tulane University, United States Reviewed by: Mohammad Atasi , Tulane University, United States Alex El Darzi , Tulane Medical Center, United States Author contributions YD: Methodology, Project administration, Resources, Writing &#8211; original draft, Writing &#8211; review &amp; editing. PY: Conceptualization, Data curation, Formal analysis, Writing &#8211; original draft, Writing &#8211; review &amp; editing. YL: Data curation, Investigation, Methodology, Writing &#8211; review &amp; editing. CD: Data curation, Formal analysis, Software, Visualization, Writing &#8211; review &amp; editing. XL: Data curation, Investigation, Software, Supervision, Writing &#8211; review &amp; editing. Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. Generative AI statement The authors declare that no Gen AI was used in the creation of this manuscript. Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us. Publisher&#8217;s note All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher. References 1. Pathan A . Urgent health challenges for the next decade 2030: World Health Organization . NeuroPharmac J . ( 2020 ): 113 &#8211; 7 . doi: 10.37881/1.512 2. Iovino P Uchmanowicz I Vellone E . Self-care: an effective strategy to manage chronic diseases . Adv Clin Exp Med . ( 2024 ) 33 : 767 &#8211; 71 . doi: 10.17219/acem/191102 , PMID: 39194160 3. Hamine S Gerth-Guyette E Faulx D Green BB Ginsburg AS . Impact of mHealth chronic disease management on treatment adherence an d patient outcomes: a systematic review . J Med Internet Res . ( 2015 ) 17 : e52 . doi: 10.2196/jmir.3951 , PMID: 25803266 PMC4376208 4. Ara'ujo-Soares V Hankonen N Presseau J Rodrigues A Sniehotta FF . Developing behavior change interventions for self-management in chroni c illness: an integrative overview . Eur Psychol . ( 2019 ) 24 : 7 &#8211; 25 . doi: 10.1027/1016-9040/a000330 , PMID: 31496632 PMC6727632 5. Pereira Guerreiro M Strawbridge J Cavaco AM Br'ito F'elix I Marques MM Cadogan C . Development of a European competency framework for health and other pr ofessionals to support behaviour change in persons self-managing chron ic disease . BMC Med Educ . ( 2021 ) 21 : 287 . doi: 10.1186/s12909-021-02720-w , PMID: 34016108 PMC8136137 6. Igwama GT Nwankwo EI Emeihe EV Ajegbile MD . AI-enhanced remote monitoring for chronic disease management in rural areas . Int J Appl Res Soc Sci . ( 2024 ) 6 : 1824 &#8211; 47 . doi: 10.51594/ijarss.v6i8.1428 7. Canaud B Davenport A Leray-Moragues H Morena-Carrere M Cristol JP Kooman J . Digital health support: current status and future development for enha ncing dialysis patient care and empowering patients . Toxins . ( 2024 ) 16 : 211 . doi: 10.3390/toxins16050211 , PMID: 38787063 PMC11125858 8. Muthineni SR . AI in mobile health apps: transforming chronic disease management . Int J Sci Res Computer Sci Eng Inf Technol . ( 2025 ) 11 : 108 &#8211; 16 . doi: 10.32628/CSEIT25111212 9. Klonoff AN Lee W-A Xu NY Nguyen KT DuBord A Kerr D . Six digital health technologies that will transform diabetes . J Diabetes Sci Technol . ( 2021 ) 17 : 239 &#8211; 49 . doi: 10.1177/19322968211043498 , PMID: 34558330 PMC9846384 10. Farai OA Ogundairo O Maduka CP Okongwu CC Babarinde AO Sodamade OT . Digital health technologies in chronic disease management: a global pe rspective . Int J Res Sci Innov . ( 2024 ) X : 533 &#8211; 51 . doi: 10.51244/IJRSI.2023.1012041 11. Subramanian M Wojtusciszyn A Favre L Boughorbel S Shan J Letaief KB . Precision medicine in the era of artificial intelligence: implications in chronic disease management . J Transl Med . ( 2020 ) 18 : 472 . doi: 10.1186/s12967-020-02658-5 , PMID: 33298113 PMC7725219 12. Farrag AN Kamel AM El-Baraky IA . Opportunities and challenges for the application of artificial intelli gence paradigms into the management of endemic viral infections: the e xample of chronic hepatitis C virus . Rev Med Virol . ( 2024 ) 34 . doi: 10.1002/rmv.2514 13. Liu K Li L Ma Y Jiang J Liu Z Ye Z . Machine learning models for blood glucose level prediction in patients with diabetes mellitus: systematic review and network meta-analysis . JMIR Med Inform . ( 2023 ) 11 : e47833 . doi: 10.2196/47833 37983072 PMC10696506 14. Kurdi S Alamer A Wali H Badr AF Pendergrass ML Ahmed N . Proof-of-concept study of using supervised machine learning algorithms to predict self-care and glycemic control in type 1 diabetes patients on insulin pump therapy . Endocr Pract . ( 2023 ) 29 : 448 &#8211; 55 . doi: 10.1016/j.eprac.2023.03.002 , PMID: 36898528 15. Hankosky ER Katz ML Fan L Liu D Chinthammit C Brnabic AJ . Predictors of insulin pump initiation among people with type 2 diabetes from a US claims database using machine learning . Curr Med Res Opin . ( 2023 ) 39 : 843 &#8211; 53 . doi: 10.1080/03007995.2023.2205795 , PMID: 37139823 16. Ali H Niazi IK White D Akhter MN Madanian S . Comparison of machine learning models for predicting interstitial glucose using smart watch and food log . Electronics . ( 2024 ) 13 : 3192 . doi: 10.3390/electronics13163192 17. Jafar A Kobayati A Tsoukas MA Haidar A . Personalized insulin dosing using reinforcement learning for high-fat meals and aerobic exercises in type 1 diabetes: a proof-of-concept trial . Nat Commun . ( 2024 ) 15 : 6585 . doi: 10.1038/s41467-024-50764-5 , PMID: 39097566 PMC11297938 18. Khedekar L. Jain S. Jadhav S. Jagdale S. Jain J. Jain J. ( 2025 ) Optimizing disease prediction using machine learning techniques and personalized nutrition and diet plan 19. Contreras I Vehi J . Artificial intelligence for diabetes management and decision support: literature review . J Med Internet Res . ( 2018 ) 20 : e10775 . doi: 10.2196/10775 , PMID: 29848472 PMC6000484 20. Nomura A Noguchi M Kometani M Furukawa K Yoneda T . Artificial intelligence in current diabetes management and prediction . Curr Diab Rep . ( 2021 ) 21 : 61 . doi: 10.1007/s11892-021-01423-2 , PMID: 34902070 PMC8668843 21. Joachim S Forkan ARM Jayaraman PP Morshed A Wickramasinghe N . A nudge-inspired AI-driven health platform for self-management of diab etes . Sensors . ( 2022 ) 22 : 4620 . doi: 10.3390/s22124620 , PMID: 35746402 PMC9227220 22. Faruqui SHA Alaeddini A Du Y Li S Sharma K Wang J . Nurse-in-the-loop artificial intelligence for precision management of type 2 diabetes in a clinical trial utilizing transfer-learned predict ive digital twin . arXiv . ( 2024 ) 23. Jin X Cai A Xu T Zhang X . Artificial intelligence biosensors for continuous glucose monitoring . Interdiscip Mater . ( 2023 ) 2 : 290 &#8211; 307 . doi: 10.1002/idm2.12069 24. Nimri R Phillip M . Enhancing care in type 1 diabetes with artificial intelligence driven clinical decision support systems . Horm Res Paediatr . ( 2025 ) 98 : 1 &#8211; 22 . doi: 10.1159/000546713 40472820 25. Mistry P . Artificial intelligence in primary care . Br J Gen Pract . ( 2019 ) 69 : 422 &#8211; 3 . doi: 10.3399/bjgp19X705137 , PMID: 31467001 PMC6715470 26. Hinchliffe N Capehorn MS Bewick M Feenie J . The potential role of digital health in obesity care . Adv Ther . ( 2022 ) 39 : 4397 &#8211; 412 . doi: 10.1007/s12325-022-02265-4 , PMID: 35925469 PMC9362065 27. Jiang X Lv G Li M Yuan J Lu ZK . Predicting diabetes self-management education engagement: machine learning algorithms and models . BMJ Open Diabetes Res Care . ( 2025 ) 13 : e004632 . doi: 10.1136/bmjdrc-2024-004632 , PMID: 39965870 PMC11836835 28. Li J Huang J Zheng L Li X . Application of artificial intelligence in diabetes education and manag ement: present status and promising prospect . Front Public Health . ( 2020 ) 8 : 173 . doi: 10.3389/fpubh.2020.00173 , PMID: 32548087 PMC7273319 29. Schneider D Liedtke W Klausen AD Lipprandt M Funer F Bratan T . Indecision on the use of artificial intelligence in healthcare&#8212;a qualitative study of patient perspectives on trust, responsibility and self-determination using AI-CDSS . Digit Health . ( 2025 ) 11 : 20552076251339522 . doi: 10.1177/20552076251339522 , PMID: 40469779 PMC12134509 30. Faruqui S. H. A. Alaeddini A. Du Y. Li S. Sharma K. Wang J. ( 2024 ). Nurse-in-the-loop artificial intelligence for precision management of type 2 diabetes in a clinical trial utilizing transfer-learned predictive digital twin . arXiv preprint arXiv:2401.02661. 31. Molt&#243;-Balado P Revert&#233;-Villarroya S Alonso-Barber&#225;n V Moncl&#250;s-Arasa C Balado-Albiol MT Clua-Queralt J . Machine learning approaches to predict major adverse cardiovascular events in atrial fibrillation . Technologies . ( 2024 ) 12 : 13 . doi: 10.3390/technologies12020013 32. Steinman L Heang H Pelt M Ide N Cui H Rao M . Facilitators and barriers to chronic disease self-management and mobil e health interventions for people living with diabetes and hypertensio n in Cambodia: qualitative study . J Med Internet Res Mhealth Uhealth . ( 2020 ) 8 : e13536 . doi: 10.2196/13536 , PMID: 32329737 PMC7210501 33. Li Y Wu X Liu M Deng K Tullini A Zhang X . Enhanced control of periodontitis by an artificial intelligence-enable d multimodal-sensing toothbrush and targeted &lt;scp&gt;mHealth&lt;/scp&gt; microm essages: a randomized trial . J Clin Periodontol . ( 2024 ) 51 : 1632 &#8211; 43 . doi: 10.1111/jcpe.13987 , PMID: 38631679 PMC11651722 34. Zhuang M Hassan II Ahmad WWMA Abdul Kadir A Liu X Li F . Effectiveness of digital health interventions for chronic obstructive pulmonary disease: systematic review and meta-analysis . J Med Internet Res . ( 2025 ) 27 : e76323 . doi: 10.2196/76323 40418567 PMC12149779 35. Park Y Lee C Jung JY . Digital healthcare for airway diseases from personal environmental exposure . Yonsei Med J . ( 2022 ) 63 : S1 &#8211; S13 . doi: 10.3349/ymj.2022.63.S1 , PMID: 35040601 PMC8790581 36. Wang X Qiao Y Cui Y Ren H Zhao Y Linghu L . An explainable artificial intelligence framework for risk prediction of COPD in smokers . BMC Public Health . ( 2023 ) 23 : 2164 . doi: 10.1186/s12889-023-17011-w , PMID: 37932692 PMC10626705 37. Easton K Potter S Bec R Bennion M Christensen H Grindell C . A virtual agent to support individuals living with physical and mental comorbidities: co-design and acceptability testing . J Med Internet Res . ( 2019 ) 21 : e12996 . doi: 10.2196/12996 , PMID: 31148545 PMC6658240 38. Yang X . Application and prospects of artificial intelligence technology in early screening of chronic obstructive pulmonary disease at primary healthcare institutions in China . Int J Chron Obstruct Pulmon Dis . ( 2024 ) 19 : 1061 &#8211; 7 . doi: 10.2147/COPD.S458935 , PMID: 38765765 PMC11102166 39. Robertson NM Centner CS Siddharthan T . Integrating artificial intelligence in the diagnosis of COPD globally: a way forward . Chronic Obstr Pulm Dis . ( 2023 ) 11 : 114 . 10.15326/jcopdf.2023.0449 PMC10913925 37828644 40. Aminnejad N Greiver M Huang H . Predicting the onset of chronic kidney disease (CKD) for diabetic patients with aggregated longitudinal EMR data . PLoS Digital Health . ( 2025 ) 4 : e0000700 . doi: 10.1371/journal.pdig.0000700 , PMID: 39841679 PMC11753645 41. Cleary F. A. Y. E. ( 2024 ) Challenges of studying and predicting chronic kidney disease progression and its complications using routinely collected electronic healthcare records (doctoral dissertation, London School of Hygiene &amp; tropical medicine) . London . 42. Li Z Liu X Tang Z Jin N Zhang P Eadon MT . Trajvis: a visual clinical decision support system to translate artificial intelligence trajectory models in the precision management of chronic kidney disease . J Am Med Inform Assoc . ( 2024 ) 31 : 2474 &#8211; 85 . doi: 10.1093/jamia/ocae158 , PMID: 38916922 PMC11491615 43. Sawhney R Malik A Sharma S Narayan V . A comparative assessment of artificial intelligence models used for early prediction and evaluation of chronic kidney disease . Decis Anal J . ( 2023 ) 6 : 100169 . doi: 10.1016/j.dajour.2023.100169 44. Barbieri C Cattinelli I Neri L Mari F Ramos R Brancaccio D . Development of an artificial intelligence model to guide the management of blood pressure, fluid volume, and dialysis dose in end-stage kidney disease patients: proof of concept and first clinical assessment . Kidney Dis . ( 2019 ) 5 : 28 &#8211; 33 . doi: 10.1159/000493479 , PMID: 30815462 PMC6388445 45. Alhur A . Redefining healthcare with artificial intelligence (AI): the contributions of ChatGPT, Gemini, and co-pilot . Cureus . ( 2024 ) 16 : e57795 . doi: 10.7759/cureus.57795 38721180 PMC11077095 46. Alanezi F . Assessing the effectiveness of ChatGPT in delivering mental health support: a qualitative study . J Multidiscip Healthc . ( 2024 ) 17 : 461 &#8211; 71 . doi: 10.2147/JMDH.S447368 38314011 PMC10838501 47. Babington-Ashaye A Moerloose P Diop S Geissbuhler A . Design, development and usability of an educational AI chatbot for people with Haemophilia in Senegal . Haemophilia . ( 2023 ) 29 : 1063 &#8211; 73 . doi: 10.1111/hae.14815 37347648 48. Yoon S Lau R Kwan YH Liu H Sahrin R Phang JK . Acceptability of an AI-enabled family module in a mobile app for enhanced diabetes management: patient and family perspectives . Digit Health . ( 2025 ) 11 : 20552076251322654 . doi: 10.1177/20552076251322654 , PMID: 40144049 PMC11938869 49. Sone PE Ebune EJ Odama A . AI-driven behavioral health education to reduce diabetes distress: early clinical evidence informing AI chatbot design . Glob Acad J Med Sci . ( 2024 ) 6 . doi: 10.36348/gajms.2024.v06i06.010 50. Barrett M Boyne J Brandts J Brunner-La Rocca H-P De Maesschalck L De Wit K . Artificial intelligence supported patient self-care in chronic heart f ailure: a paradigm shift from reactive to predictive, preventive and p ersonalised care . EPMA J . ( 2019 ) 10 : 445 &#8211; 64 . doi: 10.1007/s13167-019-00188-9 , PMID: 31832118 PMC6882991 51. Zhang Q Zhang Y Long T Wu Y Zhang Y Li M . Effects of nudge strategy-based dietary education intervention in patients with type 2 diabetes mellitus: a cluster randomized controlled trial . Diabetes Metab . ( 2024 ) 50 : 101563 . doi: 10.1016/j.diabet.2024.101563 , PMID: 38981568 52. Yu J Fu Y Du H Wu Q Zhang S Zhao B . The effectiveness of nudge-based interventions on self-monitoring behaviours among patients with cardiometabolic diseases: a systematic review and meta-analysis . Health Psychol Rev . ( 2025 ): 1 &#8211; 28 . doi: 10.1080/17437199.2025.2532017 40701164 53. Khalifa M Albadawy M . Artificial intelligence for diabetes: enhancing prevention, diagnosis, and effective management . Comput Methods Programs Biomed Update . ( 2024 ) 5 : 100141 . doi: 10.1016/j.cmpbup.2024.100141 54. Sarma AD Devi M . Artificial intelligence in diabetes management: transformative potential, challenges, and opportunities in healthcare . Hormones . ( 2025 ) 24 : 307 &#8211; 22 . doi: 10.1007/s42000-025-00644-4 , PMID: 40116992 55. Goldstein J Weitzman D Lemerond M Jones A . Determinants for scalable adoption of autonomous AI in the detection of diabetic eye disease in diverse practice types: key best practices learned through collection of real-world data . Front Digital Health . ( 2023 ) 5 : 1004130 . doi: 10.3389/fdgth.2023.1004130 , PMID: 37274764 PMC10232822 56. Hwang M Zheng Y Cho Y Jiang Y . AI applications for chronic condition self-management: scoping review . J Med Internet Res . ( 2025 ) 27 : e59632 . doi: 10.2196/59632 , PMID: 40198108 PMC12015343 57. Zhang M Zhu L Lin SY Herr K Chi CL Demir I . Using artificial intelligence to improve pain assessment and pain management: a scoping review . J Am Med Inform Assoc . ( 2023 ) 30 : 570 &#8211; 87 . doi: 10.1093/jamia/ocac231 , PMID: 36458955 PMC9933069 58. Kim M Lee S Kim S Heo JI Lee S Shin YB . Therapeutic potential of social chatbots in alleviating loneliness and social anxiety: quasi-experimental mixed methods study . J Med Internet Res . ( 2025 ) 27 : e65589 . doi: 10.2196/65589 , PMID: 39808786 PMC11775481 59. Seidu S Owusu-Agyeman AK Ibrahim M Kyiu C Ababio-Boamah C . The role of AI in improving the management of chronic diseases in developing countries . Ghana J Nurs Midwifery . ( 2024 ) 1 : 1 &#8211; 15 . doi: 10.69600/gjnmid.2024.v01.i04.1-15 60. Dawood S. Alsarhan R. Albesher A. Alsedais F. Aldakheel A. Alangari S. . ( 2024 ) The co-design process in the creation of conversational agents for people with dementia International Conference on Human-Computer Interaction 347 &#8211; 357 Cham Springer Nature Switzerland 61. Khan F. Wu Y. Dray J. Hemsley B. Kocaballi A. B. ( 2025 ). Conversational agents to support people with communication disability: a co-design study with speech pathologists . In Proceedings of the Extended Abstracts of the CHI Conference on Human Factors in Computing Systems (pp. 1 &#8211; 9 ). 62. Hanif M. I. Sarrafan S. Mohamed M. Elashmawy S. ( 2025 ). The evolution of auscultation: harnessing artificial intelligence (AI) for the future of bedside diagnostics . 63. Venditto L Morano S Piazza M Zaffanello M Tenero L Piacentini G . Artificial intelligence and wheezing in children: where are we now? Front Med . ( 2024 ) 11 : 11 . doi: 10.3389/fmed.2024.1460050 , PMID: 39257890 PMC11385867 64. Perez Vallejos E Dowthwaite L Creswich H Portillo V Koene A Jirotka M . The impact of algorithmic decision-making processes on young people&#8217;s well-being . Health Informatics J . England : Sage Publications Ltd . ( 2021 ) 27 : 1460458220972750 . doi: 10.1177/1460458220972750 , PMID: 33446031 65. A5 Maheshwari K Cywinski JB Papay F Khanna AK Mathur P . Artificial intelligence for perioperative medicine: perioperative intelligence . Anesth Analg . ( 2023 ) 136 : 637 &#8211; 45 . doi: 10.1213/ANE.0000000000005952 35203086 66. Tran K-V Filippaios A Noorishirazi K Ding E . False atrial fibrillation alerts from smartwatches are associated with decreased perceived physical well-being and confidence in chronic sym ptoms management . Cardiol Cardiovasc Med . ( 2023 ) 7 . doi: 10.26502/fccm.92920314 PMC10358285 37476150 67. Hay&#305;ro&#287;lu M&#304; Altay S . The role of artificial intelligence in coronary artery disease and atr ial fibrillation . Balkan Med J . ( 2023 ) 40 : 151 &#8211; 2 . doi: 10.4274/balkanmedj.galenos.2023.06042023 , PMID: 37025078 PMC10175890 68. Bagheri AB Rouzi MD Koohbanani NA Mahoor MH Finco MG Lee M . Potential applications of artificial intelligence and machine learning on diagnosis, treatment, and outcome prediction to address health car e disparities of chronic limb-threatening ischemia . Semin Vasc Surg . ( 2023 ) 36 : 454 &#8211; 9 . doi: 10.1053/j.semvascsurg.2023.06.003 , PMID: 37863620 69. Deniz-Garcia A Fabelo H Rodriguez-Almeida AJ Zamora-Zamorano G Castro-Fernandez M Alberiche Ruano MP . Quality, usability, and effectiveness of mHealth apps and the role of artificial intelligence: current scenario and challenges . J Med Internet Res . ( 2023 ) 25 : e44030 . doi: 10.2196/44030 , PMID: 37140973 PMC10196903 70. Barreveld AM Ros&#233;n Klement ML Cheung S Axelsson U Basem JI Reddy AS . An artificial intelligence-powered, patient-centric digital tool for s elf-management of chronic pain: a prospective, multicenter clinical tr ial . Pain Med . ( 2023 ) 24 : 1100 &#8211; 10 . doi: 10.1093/pm/pnad049 , PMID: 37104747 71. Lo WLA Lei D Li L Huang DF Tong K-F . The perceived benefits of an artificial intelligence&#8211;embedded mobile a pp implementing evidence-based guidelines for the self-management of c hronic neck and back pain: observational study . JMIR Mhealth Uhealth . ( 2018 ) 6 : e198 . doi: 10.2196/mhealth.8127 , PMID: 30478019 PMC6288595 72. Da Rio L Spadaccini M Parigi TL Gabbiadini R Dal Buono A Busacca A . Artificial intelligence and inflammatory bowel disease: where are we g oing? World J Gastroenterol . ( 2023 ) 29 : 508 &#8211; 20 . doi: 10.3748/wjg.v29.i3.508 , PMID: 36688019 PMC9850939 73. Luedke MW Blalock DV Goldstein KM Kosinski AS Sinha SR Drake C . Self-management of epilepsy: a systematic review . Ann Intern Med . ( 2019 ) 171 : 117 &#8211; 26 . doi: 10.7326/M19-0458 , PMID: 31261386 74. Seliverstov PV . Psychology of patient adaptation to the use of artificial intelligence in screening for chronic noncommunicable diseases . Meditsinskiy Sovet . ( 2025 ): 266 &#8211; 72 . doi: 10.21518/ms2024-551 75. Topol EJ . High-performance medicine: the convergence of human and artificial intelligence . Nat Med . ( 2019 ) 25 : 44 &#8211; 56 . doi: 10.1038/s41591-018-0300-7 , PMID: 30617339 76. Rajkomar A Dean J Kohane I . Machine learning in medicine . N Engl J Med . ( 2019 ) 380 : 1347 &#8211; 58 . doi: 10.1056/NEJMra1814259 30943338 77. Parikh RB Obermeyer Z Navathe AS . Regulation of predictive analytics in medicine . Science . ( 2019 ) 363 : 810 &#8211; 2 . doi: 10.1126/science.aaw0029 , PMID: 30792287 PMC6557272 78. Vellido A . The importance of interpretability and visualization in machine learning for applications in medicine and healthcare . Neural Comput Applic . ( 2020 ) 32 : 18069 &#8211; 83 . doi: 10.1007/s00521-019-04051-w 79. Matheny ME Whicher D Thadaney Israni S . Artificial intelligence in health care: a report from the National Academy of medicine . JAMA . ( 2020 ) 323 : 509 &#8211; 10 . doi: 10.1001/jama.2019.21579 , PMID: 31845963 80. He J Baxter SL Xu J Xu J Zhou X Zhang K . The practical implementation of artificial intelligence technologies in medicine . Nat Med . ( 2019 ) 25 : 30 &#8211; 6 . doi: 10.1038/s41591-018-0307-0 , PMID: 30617336 PMC6995276 81. Perez MV Mahaffey KW Hedlin H Rumsfeld JS Garcia A Ferris T . Large-scale assessment of a smartwatch to identify atrial fibrillation . N Engl J Med . ( 2019 ) 381 : 1909 &#8211; 17 . doi: 10.1056/NEJMoa1901183 , PMID: 31722151 PMC8112605 82. Lubitz SA Faranesh AZ Selvaggi C Atlas SJ McManus DD Singer DE . Detection of atrial fibrillation in a large population using wearable devices: the Fitbit heart study . Circulation . ( 2022 ) 146 : 1415 &#8211; 24 . doi: 10.1161/CIRCULATIONAHA.122.060291 , PMID: 36148649 PMC9640290 83. Han D Yu Y Lee IB Wang Z Han D Mohagheghian F . Accuracy, usability, and adherence of smartwatches for atrial fibrillation detection in older adults after stroke: randomized controlled trial . JMIR Cardio . ( 2023 ) 7 : e45137 . doi: 10.2196/45137 38015598 PMC10716742 84. Calkins H Hindricks G Cappato R Kim YH Saad EB Aguinaga L . 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation . Heart Rhythm . ( 2017 ) 14 : e275 &#8211; 444 . doi: 10.1016/j.hrthm.2017.05.012 , PMID: 28506916 PMC6019327 85. Reddy VY Grimaldi M De Potter T Vijgen JM Bulava A Duytschaever MF . Pulmonary vein isolation with very high power, short duration, temperature-controlled lesions: the Q-FFICIENCY study . JACC Clin Electrophysiol . ( 2019 ) 5 : 778 &#8211; 86 . doi: 10.1016/j.jacep.2019.04.002 , PMID: 31320006 86. Ha&#239;ssaguerre M Hocini M Denis A Shah AJ Komatsu Y Yamashita S . Driver domains in persistent atrial fibrillation . Circulation . ( 2014 ) 130 : 530 &#8211; 8 . doi: 10.1161/CIRCULATIONAHA.113.005421 , PMID: 25028391 87. Seitz J Durdez TM Albenque JP Pisapia A Gitenay E Durand C . Artificial intelligence software standardizes electrogram-based ablation outcome for persistent atrial fibrillation . J Cardiovasc Electrophysiol . ( 2022 ) 33 : 2250 &#8211; 60 . doi: 10.1111/jce.15593 35989543 PMC9826214 88. Martin CA Curtin J Gajendragadkar P . Advanced electroanatomic mapping: current and emerging technologies . Arrhythm Electrophysiol Rev . ( 2024 ) 13 : e01 . doi: 10.15420/aer.2023.01 38544812 89. Xiong Z Fedorov VV Fu X Cheng E Macleod R Zhao J . Fully automatic left atrium segmentation from late gadolinium enhanced magnetic resonance imaging using a dual fully convolutional neural network . IEEE Trans Med Imaging . ( 2019 ) 38 : 515 &#8211; 24 . doi: 10.1109/TMI.2018.2866845 , PMID: 30716023 PMC6364320 90. Yang G Chen J Gao Z . Deep learning for cardiovascular magnetic resonance: a review . IEEE Trans Med Imaging . ( 2020 ) 39 : 4060 &#8211; 78 . doi: 10.1109/TMI.2020.3004562 32746147 91. Huang Z Wessler BS Hughes A Bhayani S Arnold JH Ouwerkerk W . Fully automated artificial intelligence assessment of aortic stenosis by echocardiography . JACC Cardiovasc Imaging . ( 2023 ) 16 : 908 &#8211; 19 . doi: 10.1016/j.jcmg.2023.01.006 36958708 92. Khurshid S Kartoun U Ashburner JM . Prediction of incident atrial fibrillation: a comprehensive evaluation of methodologies including artificial intelligence . JAMA Netw Open . ( 2025 ) 8 : e2431853 . doi: 10.1001/jamanetworkopen.2024.31853 93. Christopoulos G Headid RJ 3rd Kuno T . Artificial intelligence-enhanced electrocardiography for early assessment of acute coronary syndromes in the emergency department . J Am Coll Cardiol . ( 2024 ) 83 : 1360 &#8211; 70 . doi: 10.1016/j.jacc.2024.02.025 94. Attia ZI Noseworthy PA Lopez-Jimenez F . An artificial intelligence-enabled electrocardiogram algorithm for the prediction of atrial fibrillation from a sinus rhythm: a retrospective cohort study . Lancet Digit Health . ( 2019 ) 1 : e273 &#8211; 81 . doi: 10.1016/S2589-7500(19)30076-6 95. Taghji P El Haddad M Phlips T . Artificial intelligence for individualized treatment of persistent atrial fibrillation: the TAILORED-AF randomized clinical trial . Nat Med . ( 2025 ) 31 : 1078 &#8211; 86 . doi: 10.1038/s41591-025-02877-0 PMC12003177 39953289 96. Hu JR Power JR Zannad F Lam CS . Artificial intelligence and digital tools for design and execution of cardiovascular clinical trials . Eur Heart J . ( 2025 ) 46 : 814 &#8211; 26 . doi: 10.1093/eurheartj/ehae794 39626166 97. Khan AH Zainab H Khan R Hussain HK . Implications of AI on cardiovascular patients &#8216;routine monitoring and telemedicine . BULLET . ( 2024 ) 3 : 621 &#8211; 37 . 98. Reddy S . Global harmonization of artificial intelligence-enabled software as a medical device regulation: addressing challenges and unifying standards . Mayo Clin Proc . ( 2025 ) 3 . doi: 10.1016/j.mcpdig.2024.100191 PMC11975980 40207007 99. Rahi S Lather V Rana A Pandit J . Comprehensive framework for the global regulation and approval of AI-integrated medical devices . Appl Drug Res Clin Trials Regul Affairs . ( 2025 ) 11 : E26673371347630 . doi: 10.2174/0126673371347630250418134235 , PMID: 41111475 100. Lee TT Kesselheim AS . Us food and drug administration precertification pilot program for digital health software: weighing the benefits and risks . Ann Intern Med . ( 2018 ) 168 : 730 &#8211; 2 . doi: 10.7326/M17-2715 29632953 101. Mittal S Movsowitz C Steinberg JS . Ambulatory external electrocardiographic monitoring: focus on atrial fibrillation . J Am Coll Cardiol . ( 2011 ) 58 : 1741 &#8211; 9 . doi: 10.1016/j.jacc.2011.07.026 21996384 102. Kurniawan MH Handiyani H Nuraini T Hariyati RTS Sutrisno S . A systematic review of artificial intelligence-powered (AI-powered) chatbot intervention for managing chronic illness . Ann Med . ( 2024 ) 56 : 2302980 . doi: 10.1080/07853890.2024.2302980 , PMID: 38466897 PMC10930147 103. Feng G Weng F Lu W Xu L Zhu W Tan M . Artificial intelligence in chronic disease Management for Aging Populations: a systematic review of machine learning and NLP applications . Int J Gen Med . ( 2025 ) 18 : 3105 &#8211; 15 . doi: 10.2147/IJGM.S516247 , PMID: 40529344 PMC12170813 104. Pan M Li R Wei J Peng H Hu Z Xiong Y . Application of artificial intelligence in the health management of chronic disease: bibliometric analysis . Front Med . ( 2025 ) 11 : 1506641 . doi: 10.3389/fmed.2024.1506641 , PMID: 39839623 PMC11747633 105. Marcuzzi A Nordstoga AL Bach K Aasdahl L Nilsen TIL Bardal EM . Effect of an artificial intelligence&#8211;based self-management app on musculoskeletal health in patients with neck and/or low back pain referred to specialist care: a randomized clinical trial . JAMA Netw Open . ( 2023 ) 6 : e2320400-e2320400 . doi: 10.1001/jamanetworkopen.2023.20400 , PMID: 37368401 PMC10300712 106. Wang B Asan O Zhang Y . Shaping the future of chronic disease management: insights into patient needs for AI-based homecare systems . Int J Med Inform . ( 2024 ) 181 : 105301 . doi: 10.1016/j.ijmedinf.2023.105301 , PMID: 38029700 107. Yu G Tabatabaei M Mezei J Zhong Q Chen S Li Z . Improving chronic disease management for children with knowledge graphs and artificial intelligence . Expert Syst Appl . ( 2022 ) 201 : 117026 . doi: 10.1016/j.eswa.2022.117026 108. Stubberud A Langseth H Nachev P Matharu MS Tronvik E . Artificial intelligence and headache . Cephalalgia . ( 2024 ) 44 . doi: 10.1177/03331024241268290 , PMID: 39099427"
}